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Worldwide the swine industries are under pressure to reduce the use of antibiotics while 
maintaining animal health and performance. The control and prevention of infectious diseases in of 
basic economic importance although the occurrence of production disease has relevance not only to 
economic production, but also to animal welfare. The introduction of antibiotics to treat bacterial 
infections almost 50 years ago led to an improvement in animal production but the use of antibiotics 
feed additives in food production animals was linked to emergence in the food chain of multiple 
drug-resistance bacteria. The emergence of antibiotics resistant strains presumably demonstrated 
that treatment of bacterial infections can not rely on the use of antibiotics without critical 
considerations. In 2006 all the  AGP (antibiotic growth promoters) and some feed additives with 
growth promoting activities (Cu, Zn) have been limited. Since the first restrictive measures were 
taken, and due to the beginning of the negative consequences of the ban, numerous efforts have 
been done to find alternatives or replacement strategies to maintain pig growth performance and 
controlling enteric bacterial diseases. The need of more economic and safety substances as replacers 
of AGP for livestock animals as probiotics, prebiotics and feed additives of natural origin, focused 
the attention of the research of the last years. Several studies reported the effects of probiotics, 
prebiotics, organic acids, bioactive milk molecules and plant extracts on pig gut and general health 
status. From literature they showed promising results, although still not comparable of AGP. In 
some cases they were supplemented as single additive, while more recently additives of different 
nature were pooled with the aim to evaluate possible additive or combined effects. Most of these 
compounds are thought to act by modulating the microbiota equilibrium, the mucosa intestinal 
morphometry and gut associate lymphoid tissue (GALT), while others might be active in the 
improvement of pig health and performance by other different mechanisms. In order to asses, the 
primary mode of action, metabolic pathways and optimal dosage of the additives more research will 
be needed. Therefore, the aims of the following trials were to study the effects of prebiotics, natural 
substances and bioactive milk peptides on health and performance of post-weaned piglets.   
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1.1   General Introduction 
 
1.1.1 Development of gut immune system 
 
Weaning is a crucial phase in pig production. Piglet’s immune system that is inexperienced and 
immature moreover it is continuously challenged by lot of pathogens. The immune system gathers 
experience as it is continuously faced with a myriad of antigens. Quantitatively, as well as 
qualitatively, the most important site of this interaction is the intestine. Encounter alone does not 
guarantee maturation, however, the intestinal immune system develops in intimate connection with 
the indigenous microbiota of the gut and has distinct features, the most prominent of which being 
the ability to launch suppressive, tolerogenic responses essential to maintaining a disease free state 
in the gut as well as systemically. Aberrant immune responsiveness with an imbalance in the 
composition of microbiota in the gut is characteristic to the pathogenesis of many inflammatory 
conditions. The development of atopic diseases in particular appears to be associated with defective 
tolerogenic responsiveness in the gut and alterations in the gut microbiota. The rise in incidence of 
atopic diseases in the industrialised pig during the last decades, attributed to changes of farm 
strategies (as the anticipated weaning at 21 days) in feeding and hygiene, may thus be partly 
explained by altered gut microecology. Piglets are nowadays weaned around three/four weeks of 
age because this procedure is commercially advantageous, but thus they often suffer altered 
gastrointestinal conditions, in part because of the sudden alteration in the intestinal microflora 
consequent to the rough passage from mother’s milk to a solid food. This in addition may cause a 
strong reduction in the length of intestinal villi height and the depth of the intestinal crypts, which 
consequently reduces the gut digestive as well as absorptive capacities (Pluske et al., 1997; Van 
Beers-Schreurs et al., 1998). This in turn may cause negative effects on average daily gain (ADG), 
as well as on defensive responses against infectious diseases. Actually, recent scientific evidence 
suggests that weaning piglets at three to four weeks of age may overwhelmingly challenge a 
substantially immature immune system, conducting it to a possible paralysis condition and creating 
an ideal environment for diseases to develop (Ladekjær-Mikkelsen et al., 2002). In this fragile 
equilibrium the development of diseases has a great economical impact in pig production.  
One critical change associated with weaning is the shift from sow’s milk to a dry feed, which 
induces a period of fasting during the first few days following weaning. This weaning anorexia has 
a negative impact on growth and leads to mobilization of fat stores, as shown by the sharp increase 
of circulating free fatty acids levels (Barke et al., 1996). It may also be involved in the digestive 
problems that are frequently encountered after weaning (McCracken et al., 1999). Experimental 
data indicates that this period of under nutrition markedly alters the functioning of several 
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neuroendocrine system during the post-weaning period. For instance, the changed measured in the 
somatotrophic axis (increased GH and reduction IGF levels) and in the autonomic nervous system 
(reduced cathecolamine excretion in urine) are similar to those measured in fasting animals (Carroll 
et al., 1998, Hay et al., 2001). These changes may be long lasting, as in the case of weaning at 6 
days of age for instance (Hay et al., 2001). Some of the metabolic response to weaning can be 
corrected by milk feeding, which improves the growth rate of the animals as compared to dry feed 
(McCracken et al.,1995, Kim et al., 2001). Indeed, piglets weaned at 2-3 days of age and 
subsequently fed with a milk replacer display greater growth rates by day 7-8 of lactation than 
piglets raised by their dam, showing that sow milk yield is a limiting factor to piglet growth (Harrel 
et al., 1993). The increase factor of voluntary food intake after weaning by using whole cow’s milk 
(due to it’s palatability) also improves the mucosa architecture of the small intestine (Pluske et al., 
1996). However in commercial settings, weaning piglets are usually offered dry food, for 
economical reasons. Such a food is not accepted as well as a liquid milk replacer, and weaning 
alters average daily feed intake and average daily weight gain, the magnitude of which is larger 
with earlier weaning age (2, 3 and 4 weeks) resulted in reduced weight gain depression. All the 
animals nevertheless reached similar body weight at 6 weeks of age (Leibbrandt et al., 1975). There 
is no doubt that weaning is a period of intense stress for piglets, with profound consequences on 
growth, physiology and disease outbursts, which reveal severe welfare problems. Experimental data 
clearly show that the anorexia or, at least, the nutritional deficit due to the abrupt transition between 
milk and solid food, induces severe taxation of the adaptive mechanisms of piglets and may be of 
special relevance from a welfare point of view. Most of the problem comes from the fact that during 
lactation spontaneous intake of dry food remains very low up to 3 weeks of age and does not 
become significant until the 4th week, indicating that the appetite for dry food is very low in 
younger animals. The large individual variation suggests that this trait may be influenced by genetic 
factors and could therefore respond to genetic selection. It would be valuable to gain more 
information on the physiological changes induced by weaning at different ages. Maintanance of gut 
health in the pig is probably the last emerging problem when the other pathologies are under 
control. Infact gut health degradation is most often observed during the post-weaning period and 
may in turn affect further general health through enhancement of bacterial translocation and 
disturbances in the maturation of the immune system including immuno-tolerance. 
One approach to improve the gut health of the piglets is the dietary manipulation. Dietary 
manipulation of the gut environment by the use of feed additives, or by choice of dietary raw 
materials that may influence the luminal environment throughout the entire length of the intestinal 
tact and thereby improving “gut health”( Knud E. et al.). As discussed by Montagne et al. (2003), 
the concept of gut health is complex and, at present, it is an ill-defined notion. Conway (1994) 
proposed that there are three mayor components of gut health, namely the diet, the mucosa and the 
commensal flora. The mucosa is composed of the digestive epithelium, the gut-associated lympoid 
tissue (GALT) and the mucus overlying the epithelium. The GALT, commensal bacteria, mucus 
and host epithelial cells interact with each other forming a fragile and dynamic equilibrium within 
the alimentary tract that ensures efficient functioning and absorption capacity of the digestive 
system. The feed should be selected to favour conditions in the gut that create and stabilise this 
balance between the host, the microflora and environment, and to prevent disturbance of the 
structure and function of the gut. In this respect, the relative gut health value of a dietary component 
or diets should rest with their capacity either to stabilise or to perturb this equilibrium. 
 
1.1.2 Gut barrier and colonization resistance establishment  
 
The indigenous microbiota suppresses colonization of incoming bacteria by a process named 
colonization resistance that is a first line of defense against invasions by exogenous bacteria, 
potential pathogenic organisms or indigenous opportunists (Van der Waaij et al., 1989; Hooper et 
al.,1998). This process involves several different complex interacting 
 
 
 
  
Fig. 1 Schematic representation of the different elements in the gut ecosystem making yp the concept of gut 
health. Modified from Conway (1994) as discussed by Montagne et al. 2003. 
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mechanisms of both the bacteria and the hosts. The host factors involved in colonization resistance 
are different: the peristaltic movement; the secretion of diverse digestive enzymes and electrolytes; 
the mucus secretion; the epithelial cell desquamation; the gut associated lymphoid tissue; and 
secretory IgA (Stewart et al., 1993). Besides, indigenous microbiota prevents bacterial colonization 
by competing for epithelium receptors (Blomberg et al., 1993; Bernet et al., 1994) and enteric 
nutrients (Stewart et al., 1999) producing antimicrobial compounds such as bacteriocines (Brook, 
1999) and metabolizing nutrients to create a restrictive environment which is generally unfavorable 
for the growth of many enteric pathogens (Lievin et al., 2000). Moreover, bacterial recognition and 
adhesion to receptors is not only a prerequisite for colonization, which determines microbiota 
composition and  permanent colonization, especially in the upper gastrointestinal tract (Alandet et 
al., 1999). It also determines antagonistic activity against enteropathogens (Coconnier et al., 1993), 
modulation of the immune system and also the improvement of healing in the damaged gastric 
mucosa (Elliot et al., 1998). Several factors are involved in the control of bacterial attachment and 
thus in the modulation of the indigenous microbiota profile (Freitas et al., 2002). Special interest is 
nowadays focused on genetic modulation of receptors by the host and the bacteria. Bacterial-
mucose attachment appears consequently as a key point defining indigenous microbiota 
composition and different bacterial-mediated functions. Two main components are essential to the 
recognition between the host and the bacteria: the glucoconjugates on the gut enterocytes and 
bacterial adhesions metabolize cholesterol to coprostanol (Baron and Hylemon, 1997).      
  
1.1.3 Development of immune system 
 
Pigs have evolved many immunological characteristics in response to the environmental and 
infectious selection pressures they continually face. Pigs are omnivores and their enteric system 
must logically be adapted to respond to the range of intestinal pathogens, and therefore defence 
mechanisms have developed to protect the host and maintain intestinal health. Nevertheless the 
piglet is immunodeficient during the early phase of his life and is highly dependent upon a supply 
of both specific and non specific immune factors present in maternal colostrums and milk for 
immune protection, development and survival (Varley et al., 1987). Therefore, development of 
immunocompetence is an absolute requirement for optimum growth and performance (Stokes et al., 
2004). Bailey et al. (2001) surmised that immunological development in the neonatal pig occurs as 
a balance between regulatory function and effector functions, and that GIT integrity depends on the 
maintenance of this balance. The immune system in the young pig comprises several organs (bone 
marrow, thymus, spleen, mesenteric lymphonodes) and several cell types (lymphocites-specific 
immune recognition of foreign antigen, phagocytes – production of innate immunity) that recognize 
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foreign antigens. The immune defence system has two “arms” the innate or the acquired. The innate 
immune system is thought to have evolved before the adaptive immune system, and hence has 
evolved also as the first line of defence against a pathogenic/antigenic challenge.  
Development of the immune system in early weaned piglet and the atopic type of immune 
responsiveness T helper cells have paradigmatically been labelled either T helper (Th)1 or Th2 cells 
depending on the cytokines they produce (Mosmann et al., 1986; Del Prete et al., 1991). Th1 cells 
produce predominantly interferon γ (IFN- γ) and play a central role in immune defence against 
intracellular pathogens. In contrast, Th2 cells produce cytokines such as interleukin (IL-4-5-13) 
implicated in responses to helminthic infections. Both Th1- and Th2-type responses have been 
recognised in the pathogenesis of human disease as well (Romagnani, 1996). It is well established 
that there is a counter-regulatory balance between Th1 and Th2 responses, but recently distinct 
mechanisms effecting both Th1 and Th2 cells have been discovered. Suppressive cytokines, such as 
transforming growth factor ß (TGF-ß) and IL-10, secreted by gut-derived regulatory T cells named 
Th3 and Tr1 cells, respectively, provide important suppressive balance and protection from disease 
(Nagler and Anderson, 2000). Notwithstanding the ample evidence indicating the involvement of 
Th2-skewed immune responsiveness in fully established atopic disease, the events leading to the 
establishment of such pathological skewness early in life remain less well understood. It is of note 
that due to the immunological balance prevailing in utero the immune responses early in life are 
physiologically predominantly of the Th2-type (Piccinni et al., 1998). Recently, it has been 
observed that neonatal CD8 T cells produce large amounts of IL-13 which may account for the Th2 
bias in the newborn (Ribeiro-do-Couto et al., 2001). Interestingly, however, a previous study 
indicated that infants who later develop atopic disease exhibit impaired IL-13 production at birth 
(Williams et al., 2000). The same phenomenon has been demonstrated with regard to IL-4 as well, 
as neonatal IL-4 responses were lower in infants who developed atopic disease as compared to 
those who remained healthy (Prescott et al., 1999). Consequently, a significant overlap in the 
concentrations of Th2 cytokines, such as IL-4, and IgE antibodies prevails between atopics and non-
atopics at an early age (Kulig et al., 1999; Prescott et al., 1999). Thus the concentration of IgE 
antibodies in cord blood, thought to reflect sensitisation in utero, predicts poorly the development of 
atopic disease (Bergmann et al., 1997). An age-dependent decline in Th2 responses during the early 
postnatal period in non-atopic children and a converse pattern in atopic children has been observed, 
suggesting that infants who develop atopic disease may exhibit defective suppression of Th2-type 
responsiveness (Prescott et al., 1999). Recent observations have lead to the conclusion that such 
suppressive mechanisms at least in part originate in the gut as a result of stimulation by dietary and 
microbial antigens. Whilst there is a strong hereditary component in the development of atopic 
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disease, the rapid increase in morbidity can only be explained by environmental factors (Bergmann 
et al., 1997). The hygiene hypothesis of allergy, first introduced by Strachan, suggests a causal 
relationship between reduced exposure to microbes at an early age and the increase in the 
prevalence of atopic disease (Strachan et al., 1989). There is epidemiological evidence indicating 
that infectious diseases early in life may protect the individual from atopy. However, as it has 
recently been pointed out, the most important source of tolerogenic stimuli may be the indigenous 
microbiota of the intestine (Monteleone et al., 2001). The immunomodulatory events produced by 
the interaction between the intestinal immune system and microbiota as well as the induction and 
maintenance of oral tolerance is complex and surpass the Th1/Th2 paradigm. The intestinal immune 
system must be able to discriminate between potentially pathogenic microbial antigens and the non-
pathogenic dietary and indigenous microbial antigens in order to avoid both invasive infections and 
chronic inflammatory conditions. The unresponsiveness to dietary proteins and indigenous 
microbiota, known as oral tolerance, is the result of several distinct processes. Furthermore, there is 
growing evidence suggesting that resident microbiota provide the intestinal immune system with 
endogenous stimuli which are essential for its normal maturation and function (Toms et al., 2001). 
There are somewhat contradictory data on the type of immune responsiveness preferentially elicited 
by the intestinal immune system although it is apparent that T lymphocytes are the main effector 
cells in responses to luminal antigens. Results obtained from animal models suggest that mucosal T 
cell responses are favourably of the Th2 type (Xu-Amano et al., 1992). This Th2-bias is thought to 
originate in utero and as a result, transient sensitisation to dietary antigens is common at an early 
age. On the other hand, however, Th2-type responsiveness, such as IgE antibody production seems 
to be most readily susceptible to suppression (Nagler-Anderson, 2000). Furthermore, dietary 
antigens appear to induce Th1-type responsiveness in the human intestine, which may down-
regulate Th2-type responsiveness (MacDonald et al., 2001). Oral tolerance has traditionally been 
defined as the induction of peripheral unresponsiveness as the result of oral administration of 
soluble protein antigens (Nagler- Anderson, 2000). It is well documented that there are distinct 
mechanisms, including clonal deletion, clonal anergy and active suppression, by which tolerance, 
defined recently not only as unresponsiveness but more broadly as any mechanism by which a 
potentially injurious immune response is prevented, suppressed, or shifted to a noninjurious class of 
immune response, is induced and maintained in the intestinal mucosa (Weiner, 2001). The relative 
contributions of these mechanisms appears to be dependent on the dose of the antigen: High doses 
of oral antigen result in clonal anergy/deletion, a phenomenon often explained by small amounts of 
antigen bypassing the intestinal immune system, gaining access to circulation and thus inducing 
anergy due to the lack of sufficient costimulatory signalling (Weiner, 2001). Oral administration of 
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antigen leads to the generation of a unique subset of T cells named Th3 cells in both animal models 
and humans (Chen et al., 1996; Fukaura et al., 1996). Th3 cells produce predominantly TGF-ß and 
are thought to be pivotal in the active suppression leading to oral tolerance after low doses of oral 
antigen. After the priming of Th3 cells has taken place in the Peyer’s patches, the gut-originating 
cells migrate to the periphery and are capable of suppressing inflammatory responses upon 
reactivation thus mediating tolerance in sites other than the gut as well (Weiner, 2001). In addition 
to down-regulating both Th1- and Th2 type responses, TGF-ß elicits immunomodulatory effects on 
antigen-presenting cells (Takeuchi et al., 1998). Furthermore, TGF-ß may favour the development 
of IL-10-secreting regulatory Tr1 cells (Toms et al., 2001), another subset of suppressive T cells 
characteristic of the intestinal immune system. IL-10 has a central role in maintaining intestinal 
homeostasis, especially by suppressing inflammatory responses towards intestinal microbial agents. 
There is an intimate interplay between different subsets of T cells and antigen-presenting cells, such 
as dendritic cells, in the intestine. In murine models, high basal levels of IL-4, IL-10 and TGF-ß 
expression have been detected in the intestinal mucosa and this cytokine milieu may be crucial for 
the induction of Th2 and Th3 type responsiveness (Weiner, 2001). However, as it has recently been 
pointed out there may be major differences between species in mucosal immune responses. In fact, 
there are data on record indicating a Th1-skewed cytokine profile as a constant finding in the 
intestine of humans (MacDonald, 2001; Nagata et al., 2000). A transient induction of IFN-γ 
producing Th1 cells has been detected in the early phases of oral tolerance formation (Mowat et al., 
1999). Even though both Th1 and Th2 cytokines regulate the function of Th3 cells, neither are 
essential for the induction of peripheral tolerance in a murine model (Garside et al., 1995; Mowat et 
al., 1999; Shi et al., 1999). The individual role of each functional subset of T cells in the inductive 
phase of oral tolerance thus remains to be elucidated, but it is evident that Th3 cells provide 
tolerogenic suppression both in the intestine and in other target organs.  
 
1.1.4 Modulation of intestinal equilibrium through the feed 
 
Weaning is characterized by significant nutritional, social and environmental changes that can 
impose a significant penalty on subsequent growth and production. A marked feature of weaning is 
the transient decrease in macronutrient and micronutrient intake that occurs as piglets are switched 
abruptly from a mostly all milk diet to a solid diet. Despite to the studies conducted in the past years 
concerning nutrition and weaning under commercial farm conditions, there appears to have been 
very little research directed specifically towards immune system (Pluske J.R., 2007). There are 
surprisingly few studies examining the roles specifically of feed additives/feed ingredients on the 
immune system GIT in young pigs, although an increasing number of studies deriving 
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predominantly from Europe have occurred more recently in view of the ban on antibiotic feed 
additives in diets. The use of nutraceuticals or functional foods plays an interesting role in the 
intestinal equilibrium of the early weaned piglet. Functional foods have been defined as food with 
ingredients (either naturally occurring or added) that provide a health benefit beyond the traditional 
nutrient value of the food. The following sections discuss several feed additives and functional 
foods with an important role on the GIT immune function.  
 
1.1.5 Functional properties of milk and its Physiological Characteristics 
 
The discovered of functional molecules in food with extra-nutritional activities opened the way to a 
nutrition not just only with the aim of to meet the nutritional needs, but also to improve the health 
of humans and animals. Bioactive substances in functional foods able to improve the health of the 
animals are defined as nutraceutical. For its physiological significance in primis milk can be 
considered "functional food" for its essential components for the growth during the neonatal period 
and for its richness in bioactive molecules with immunological, anti-infective actions due to protect 
the health of the newborn. Among the native components of milk, of particular importance and 
interest are attributable to some lipid and protein fraction. The importance of these compounds is 
due not only for their content but also for their bioavailability and bioaccessibility often positively 
affected by their inclusion in a milk matrix (Baldi and Pinotti, 2008). In the evaluation of the 
functional activity of milk it is important remember the protective activity towards the 
oligosaccharide component against intestinal infectious diseases. The protective role of the 
bioactive components of milk has an action on intestinal ecosystem, developing newborn immune 
system, reducing the  risk of developing  of health problems improving performance. These 
components may have a potential use as nutraceuticals to improve health, both in relation to their 
presence in food or as food additives. In this field, knowledge is more developed with regard to 
human or bovine milk, while less known or are missing data on the sow's milk and other species. 
The importance of milk in the nutrition of all mammals has been recognized from time immemorial. 
The biosynthetic capacity of the mammary gland, both in terms of the number of substances 
synthesized and the magnitude of the total synthetic ability is remarkable. Mammary gland 
synthesizes a number of proteins that have unique aminoacids composition and highly desirable 
physicochemical properties. Caseins and whey proteins are the two main protein groups in milk. 
Caseins designate the predominant group of proteins and they are characterized by ester-bound 
phosphate, high proline content, few or no cysteine residues and low solubility at pH 4.0–5.0. 
Cow’s milk contains 4 individual caseins: as1-casein, comprising of 199 amino acids (aa), b-casein 
(209 aa), k-casein (169 aa) and as2-casein (207 aa). The major whey proteins in milk include b-
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lactoglobulin, a-lactalbumin, immunoglobulins and bovine serum albumin (Ng Kwai Hang, 2003). 
In addition to the major milk proteins, milk contains a wide group of biologically active proteins, 
involved in development and healthfulness of the neonate. Among these bioactive components the 
80 KDa iron-binding glycoprotein lactoferrin is recognized as one of the most versatile. Its role was 
originally considered to be essentially antimicrobial, but several findings have demonstrated that the 
protein has nutritional and physiological significance (Lo¨nnerdal & Iyer, 1995). Milk proteins can 
be subjected to inadvertent proteolysis during storage before or after milking. Proteolysis in the 
mammary gland can be attributed to native proteases, such as the plasmin/plasminogen system 
(Baldi et al. 1996; Fantuz et al. 2001; Politis, 2007). Proteins can be subjected to deliberate 
proteolysis such as the proteolysis occurring during manufacture of fermented dairy products 
(yoghurt) and cheese manufacture and/or ripening. Lastly, proteins are subjected to hydrolytic 
breakdown during gastric processing and later upon exposure of the proteins with indigenous or 
intestinal bacteria-derived enzymes in the gut. Proteolytic breakdown of milk proteins generates a 
number of peptides endowed with various biological properties (antimicrobial, antihypertensive, 
antithrombotic) including those that have the ability to modulate immune function (Hill et al. 2000). 
Immunomodulatory peptides are inactive within the sequence of the parent protein and they can be 
released by enzymatic proteolysis. One good example is the proteolysis occurring by the action of 
proteinases and peptidases from lactic acid bacteria (LAB). LAB utilize milk proteins, mainly 
caseins, as their prime source of essential aminoacids. The proteolytic machinery of LAB includes a 
cell wall bound proteinase and several intracellular peptidases. The transport system of LAB 
enables them to internalize oligopeptides up to 18 aa in length. Longer oligopeptides can become a 
major source of bioactive peptides in fermented milk when further degraded by gastrointestinal 
enzymes or by intracellular peptidases of lysed LAB after consumption of these products (Law & 
Haandrikman,1997). 
  
1.1.5.1 Immunomodulatory Milk peptides 
 
Suppression or Induction Milk proteins represent the exclusive protein supply for the newborn; all 
human and animals neonates depend upon milk proteins until they enter the fifth month of their life 
(Table 1). Evidence will be presented regarding the ability of milk peptides to regulate 
gastrointestinal immune function leading us to hypothesize that these peptides may guide the local 
immune system until it develops its full functionality. The first few weeks is a very critical period in 
life because the immune system should develop oral tolerance to nutrient molecules and avoid 
tolerance to pathogen-derived antigens. The term immunomodulation was purposely adopted to 
indicate that suppression of the immune system may be required in certain instances (oral tolerance) 
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or induction towards pathogen-derived antigens. The latter is very important in order to avoid the 
well recognized susceptibility of newborns to infection (Hill, 1987).  
 
Table 1 Biological function of the principle bioactive milk component (adapted from Séverin e 
Wenshui, 2005).  
 
Protein Function 
Caseine (α-, β-, κ-caseine) Ionic Carrier (Ca, PO4, Fe, Zn, Cu), precursors of bioactive 
peptides 
Serum proteins  
β-Lattoglobuline Carrier del retinolo, legante acidi grassi, possibile antiossidante 
α-Lattalbumine Lactose synthesis in mamary gland, Ca carrier, immunomodulator, 
anticarcinogenic 
Immunoglobuline (A, M & G) Immunoprotection 
Lactoferrine Antimicrobial, antioxidant, immunomodulator, iron absorption, 
anticarcinogenic 
Lactoperossidase Antimicrobial 
Lysozyme Antimicrobial, synergic action with immunogglobuline and 
lactoferrine 
Glicomacropeptide Antivirus, biphydogenic 
 
 
1.1.5.2 Milk peptides – Suppression of immune  response      
 
The mucosal immune system of infants is stimulated daily by the continuous passage of milk 
proteins. Breakdown of proteins in the gut and activation of suppressor T-cells lead to a systemic 
hypo-responsiveness to ingested protein antigens, a phenomenon known as ‘oral tolerance’. Pecquet 
et al. (2000) reported that peptides obtained from tryptic hydrolysis of bovine b-lg down regulate 
various immune functions and induce specific oral tolerance in mice. Mice fed with either b-lg 
hydrolyzates or fractions of the hydrolyzate were tolerized against b-lg. Specific serum and 
intestinal IgE levels were reduced. Delayedtype hypersensitivity and proliferative responses were 
inhibited. In a more recent study, Prioult et al. (2004) examined the possibility that the 
microorganism Lactobacillus paracasei induces oral tolerance by generating a number of 
immunomodulatory peptides from the hydrolysis of b-lg. They showed that Lb. paracasei peptidases 
were capable of further hydrolyzing, tryptic-chymotryptic peptides of b-lg. Furthermore, they 
reported that these peptides repressed lymphocyte proliferation and up regulated interleukin-10 (IL-
10) production. Based on these results, they concluded that Lb. paracasei induces oral tolerance to 
b-lg in vivo by degrading its acidic peptides  and releasing immunomodulatory peptides capable of 
stimulating regulatory T-cells, which function as major immunosuppresants by secreting IL-10. 
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Hydrolysis of casein with pepsin and trypsin or additionally with enzymes derived from Lb. casei 
strain GG generates molecules capable of inhibiting lymphocyte proliferation (Sutas et al. 1996b). 
Thus, indigenous enzymes in the gut together with enzymes of bacteria origin have been proven 
beneficial in the down regulation of hypersensitivity reactions to ingested proteins in human 
neonates. Pessi et al. (2001) investigated the effect of digests of bovine casein by enzymes derived 
from Lb. rhamnosus GG on T-cell activation. They found that the digests reduced expression of IL-
2 and inhibited protein kinase C translocation. Both effects indicate suppression of T-cell activation 
by casein digests. Peptides obtained from the hydrolysis of casein by trypsin induce oral tolerance 
in mice (Hachimura et al. 1993). A synthetic peptide corresponding to residues 142–149 of as1-
casein was proven to be an effective inducer of CD8(+) T-cells which recognize the parent peptide 
and secrete interferon-gamma (IFNc) , a potent inhibitor of Th-2 dependent events, including IgE 
production (Totsuka et al. 1998). Otani & Hata (1995) reported that intact bovine k-casein inhibited 
proliferative responses of mouse spleen lymphocytes and rabbit Peyer’s patch cells to various 
mitogens. Pancreatin and trypsin digests of k-casein, as1-casein and b-casein inhibited cell 
proliferation in response to mitogens. Based on these results, they suggested that peptides obtained 
from various caseins by the action of trypsin may suppress immune response of neonates. In further 
support of this notion, Kayser & Meisel (1996) reported that pepsin and trypsin digests of bovine 
as1-casein and b-casein inhibited mitogen-induced proliferation of peripheral blood mononuclear 
cells. The k-caseinoglycopeptide corresponding to residues 106–169 of bovine k-casein is a potent 
inhibitor of phytohaemagglutinin-induced and lipopolysaccharide-induced proliferation of murine 
splenic lymphocytes and rabbit Peyer’s patch cells and well as antibody production in various 
spleen cell cultures (Otani et al. 1995). They suggested that the k-caseinoglycopeptide down 
regulates immune response by acting on both T- and B-lymphocytes. Furthermore, they showed that 
the inhibitory effect was abolished after neuraminidase treatment which indicates that both the 
peptide and the carbohydrate parts of the molecule are necessary for the inhibitory effect. Elitsur & 
Luk (1991) investigated the effect of b-casomorphins (fragments of b-casein, residues 60–70) on 
immune function. They reported that casomorphins inhibited proliferation of human lamina propria-
derived lymphocytes in vitro. However, these results should be interpreted with caution because 
casomorphins appear to stimulate resistance of mice to infection (Klebsiella pneumoniae), thus, 
having the opposite effect in vivo. Despite the fact that casomorphins are rapidly degraded once 
they enter the blood stream, casomorphins were found in the plasma of new born calves after their 
first milk intake (Umbach et al. 1985). Thus, the neonatal intestine appears to be permeable to pre-
casomorphins (Clare & Swaisgood, 2000). Recent data obtained at the Agricultural University of 
Athens indicate that the effect of casein digests on immune parameters may depend upon the 
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maturity of the immune system. We have examined the effect of two synthetic peptides on 
membrane-bound urokinase plasminogen activator (uPA) and expression of major 
histocompatability complex (MHC) class II antigens by porcine blood neutrophils. The two 
peptides utilized were the tripeptide LLY which corresponds to residues 191–193 of bovine b-
casein and the hexapeptide PGPIPN which corresponds to residues 63–68 of bovine b-casein. The 
uPA is a critical enzyme for neutrophil diapedesis and the overall ability of neutrophils to resist 
against various pathogens (Politis et al.2003). In this model system, neutrophils are obtained at 
weaning which is considered a period of immaturity of the immune system and 4 weeks later when 
the immune system is thought to have gained its full functionality (Fragou et al. 2004). Results 
indicated that both peptides reduced the amount of u-PA present on the cell membrane as well as 
the expression of MHC class II antigens only at the time of weaning and not 4 weeks later. Thus, b-
casein synthetic peptides appear to be effective only at a time period which coincides with 
immaturity of the immune system and they are not effective when the immune system has 
presumably gained its full functionality.  
                                                   
1.1.5.3 Milk peptides – Induction of immune response 
 
The main mechanism of protection against pathogen derived antigens provided by mucosal 
immunity is mediated through IgA-producing cells and secretory IgA which neutralize and, thus, 
prevent the entry of potentially harmful antigens in the host. Thus, stimulation of local immune 
response can be effective in preventing certain diseases caused by microorganisms entering the host 
through the oral route. Feeding mice with milk fermented with Lb. helveticus increased the number 
of IgA(+) B cells in the small intestine and bronchial tissues. A protease deficient derivative of Lb. 
helveticus was ineffective (Matar et al. 2001). These results taken together indicate that peptides 
generated by the action of proteases are responsible for this effect. 
Furthermore, it appears that the peptides can stimulate local immune response in the gut and 
activate the IgA cycle as shown by the increase of the IgA(+) B cells in the bronchial tissues. In 
another study, Perdigon et al. (1999) demonstrated that feeding mice with milk fermented by LAB 
resulted in increases in IgA(+) cells in the gut, macrophage activity and specific antibody responses 
during infection. However, it was not certain whether the effect was mediated by milk peptides 
and/or the presence of the LAB. To further elucidate the mechanism, Leblanc et al.(2002) 
investigated the effect of specific peptides generated following fermentation of milk with Lb. 
helveticus on humoral immunity. Three specific peptide fractions were isolated from fermented 
milk by chromatography and then were fed to mice. All fractions increased the number of the 
IgA(+) B cells in the gut which indicates that bioactive  peptides are generated by the action of 
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LAB. There was no increase in the number of the IgA(+) B cells in the bronchial tissues which 
indicates that the effect of the peptides was restricted in the gut and there was no activation of the 
IgA cycle. A great number of studies demonstrating the ability of milk peptides to enhance the 
function of immune system were performed in the 80s and early to middle 90s and some excellent 
reviews of these studies are available (Clare & Swaisgood, 2000; Hill et al. 2000). Therefore, 
emphasis in the present review will be given towards recent studies or those not adequately covered 
in the previous reviews. A recent study investigated the effect of bovine glycomacropeptide on 
proliferation and phagocytic activity of the U937 human macrophages like cell line (Li & Mine, 
2004). They showed that the glycomacropeptide to be a potent enhancer of cell proliferation and 
phagocytic ability. Furthermore, they showed that both the peptide and the carbohydrate portions 
were essential for the stimulatory effect. Politis (1995-2007) investigated the effect of a synthetic 
hexapeptide corresponding to residues 63–68 of bovine b-casein on several immune parameters of 
bovine macrophages and neutrophils. Results showed that the hexapeptide up regulated interleukin-
1 production and expression of MHC class II molecules by macrophages and superoxide production 
by neutrophils. In contrast, the hexapeptide had no effect on chemotactic responsiveness of bovine 
neutrophils. It is clear that the effectiveness of milk peptides is cell-specific. It is difficult to 
speculate as to why the hexapeptide differentially affects two functions of bovine neutrophils 
(superoxide production, chemotactic responsiveness). A study performed in the 90s demonstrates 
the dichotomy between suppression and/or induction of immune response by milk peptides. Sutas et 
al. (1996a) examined the effect of milk peptides generated by an intestinal Lactobacillus strain on 
various immune functions. They showed that purified casein peptides up regulated IL-4 and IFN-
gamma production by blood peripheral mononuclear cells. In contrast, Lactobacillus-degraded 
caseins up regulated IL-4 production but they had no effect on IFNgamma. It is clear that the 
overall effect of milk peptides on the immune system might be peptide-specific. Non-nutrient milk 
components modulating gastrointestinal development: Colostrum and milk contain a high number 
of biologically active compounds that modulate gastrointestinal activity and function and promote 
the development of the newborn (Blum & Baumrucker, 2002). A significative number of studies 
demonstrated the efficacy of these peptides to modulate the intestinal immune response of the 
newborn (Baldi et al., 2005). Chronopoulou et al. (2006) demonstrated an increase of superoxide 
anion production from macrophages and neutrophils isolated from weaning piglets treated with 
casein peptides. This research group tested hanno testato in vivo the effect of casein peptides on 
phagocytic cells of 27 piglets in the first weaning phase in three experimental groups: control (basal 
diet), low integration (300 mg/die), high integration (600 mg/die) (Politis e Chronopoulou 2008). 
The production of sueroxide anions from serum monocytes, macrophages and neutrophils at days 7, 
14, 21 increased compared to the level of the integration (Figure 2). 
 
 
  
Figure 2 Milk peptides and immune response in the neonate adapted from (Politis I., Chronopoulou R. 2008). 
 
Among these compounds there are:  lactoferrin, a multifunctional protein involved in non-specific 
immune defence against bacteria and viruses, immunoregulation, anti-inflammation and iron 
metabolism (Brock, 2002). From a nutritional point of view lactoferrin may be of interest not so 
much as a dietary protein source of amino acids but for iron bioavailability (Lo¨nnerdal & Iyer, 
1995). Although amino acid composition of lactoferrin suggests a high biological value of the 
protein, some evidence indicated that the major function is not as a nutritional support of amino 
acids for the newborn. In fact, lactoferrin is extremely resistant to proteolytic enzymes and the 
ironsaturated form is more resistant to enzymatic digestion than the apoprotein (Brines & Brock, 
1983; Kuwata et al. 2001). As a consequence, ingested lactoferrin is not highly degraded in the 
gastrointestinal tract and nearly intact protein is delivered in the gut (Hutchens et al. 1991). This 
argument is supported by the fact that intact lactoferrin can be found in the faeces of breastfed 
neonate; thus, the protein undergoes incomplete proteolysis and it does not represent a source of 
utilizable amino acids (Davidson & Lo¨nnerdal, 1987). These data suggested that intact lactoferrin 
should have a physiological significance for the gut of the neonate. Following oral ingestion, 
survival of lactoferrin and other milk-borne bioactive compounds in the gastrointestinal tract is a 
prerequisite for direct action in the gut or for activity on peripheral targets after absorption into the 
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blood circulation (Xu et al. 2000). Lactoferrin is involved in iron uptake by the newborn; this 
potential role for the bioavailability of this micronutrient in milk arises from the observation that its 
bioavailability in breast milk is high, although its content is low (Lo¨nnerdal & Iyer, 1995). Studies 
by Kawakami & Lo¨nnerdal (1991) and Suzuki et al. (2001) showed that lactoferrin facilitates iron 
uptake by human intestinal cell cultures and this biological effect is mediated by the interaction 
with a receptor localized on enterocytes. Lactoferrin receptors were identified in the small intestine 
brush-border membrane of several species, such as mice (Hu et al. 1990), piglets (Gislason et al. 
1993) and cows (Talukder et al. 2003). The binding of lactoferrin to the receptor is highly species-
specific. Studies by Gislason et al. (1993) showed that human lactoferrin, bovine lactoferrin and pig 
transferrin do not interact with the receptor for lactoferrin localized on the small intestine of piglets. 
Another interesting aspect of the interaction of lactoferrin with its specific receptor is that the 
protein can be internalized after binding. Recent findings have showed that lactoferrin has an import 
signal for translocation into the nucleus (Penco et al. 2001) and surface nucleolin is involved in the 
binding and endocytosis of lactoferrin in target cells (Legrand et al. 2004). Ashida et al. (2004) 
studied the cellular internalization of lactoferrin in the intestinal epithelial cell line Caco-2; they 
showed that lactoferrin is localized to the nuclei after uptake. Baumrucker & Erondu (2000) 
demonstrated that bovine lactoferrin is involved in both the interaction and entry of IGFBP-3 in the 
nucleus of mammary cells. The nuclear localization of lactoferrin suggested its involvement as a 
transcription factor after binding to specific D In cow’s milk, more than 100 nutrients are included. 
Preisely, milk is categorized as perfect food containing protein, lactose, calcium, phosphorus, 
magnesium and trace elements, and varius vitamins. And it is also mentioned as a natural food with 
biological function and significant meaning to the body. The history of milk as a food started from 
B.C 6000. According to the many studies since then, we can say that milk is a great food involving 
various physiological functions, such as bone-growth and immune control.  
Immunoglobulin (Ig). The structure of the Ig present in milk is exactly same as that in the serum or 
other excreta. But the content of each Ig is totally different in between serum and milk. IgG is the 
most common Ig in serum of human, bovine and porcine (80-90 % of total Ig). In colostrum the 
most common Ig is Ig A in human, and for bovine and pig’s colostrum the most represente is the 
IgG. Lactoferrin: Is a glycoprotein in milk containing 2 molecules of iron. It presents relatively 
higher in human breast milk, and especially 10-20 times higher than cow’s milk (6-8 mg/l in 
colostrum and 2-4 mg/l in normal milk). This glycoprotein plays an important role in resistance 
toward E.coli infection and its function in colon is known to be strong. In addition, the content of 
lactoferrin is generally high in mammal colostrums, which is helpful in restricting the growth of 
pathogenic bacteria and E.coli in order to make Bifidobacteria settle down in large intestine in the 
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young. Due to its strong adherence to metal ions, this glycoprotein may provide the function of 
suppressing the pathogenic bacteria growth by transforming the active minerals into inactive ones 
which is essential for bacteria growth, and the function of preventing anemia with controlling iron 
absorption. In addition, its known functions are immune restoration, anti-inflammation, cell 
proliferation and anti-oxidation. 
Lysozyme: has anti-bacterial anti-viral and immune enhancing effects, and involves in blood 
clotting and stryptic process, anti-inflammation and milk digestion. The content of lysozyme is 
around 170 µg % in milk. When infants were fed with formula containing lysozyme shown an 
increasy of the growth of Bifidobacteria and a decrease of E.coli in the feces. 
The changes  in bacterial composition can be explained by N-acetylglucosamin, produced when 
lysozyme degrades the mucus polysaccharides on the cell walls of bacteria, that increases the 
growth of Bifidobacteria. 
Mucin: is chemical compound of olighosaccarides and glycoprotein and has lubricative and 
protectie functions, existing in pituauitary gland, gastric mucosa, cartilage, saliva, blood, nasal 
mucosa in the body. Especially, it is high in breast milk and cow’s mil and can protect stomach 
from gastric juice such as pepsin and and hydrochloride.  
 
1.1.6 Vegetable milks as functional foods 
Compared to cow's milk, vegetable milks contains more carbohydrates, but does not contain 
significant amounts of calcium or protein, and no cholesterol or lactose. Commercial brands of 
vegetable milks such as rice milk and soy milk, however, are often fortified with vitamins and 
minerals, including calcium, vitamin B12, vitamin B3, and iron. Soy milk for example has about the 
same amount of protein as cow's milk. Natural soy milk contains also little digestible calcium as it 
is bound to the bean's pulp. To counter this, many manufacturers enrich their products with calcium 
carbonate available to human digestion. Unlike cow's milk, these kind of vegetable milks have little 
saturated fat and no cholesterol. Soy products contain sucrose as the basic disaccharide, which 
breaks down into glucose and fructose. Since soy doesn't contain galactose, a product of lactose 
breakdown, soy-based infant formulas can safely replace breast milk in children with galactosemia 
(Franck M et al., 2006). Soy milk is promoted as an healthy alternative to cow's milk for reasons 
including: source of lecithin and vitamin E, lacks casein, safe for people with lactose intolerance or 
milk allergy, contains far less saturated fat than cow’s milk, contains isoflavones, organic chemicals 
that may possibly be beneficial to health. Rice milk is a kind of grain milk processed from rice. It is 
mostly made from brown rice and commonly unsweetened. The sweetness in most rice milk 
varieties is generated by a natural enzymatic process, cleaving the carbohydrates into sugars, 
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especially glucose, similar to the Japanese amazake. Some rice milk kinds may nevertheless be 
sweetened with sugarcane syrup or other sugars.  
  
1.1.6.1  Some components of vegetable milks  
 
1.1.6.2  Inositol 
 
Inositol is not-in the group of vitamin B, but is closely associated with choline and biotin. Animal 
studies have shown that vitamin B6, folic acid, pantothenic acid and PABA also have very close 
activity association with inositol. The myoinositol is the only active constituent from the nutritional 
point of view of phosphatidylinositol. Inositol is active in cell membranes and in sending messages 
to the nervous system to control the cellular functions. Like choline, inositol is also present in 
lecithin. The animal tissues and some plants contain inositol. In animal tissues is presented as a 
component of phospholipids, substances containing phosphorus, fatty acids and nitrogen bases. In 
plant cells is in the form of phytic acid, an organic acid that binds calcium and iron in an insoluble 
complex and interfere with their assimilation. Is effective to stimulate the production of lecithin in 
the body. Fats are mobilized from the liver cells with the help of lecithin and inositol, therefore, 
contributes to the metabolism of fats and helps reduce cholesterol in the blood. Combined with 
choline, prevents hardening of the fat in the arteries and protects the liver, kidneys and heart. It was 
also reported its usefulness in nutrition of brain cells. Large amounts of inositol are found in the 
nerves of the spinal cord, brain and cerebro-spinal fluid. And 'necessary for the growth and survival 
of bone marrow cells, for the eye membranes and intestines. Is important for hair growth and may 
prevent their weakening and baldness. Of all the isomers present in nature only mio-inositol is the 
active form of Inositol.  
Inositol and a number of its mono and polyphosphates function as the basis for a number of 
signaling and secondary messenger molecules. They are involved in a number of biological 
processes, including: insulin signal transduction, cytoskeleton assembly, nerve guidance (Epsin), 
intracellular calcium (Ca2+) concentration control, cell membrane potential maintenance, serotonin 
activity modulation, breakdown of fats and reducing blood cholesterol, gene expression. 
 
 
 
 
 
 
 
 
 
  
myo- scyllo- muco- chiro- 
   
 
Fig.3 Isomers of Inositol 
 
 
1.1.6.3  Ɣ Oryzanol 
 
Gamma-oryzanol, a mixture of ferulic acid esters of sterol and triterpene alcohols, it occurs in rice 
bran oil at a level of 1 to 2%, where it serves as natural antioxidant. Recent research has shown that 
gamma-Oryzanol can lower the cholesterol levels in the blood, lowering the risk of coronary heart 
disease, besides that, also has been used in Japan like natural antioxidant in foods, beverages and 
cosmetics. Gamma-Oryzanol plays an important role for its physiochemical properties, its presence 
in the rice bran oil, its antioxidant and hypocholesterolemic activity, as well as, identification, 
quantitation and extraction methods. (Scavariello EM et al. 1998). Gamma-oryzanol may be a more 
important antioxidant of rice bran in the reduction of cholesterol oxidation than vitamin E, which 
has been considered to be the major antioxidant in rice bran. The antioxidant function of these 
components against cholesterol oxidation may contribute to the potential hypocholesterolemic 
property of rice bran (Xu Z et al. 2001). 
 
1.1.7 Prebiotics  
 
In 1995 Gibson and Robertfroid defined a prebiotic as a non digestible food ingredient that 
beneficially affects the host by selectively stimulating the growth and/or activity of a limited 
number of bacteria in the colon. Prebiotics are non-digestible dietary components that have a 
positive effect on intestinal well-being, selectively stimulating the growth and activity of a limited 
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number of useful bacterial species already present in the intestine. These kinds of products are not 
only presents in the plant derived products but also in the maternal milk (Table 2). Among the food 
additives the activity of these compounds is very interesting for two classes of oligosaccharides: 
fruit-oligosaccharides (FOS) and mannan-oligosaccharides (MOS). Both of the two classes of 
oligosaccharides can be a good alternative to the use of AGP, in fact they facilitate and support the 
symbiotic relationship between the host and the intestinal microflora.  
 
Table 2. Human milk: glicoconiugates and oligosaccharides pathogens inhibitorsi (adapted from 
Newburg et al., 2005; Séverin e Wenshui, 2005).  
 
Glicoconiugates Pathogens Action Concentration(*) 
GM1  
 
Vibrio cholera 
Campylobacter jejuni 
Legame con tossina 180 µg/L 
GM3 E. coli enteropathogenic Bind the toxin 13 mg/L 
Gb3 Shiga toxin Bind the toxin 100-150 µg/L 
Condroitin sulphate HIV Bind the virus 6 mg/L 
Lactaderine Rotavirus Bind the virus 100 µg/L 
Mucine E. coli  Bind the pathogen 1 g/L 
Mannosilate 
Glycopeptides 
E. coli enteroemorragic Bind the toxin 60 mg/L 
Oligosaccharides Streptococcus pneumoniae 
E. coli enteropathogenic 
Listeria monocytogenes 
Clostrium spp. 
Campylobacter jejuni 
Rotavirus 
Bind the pathogen            0.2-10 g/L 
3 g/L 
3 g/L 
Fucosilate 
Oligosaccharides 
Campylobacter jejuni 
Vibrio cholera 
E. coli (enterotoxin) 
Bind the pathogen Bind 
the toxin 
1-25 mg/L 
1-25 mg/L 
40 µg/L 
Glicoproteines associated 
to macromolecules 
Norovirus 
Pseudomonas aeruginosa 
 370 mg/L 
 
Sialillactose Cholera toxin 
E. coli 
P. aeruginosa 
Influenza virus 
Poliomavirus 
Helicobacter pylori 
  
 
 
200 mg/L 
(*) Concentration of the active fraction/component in the milk 
 
Inulin and Mannano oligo saccharides are the most studied and well-established prebiotics in pig 
diets. They escape digestion in the upper gastrointestinal tract and reach the large intestine virtually 
intact where they are fermented. Indeed, in many studies it was shown the selective stimulation of 
growth of the beneficial flora, namely bifidobacteria, and to a lesser extent, lactobacilli and possibly 
other species like Clostridium coccoides, Eubacterium rectale, cluster known to be a butyrate 
producer. (Klesser et al., 2001). The mechanism of the bifidogenic effect of inulin and MOS is 
thought to be their selective fermentation by the bifidobacteria that produce an intracellular 
inulinase necessary to hydrolyze the β-(2 → 1) fructosyl-fructose osidic linkages. But these data 
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also call attention to the facts that not all inulin derivates have, qualitatively, the same effects on 
intestinal microflora and that for each inulin-type fructan, the different segments of the large bowel 
(including the feces), might be differently influenced (Apajalahti et al., 2002). In this regard, two 
different questions have attracted attention concerning the qualitative aspects of the prebiotic effect. 
These questions can be formulated as follows: are the different inulin-type fructans and MOS 
equally effective? Can a dose-effect relationship be established? At the population level it is the 
fecal flora composition characteristic to each individual that determines the efficacy of a prebiotics 
but not necessarily the dose itself. The ingested prebiotic stimulates the whole indigenous 
population of bifidobacteria to growth. The dose argument, as supported by scientific data can not 
be generalized because of the factors controlling the prebiotic effect are multiple (Roberfroid, 
2005). One important question remaining unanswered is the effect of prebiotic, especially inulin-
type fructans, not on the numbers of bacteria, especially bifidobacteria, but rather on activity 
associated with these bacteria. Inulin-type fructans classify as functional feed ingredients that target 
gastrointestinal functions but also, most likely, via their effects on the gut microflora, systematic 
functions that are known to be closely related to health and well-being. Nowadays gastrointestinal 
functions and especially colonic functions (control of the colonic environment, regulation of 
hormone-dependent metabolic processes, modulation of the brain-gut axis, systemic impact of gut 
fermentation products and activity of the immune system) deserve special attention. Indeed 
disturbances of colon functions may lead to dysfunctions not only in the gut but also in the whole 
body (Table 3).  
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Table 3 Experimental data that support the substantiate claims on inulin-type fructans 
Property or target functions Supportive evidence Claims 
Dietary fibre Oligo/polysaccharides resistant to 
digestion, fermentation 
Inulin-type fructans are 
dietary fiber 
 
Caloric value Non-digestible 
oligo/polysaccharides, colonic 
feed 
 
Inulin-type fructans are 
low calorie carbohydrates 
Bowel functions, stool 
production 
Bulking effect, regulation of stool 
production, improved stool 
consistency 
 
Inulin-type fructans 
regulate bowel functions 
Colonic microbiota Substrates for anaerobic 
saccharolytic fermentation, 
selective stimulation of growth of 
health-promoting bacteria  
 
Inulin-type fructans are 
prebiotic 
GI absorption Ca and Mg Increased absorption of Ca and 
Mg 
Inulin-type fructans 
increase Ca and Mg 
absorption 
 
Lipid homeostasis Reduction of triglyceridaemia Inulin-type fructans 
reduce triglyceridaemia in 
slightly 
hypertriglyceridaemic 
individuals 
 
1.1.7.1 Mannanoligosaccharides (MOS) 
 
The mannanoligosaccharides are derived from the wall of yeasts and have mannose as a primary 
carbohydrate. The mannanoligosaccharides are not used as a substrate for microbial fermentation, 
but they carry out their action as growth promoters, increasing the resistance of the animal to enteric 
diseases. The MOS act as: preventing the adhesion of enteric bacterial pathogens to the mucosa, 
improving the immunity of the host, modulating the gut microflora, increasing the enteric mucosal 
barrier, reducing the red cell turnover, enhancing the integrity of the intestinal mucosa and inhibition 
of microbial colonization. Aim of this functional compound is offer a substrate to certain beneficial 
members of the gut flora and by this to achieve a shift in the composition of the gut bacteria in 
favour of a healthy flora. Studies  showed that five of the seven strains of E. coli and seven of 10 
strains of Salmonella Typhimurium and S. Enteriditis present in the intestines of chickens, are 
agglutinated by MOS (Spring et.al. 2000). Even strains of Clostridium spp do not bind to molecules 
of the MOS, but studies have shown a significant reduction in the number of clostridia in feces of 
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animals fed MOS (Lalles et al., 2009). This is probably due to the effects of MOS increasing the 
resistance of the barrier role of mucine or enhancing the immune function. It is well known that all 
animals reared under commercial conditions, are subjected to immunological stress caused by the 
presence of a high load of pathogens in their environment. The release of cytokines, associated with 
inflammatory processes and the immature immune system, lead to hyperthermia. The consequences 
are a decrease appetite, mobilization of the body reserves of glucose, amino acids, minerals, 
decrease of the intestinal nutrients absorption, loss of body fluid and the development of diarrhea. 
The use of MOS seems to reduce the production of pro-inflammatory cytokines by reducing 
hyperthermia, and the events mentioned, allowing an increase in growth performance. It has also 
been shown that MOS have a positive influence on immunity and humoral immune status. There is 
evidence that the administration of MOS, causes an increase in the number of immunoglobulins 
(IgA, IgG and IgM) in the intestine in both serum and blood. This increase in the antibody response 
is due to the immune system's ability to respond to exogenous antigens present on the molecule of 
MOS because of their microbial origin (Sauerwein et al., 2007). Although the cecum is the main 
intestinal site where occur fermentation process, the fermentation processes that occur in the 
jejunum have a greater influence on the digestion and absorption of nutrients (Lalles et al., 2009). 
The use of MOS can decrease the concentration of strains such as Salmonella and E. coli in the 
gastrointestinal tract increasing the growth of bacteria such as Lactobacillus spp Enteric-coated and 
Bifidobacterium spp. Thanks to the increase of volatile fatty acids production decreasing intestinal 
pH (Moore WEC et al., 1987). The benefits of MOS may be also associated with intestinal 
morphology. During the weaning period, the massive colonization by microorganisms of the 
intestinal lumen and the contribution of new types of food proteins is often associated with atrophy 
of the villi, which results in a decreasing ratio of villous height / crypt depth. This phenomenon is 
often due to malabsorption syndromes with subsequent onset of diarrhea (Pierce et al. 2006-2007). 
Studies in piglets, chickens and mice, have shown that mannano oligosaccharides have a major 
influence on the morphology of intestinal villi and their use in the diet after weaning increases the 
ratio villus height / crypt depth (Konstantinov et al. 2004a-2006). Maintaining a good relationship 
villus height / crypt depth is necessary for good absorption of nutrients and prevent the onset of 
diarrhea. The state of the lining of the intestinal lumen, is the first barrier that opposes the gut 
against enteric pathogens. Mucus production is proportional to the number of goblet cells in the gut 
and nutrition including MOS has been shown to be able to increase the number of these cells at the 
level of enteric villi (Bontempo et al. 2006). Thus, increased of prebiotics creates favourable lumen 
conditions for gut health but direct evidence for enhanced resistance to unfavourable conditions is 
still lacking (Lalles JP et al., 2007). 
31 
 
1.1.8 Plant Products 
 
For thousands of years, herbs and spices have provided distinctive flavouring properties to foods 
and many have been proven as potent antimicrobial agents. The use of these substances was very 
common in both western and chinese culture. Some of the most common plant products (PP) known 
for their antimicrobial properties belong to the genus Allium as garlic, onion and leek; others are 
thyme, oregano, marjoram, basil and cumin. The natural plant antimicrobials are found in barks, 
roots, stems, leaves, flowers and fruits of many plants. In recent years, in vitro studies demonstrated 
the antibacterial activity of some of these products (Sen et al., 1998; Friedman et al., 2002), and 
more recently the supplementation of plant products to pigs diets has been proposed in order to 
counteract intestinal disorders, especially in the weaning period. However, the effects on growth 
performance and gut health are not so consistent which may depend on the plant product tested. 
One of the main issue concerning plant products is their characterization (Cowan, 1999). Plant 
products contain several different active compounds in different concentration and their 
composition is mainly affected by the method of extraction (solvent and extraction conditions) and 
the niche of the plant used related to plant variety and age, climatic conditions and geografic origin. 
Characterization is important for scientific as well as for legal purposes. All characteristics affecting 
plant product composition affect at the same time their biological effects. Hence, for scientific 
purpose it is better to work with pure active substances or with accurately controlled blends. In 
regards to legislation, traceability, and thus characterization, is one of the main requisites to register 
additives. It is, therefore important to accurately assess all the different compounds that the product 
contains.  
 
1.1.8.1 Effect of plant products on microbiota 
 
Plant products have intensively been used in the past for medical and food preservation purposes. 
The use is mostly motivated by the main characteristic of PP, their antimicrobial activity (Didry et 
al., 1994). This activity has been studied in several in vitro studies with promising results. This 
application is still too recent and there is too limited information available about the actual 
possibilities of these products. However, the legislative requirements and the great interest to this 
sector are motivating the appearance of the first studies using PP in vivo (Evans and Martin, 2000; 
Herman et al., 2003; Allan et al., 2005). It is difficult to define the antimicrobial or different active 
compounds present in a plant product. Usually, antimicrobial active substances in PP have a very 
different chemical structure, with high occurrence of phenolic rings, mostly hydrofobic and some of 
them with similar structure to important molecules from bacterial metabolism such as receptors or 
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enzyme substrates (Cowan, 1999). It also known that many of these substances are secondary 
metabolites that plants use against predators, or with different functions such as pigmentation, 
aromatizing or flavoring. In Table 4 the principal chemical structures producing antimicrobial 
activity in plant products and the mechanism of action referenced are reported (Guen et al., 1991). 
Some of these effects need to be better investigated while some of them are more studied as the 
hydroxyl group (-OH) present in phenol compounds. The importance of this group on antimicrobial 
activity is well known (Cowan, 1999) and any variation in its position inside the mulecule, as it 
happens between carvacrol and thymol, produces marked differences in antimicrobial power 
(Dorman and Deans, 2000). Components with phenolic structures, such as carvacrol and thymol are 
highly active against test bacteria dispite their low capacity to dissolve in water. This has been 
known for centuries, but the importance of the hydroxyl group in the phenolic ring was confirmed 
in terms of activity when carvacrol is compared to its methyl ester. The high activity of the phenolic 
components may be further explaned in terms of the alkyl substitution into the phenolics nucleus, 
which is known to enhance the antimicrobial activity of phenols (Han et al. 2006). It was suggested 
that plant products act via two main mechanisms of action. The first is related to the general 
hydrophobicity of PP, which facilitates their adhesion to the bacterial surface inducing 
unstabilization (Tsuchiya et al., 1996). The second mechanism is the inactivation of different 
molecules of the bacteria (such as enzymes or receptors) through their adhesion to specific sites 
(Sharon and Ofek, 1986).    
 
Table 4 Chemical structures implicated in antimicrobial effect of PP and relative mechanism of 
action (Cowan, 1999) 
 
Class Subclass Mechanism of action 
Phenol compounds Simple phenols and phenolic acids Enzyme inactivation (1) 
Membrane un-stabilizers (2) 
Quinones Irreversible adhesion to adhesins, 
membrane polypeptides and enzymes 
that become inactive (3) 
Flavonoids, flavones and flavonols 
Tannins 1,2,3 and metal chelators 
Coumarins Interact with eukariote DNA 
Terpenoids  Membrane un-stabilizers 
Alkaloids  Insertion in cellular wall or in DNA 
structures 
Lectines and polypeptides  Block viral fusion and adsorption 
Di-sulphur bridges formation 
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Some authors suggested a higher efficacy of plant products against gram negative organism but 
others did not find any difference between gram positive and negative bacteria  and, sometimes 
even the opposite effect was proposed (Manzanilla et al., 2004; Han et al. 2006). Actually, it is 
possible that some PP have specific actions and other PP have diverse effects due to the different 
nature and composition. In fact, as it happens for antibiotics, the chemical structure will determine 
the mode of action and hence a possible selective effect of plant product. For instance, alkilic chains 
plus a phenol group seem to perform better activity against gram negative bacteria, due to the 
characteristic of their cellular wall. In any case, the specific effect of some PP could be interesting 
in therapeutic or preventive applications like it happens with antibiotics. Concerning growth 
promotion, it must be studied if a selective effect of PP could be useful, because of the risk of 
producing detrimental effects (Dorman and Deans, 2000). The effect of PP on different bacterial 
species has been determined in a high number of in vitro studies using spectrophotometry 
measurements or agar plate inhibition rings. Many of these studies have explored the real 
antimicrobial power of classic herbal products or spices (Dorman and Deans, 2000; Friedman et al., 
2002). From these previous studies we can draw some conclusions. First of all, different bacteria 
have different sensitivity to different plant products. It can be also observed how some compounds 
as α-terpinen are highly effective against a very interesting target as Salmonella but not against the 
other microorganisms.  
 
Table 5 Antibacterial activity of different essential oils against 25 different bacteria tested (from 
Lis-Balchin M, 2003) 
 
Essential oil 
Antibacterial activity 
Number of bacteria 
Peppermint 15-22 
Petitgrain 21 
Pine niddle 19 
Rosewood 24 
Rosemary 21 
Sage, Dalmatian 16 
Tea tree 24 
Thyme 14-25 
Verbena 18 
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In the application of PP in vivo it is important to consider the dosage. Compared to antibiotics, the 
in vitro dose of PP to obtain similar effect is normally 10- to 100-fold higher (Karaman et al., 
2001). So far, we know that complex media as the chime in the digestive tract could affect the in 
vitro effective dosage.       
1.1.8.2 Receptors analogs as anti-adhesive agents  
 
There is evidence that receptor analogs as agents for anti-adhesion therapy would be practical 
primary against pathogens that bind to animal cells via carbohydrate-specific adhesins (i.e. lectins). 
In this case the receptor analogs are saccharides that are structurally similar to those of the 
glycoprotein and glycolipid receptors for the adhesin and, therefore, act by competitive inhibition. It 
was less than three decades ago that mannose was first shown to be a receptor for enterobacteria 
(Ofek et al., 1977). Since then, the sugar specifities of many bacteria have been determined, leading 
to the development of receptors-like carbohydrates, which inhibit the adhesion of pathogens to host 
cells and tissue (Ofek et al., 2003). The concentration of the carbohydrates required for effective 
inhibition of adhesion in vitro are usually high, in the millimolar range, because the affinity of the 
saccharides for the bacterial lectins is low. It can be increased several orders of magnitude by 
covalently linking a hydrophobic residue such as phenyl or methyl umbelliferyl to the saccharide 
(Firon et al., 1987). Affinity can be similarly increased by attaching many copies of the saccharide 
to a suitable carrier, yelding multivalent adhesin inhibitors, as demonstrated for type 1 fimbriated  
Escherichia coli (Lindhorst et al., 1998).   The feasibility of using saccharides to protect against 
experimental infections by bacteria expressing adhesive lectins was first demonstrated more than 
two decades ago. Administration of methyl α-mannoside together with E. coli expressing the 
mannose-specific type 1 fimbrial lectin into the bladders of mice reduced the extent of bladder 
colonization by uropathogenic E coli by about two thirds compared to animals that had received the 
bacteria alone or with methyl α-glucoside, a sugar that does not inhibit the mannose-specific 
bacterial lectin. Subsequently many studies have confirmed the ability of saccharides to prevent 
experimental infections caused by different pathogenic bacteria in a variety of animals ( Namkung 
et al., 2004) (Table 6).     
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Table 6 Carbohydrates preventing bacterial colonization and/or infection in vivo (modified from 
Ofek et al., 2003b)    
 
Organism Animal, site of action Inhibitor 
C. jejuni Mouse intestine Milk oligosaccharides 
E. coli, type 1 fimbriated Mice GT  Mannose 
E. coli, P fimbriated Mice UT Globotetraose 
(Galα1,4Gal)-containing GP* 
E. coli K99 Calf GT Glycopeptides 
H. pylori Piglet GT Sialyl-3’-LacNAc 
Shigella flexneri, type 1 
fimbriated 
Guinea pig eye Mannose 
S. pneumonia Rabbit and rat lungs Sialyl-3’-Galβ(1→4)LacNAc 
S. sobrinus Rat oral cavity Oxidized α1,6 glucan 
S. pyogenes Mouse pharynx Hyaluronan 
*Gp: glycoprotein found in dove and pigeon egg white 
 
1.1.8.3 Adhesins analogs as anti-adhesive agents 
 
The strategy for using adhesins to prevent infections is based on the assumption that the isolated 
adhesin molecules, or an active synthetic or recombinant fragment, bind to the receptor and 
competitively block adhesion of the bacteria (Ofek et al., 2003). It has thus far been impratical to 
use analogs of adhesins for anti-adhesion therapy, because they are typically macromolecules that 
are not readly available and bacause they must be employed at relatively high concentrations. In 
addition, careful consideration must be given to their toxicity and immunogenecity. Novertheless, 
modern proteomics and recombinant biotechnology have permitted the development of unique 
types of relativelly small peptides for anti-adhesion therapy, as reported by Kelly et al. (1999). Non-
proteinaceous adhesins may also be useful for anti-adhesion therapy, as shown in studies of the 
lipotheicoic acid (LTA)-mediated adhesion of group A and group B streptococci. 
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Table 7 Anti-adhesin activity of plant constituents (modified from Ofek et al.,2003) 
 
Plant Constituent Bacterium affected 
Azadirachta indica (neem 
stick) 
ND S sanguis 
Camillia sinensis (green tea) 
 
(-) epicatechin gallate, (-) 
gallocathechin gallate 
P gingivalis 
Oolong tea Polyphenol S mutans; S sobranus 
Gilanthus nivalis (snowdrop) Mannose-sensitive lectin E coli 
Gloipeltis furcata and 
Gigartina teldi (seaweeds) 
Sulfated polisaccharides S sobrinus 
Hop bracht Polyphenols (36-40 kDa) S mutans 
Melaphis chinensis Gallotannin S sanguis 
Persea americana (avocado) Tannins S mutans 
Legume storage protein Glycoprotein E coli 
ND: not determined 
  
1.1.8.4 Dietary inhibitors of adhesion  
 
Some of the most efficient anti-adhesion agents identified so far are present in feedstuffs. Feedstuffs 
containing either a mixture of inhibitors or an inhibitor with a broad spectrum of activity could be 
especially effective. While it may be possible to find suitable inhibitors for particular pathogens, it 
is unlikely that it will be possible to match every individual or group of pathogens with specific 
diets that contain complementary adhesins inhibitors (Ofek et al., 2003b). Empirical observations 
over the years have suggested that may be effective to counteract bacterial infections. However, 
caution should be used, because some dietary components may also be bactericidal and selective 
pressures imposed by such compounds are undesirable and should be avoided. Human milk and 
plant-derived constituents are rich in oligosaccharides and related compounds to which many 
bacteria bind. 
 
1.1.8.5 Plant products as bacteria adhesion inhibitors 
 
Because of their ready availability, plant materials possessing anti-adhesion activities are attractive 
candidates for antibacterial agents. There is, however a relative paucity of information regarding the 
anti-adhesive properties of most plant materials. Although plant lectins are well rappresented in the 
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diets, and many of these lectins are very characteristic, their application to anti-adhesion therapy is 
very limited. Theorically, these lecitins could interact with animal cell surface saccharides to block 
adhesion mediated by lectin-carrying bacteria and they may enhance clearance of bacteria from the 
host (Slifkin and Doyle, 1990).   Feed lectins may have deleterious effects as well. They may bind 
to mucosal cells and thus function as receptors for bacterial glycans and enhance bacterial adhesion 
to the tissue. Moreover some dietary lectins may reach the GI tract in a faunctional form and may 
similarly enhance the binding of the bacteria to the different parts of the intestine. A pratical 
advantage in the search of dietary plant extracts for agents to use in the therapy of bacterial 
infections is that clinical trials are probably easier to perform, mainly because toxicity is usually not 
as much of an issue. Among the plant extract listed in Table 8, those obtained from Vaccinium 
macrocarpon (cranberry) are the most throughly studied with respect to their anti-adhesion activity 
in vitro and, so far, are the only one sow to be effective in in vivo trials. The initial in vitro 
experiments on the effects of cranberry extracts on bacterial adhesion were stimulated by the long 
known anecdotal evidence on the beneficial effects of cranberry juice consumption in therapy of 
urinary tract infections. Several lines of evidence implicate two different cranberry constituents as 
active anti-adhesive agents. One of these is a high molecular mass (> 15 kDa) material and the other 
is a protoanthocyanin. The high molecular mass material is devoid of proteins and carbohydrates 
and behaves in some respects like tannin (Ofek et al., 1996). It inhibited the adhesion to animals 
cells of uropathogenic E. coli including P fimbriae-, S fimbriae- and non-fimbrial. 
 
Table  8 Anti-adhesion effects of juices or extracts of Vaccinium spp. (cranberry). From Ofek et 
al., 2003 (modified) 
 
Bacterium Disease Adhesion assay Effect 
E. coli UTI and 
pyelonephritis  
HA UroEp. I 
E. coli Diarrhea HA NI 
E. coli Meningitis HA I 
Oral bacteria Dental decay 
periodontitis 
Coaggregation and 
buccal epithelial 
adhesion 
I 
H. pylori Gastric ulcer Human gastric 
mucus, TC cells 
I 
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In addition, it inhibited the coaggregation of Gram-negative pairs of oral bacterial more often than it 
inhibited coaggregations between Gram positive bacteria. Extracts containing protoanthocyanins in 
their condensed form inhibited adhesion of P fimbriated E. coli to erythrocytes.  
 
1.1.8.6 Plant products: antioxidant capacity 
 
Antioxidative properties are well described for herbs and spices (Cuppett and Hall, 1998; Craig, 
1999; Nakatani, 2000; Wei and Shibamoto, 2007). Among a variety of plants bearing antioxidative 
constituents, the volatile oils from the Labiatae family (mint plants) have been attracting the 
greatest interest, especially products from rosemary. Their antioxidant activity arises from phenolic 
terpenes, such as rosmarinic acid and rosmarol (Cuppett and Hall, 1998). Other Labiatae species 
with significant antioxidative properties are thyme and oregano, which contain large amounts of the 
monoterpenes thymol and carvacrol (Cuppett and Hall, 1998). Plant species from the families of 
Zingiberaceae (ginger and curcuma) and Umbelliferae (anise and coriander), as well as plants rich 
in flavonoids (green tea) and anthocyans (many fruits), are also described as exerting antioxidative 
properties (Nakatani,2000; Wei and Shibamoto, 2007). Furthermore,pepper (Piper nigrum), red 
pepper (Capsicum annuum L.), and chili (Capsicum frutescene) contain antioxidative components 
(Nakatani, 1994). In many of these plants, parts of the active substances are highly odorous or may 
taste hot or pungent, which may restrict their use for animal feeding purposes. The antioxidant 
property of many phytogenic compounds may be assumed to contribute to protection of feed lipids 
from oxidative damage, such as the antioxidants usually added to diets (α-tocopheryl acetate or 
butylated hydroxytoluene). Although this aspect has not been explicitly investigated for piglet and 
poultry feeds, there is a wide practice of successfully using essential oils, especially those from the 
Labiatae plant family, as natural antioxidants in human food (Cuppett and Hall, 1998), as well as in 
the feed of companion animals. The principal potential of feed additives from the Labiatae plant 
family containing herbal phenolic compounds to improve the oxidative stability of animalderived 
products has been demonstrated for poultry meat (Botsoglou et al., 2002, 2003a,b; Papageorgiou et 
al., 2003; Young et al., 2003; Basmacioglu et al., 2004; Govaris et al., 2004; Giannenas et al., 2005; 
Florou-Paneri et al., 2006), pork (Janz et al., 2007), rabbit meat (Botsoglou et al., 2004b), and eggs 
(Botsoglou et al.,2005). Oxidative stability was also shown to be improbe with other herbal 
products (Botsoglou et al.,2004a; Schiavone et al., 2007). Nevertheless, it remains unclear whether 
these phytogenic antioxidants are able to replace the antioxidants usually added to the feeds (α-
tocopherols) to a quantitatively relevant extent under conditions of common feeding practice. 
The tea plant, Camellina sinensis, is used in livestock as a feed additive. The major molecules that 
make up the tea and give the biological properties are: Methylxanthines: like caffeine or protein 
(4%), smaller amounts of theobromine and theophylline, and traces of adenine and xanthine. They 
are partly related to tannins. Polyphenols: Catechins prevail, whose percentage ranged between 10 
and 20% depending on the variety and age of the leaf. Were isolated several compounds such as, 
epicatechin, gallocatechin and other 4-catechin gallates; flavanil-3-ols and diols flavanil.  Other: as 
oligomeric procyanidins, fenolcarbossilici acids, saponins, aldehydes, alcohols and monoterpenes 
(Fig. 4) 
 
    
Fig.4 Structure of molecole contained in Tea leaves (Friedman 2007) 
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The catechins contained in tea leaves, have antibacterial and antitoxic effects on different 
microorganisms. Juneja et al (2007) have shown that tea extracts are able to inhibit the growth and 
sporulation of Cl. perfrigenes in land-based broth. Studies in vivo in mice, show how green tea 
extract, protect the animals from systemic and neurological symptoms caused by toxins of E. coli 
O157: H7 (Isogai et al., 2001). Alcoholic extracts of black tea, showed inhibitory to strains of 
Salmonella typhimurium (Ciraj, Sulaim., 2001). It is well documented the role of different 
antioxidant catechins as acceptors of H, are able to protect cells from free radicals. Human studies 
have demonstrated the ability of the polyphenols in green tea inhibit in vivo oxidation of LDL, thus 
reducing the risk of atherogenesis. It also demonstrated a capacity of catechins antimicetica and 
antiviral (Weber et al, 2003). Grapes contain especially in the peel and seeds large percentage of the 
anthocyanins and  proanthocyanidins. Anthocyanins are among the most important groups of 
pigments found in plants and belong to the family of flavonoids. These molecules are composed of 
a benzene molecule with a cast of Piran (heterocyclic ring containing oxygen), connected in turn 
with a phenyl group which may in turn be linked to various substituents. This complex molecule 
called a cation flavilio and is the basic structure of all anthocyanins. (Fig.5) 
 
 
Fig.5 Flavilio cation is the basic structure of antiocians  
 
As part of the family of polyphenols, anthocyanins also have the same biological properties 
including a strong antioxidant properties.  The Olive (Olea europaea.) Is a plant belonging to the 
family of Oleaceae. The essential oil of olive leaves is used in animal husbandry due to the presence 
of high concentrations of biologically active substances, including flavonoids, triterpenes, fatty 
acids, saturated and polyunsaturated fats (alpha-linolenic acid), monounsaturated (oleic), 
oleuropein, tannins and chlorophyll . This is known as oleuropein molecule that has a strong 
antioxidative action antibattericae, common to the family of polyphenols to which it belongs. 
Oleuropein metabolites, such as football elenolato derived from its hydrolysis, seems to be also 
responsible for antiviral action of the molecule. 
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2.1 Objectives 
 
Worldwide the swine industries are under pressure to reduce the use of antibiotics while maintaining animal 
health and performance. In 2006 all the AGP (antibiotic growth promoters) and some feed additives with 
growth promoting activities were banned (Cu, Zn). Since the first restrictive measures were taken, and due to 
the beginning of the negative consequences of the ban, numerous efforts have been done to find alternatives 
or replacement strategies to maintain pig growth performance and controlling enteric bacterial diseases. 
Therefore, the following studies aimed to find ways to control additive efficacy with due consideration to 
animal welfare and consumers requirements. The main objective of this thesis was to improve our 
knowledge on the properties of new additives as feeding strategy and oral vaccination to improve general 
and gut health in young pigs with the aim to substitute antibiotics growth promoters. To achieve these 
objectives, three different trials were designed to study different strategies to improve the gut health of the 
post-weaning piglets. 
 
 
2.1.1 Abstract 1 
 
I) Evaluation of the immune response against ovalbumin (OVA) in pigs orally vaccinated with 
OVA in tablets containing carboxymethyl high amylose starch (CM-HAS), flagellin and  sow’s 
milk. 
 
This trial was designed with the aim to determine the effects of a new delivery system designed for 
oral vaccination or delivery of bioactive molecule in the gut.  The trial was also designed to 
evaluate the potential of the sow’s milk to modulate the systemic as well as local immune response 
against the antigen ovalbumin incorporated in the vaccine. Sixteen piglets of 28 days (d) of age 
were divided into 4 groups of 4 animals each. The first group was vaccinated with compressed 
tablets containing only ovalbumin (OVA); the second group was immunized with tablets containing  
ovalbumin and the B subunit of the flagellin from Salmonella enterica Typhimurium (OVA-FLA); 
the 3rd and 4th groups were immunized with tablets containing ovalbumin pre-incubated in sow milk 
with or without flagellin, respectively (OVA-LT or OVA-LT-FLA). The oral vaccination was 
performed in two periods of three days; the 1st  period being from day 28 to day 30 of age (D1-D3 
of the trial) and the 2nd  from 42 d to 45 d of age ( D14-D16).  Blood samples were collected at days 
1, 14, 21, 28 and 42 of the trial to determine, by ELISA, serum antibody titre against OVA. Feces 
samples were also collected before the first immunization and intestinal content from the ileum was 
collected at slaughtering to evaluate level of IgA anti-OVA by ELISA. All the animals were 
euthanized 42 days post-immunization to collect blood, mesenteric lymph nodes (MLN) and ileum 
content. The immune cells were isolated from the MLN and from blood and cultured  with OVA to 
evaluate the lymphocyte proliferative response by flow cytometry (CFSE cell proliferation kit) and 
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production of the main cytokine produced in adaptative immune response such as Interleukine-2 
(IL-2) , IL-4, IL-10 and interferon-gamma (IFN-γ).  Experimental animal studies have indicated that 
oral administration of antigens targets the systemic T cell compartment, diminishes cell-mediated 
immune responses, and induces tolerance. This phenomenon might lead to the induction of 
cytokines such as Transforming Growth Factor beta (TGF–β) and IL-10, and consequently enhance 
antigen-specific antibodies such as IgA and IgG. While the humoral immune response is critical in 
the control of some mucosal pathogens, those effects might be inappropriate on other mucosal 
pathogens where cell mediated immune responses may play a larger role.   
 
2.1.2 Abstract 2 
 
II) Milk rice in piglet nutrition: benefits or not? 
 
Rice milk has been shown to contain a high sugar level and antioxidants such as Ɣ-Oryzanol. For 
this reason the effects on growth performance and health status of piglets have been studied on 36 
litters from (Landrace x LargeWhite) x Penerland sows. At 10 days after birth 18 litters were 
supplemented  with rice milk (T) until weaning while the others 18 received creep feed (C). At 21 
days a total of 288 piglets were weaned. Half from each group (72 piglets) were randomly assigned 
to either control (C) or treated (T), so there were four experimental piglet groups: C-C, C-T, T-C 
and T-T. All the animals received a pre-starter (0-14 d post weaning) and a starter (14-42 d pw) 
diets. Piglets from C-T and T-T groups were also supplemented with rice milk from weaning to 14 
days pw. Piglets of T-C group had significantly higher weight at 42 d pw (P<0.01), an higher 
average daily gain (ADG) and dry matter feed intake (DMFI) (P< 0.01). Rice milk supplementation 
had no influence in glucose, urea, total protein and lysozyme. Reactive oxygen metabolites (ROMs) 
levels resulted lower in T-T piglets than C-C and C-T groups at 14 d-post w. (P<0.05). Total 
antioxidant capacity was higher in C-C and C-T than TC piglets at 14 d after weaning (P<0.05). The 
data from this trial suggest that rice milk was associated with greater post weaning growth and 
health status when supplementation was given only during the nursing period. 
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2.1.3 Abstract 3 
 
III) Effects of plant polyphenols and mannan oligosaccharide on growth performance, 
antioxidant defense system and gut health in Escherichia coli Challenged piglets 
 
Objective of the current study was to evaluate the effects of plant polyphenols (PP) and/or, mannan 
oligosaccharide (MOS) on growth performance, plasma antioxidant capacity and health in E. Coli-
challenged weaned piglets. Ninety-six piglets (7.43 + 0.89 kg L.W., 21 d age) were randomly 
allotted into 4 dietary treatments: control (basal diet), 0.1% PP, 0.1 % MOS or PP+MOS in a 6 
weeks study. At 21 and 25 d on trial half piglets of each group were orally inoculated with 4 ml of 
E.coli (1×109 cfu/ml) and half with the same amount of saline water.  
No difference was observed in growth. Plasma urea was markedly increased in PP+MOS group 
compared to PP group (P< 0.05), and lysozyme content was significantly decreased in PP+MOS 
group compared to groups on d 7 (P< 0.05). PP+MOS dietary supplementation decreased intestinal 
lipase and trypsin compared to PP on d 21 (P< 0.05). Plasma malondialdehyde content (MAD) 
increased, while plasma total antioxidant capacity (TAOC) and catalase (CAT) activities decreased 
in piglets 6 days after infection. Challenged piglets fed PP and those fed MOS showed higher 
TAOC than challenged piglets fed PP in combination with MOS. CAT activity resulted higher in 
challenged piglets fed diet supplemented with PP or PP+MOS than control or MOS at d 13 after 
infection (P< 0.05). The results showed that dietary PP or MOS had the potential to improve 
enhance systemic antioxidant capacity. However no synergic effect was observed when PP and 
MOS were combined.  
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Evaluation of the immune response against ovalbumin (OVA) in pigs orally 
vaccinated with OVA in tablets containing carboxymethyl high amylose starch 
(CM-HAS), flagellin and  sow’s milk. 
 
3.1 Abstract 
 
This trial was designed with the aim to determine the effects of a new delivery system designed for 
oral vaccination or delivery of bioactive molecule in the gut.  The trial was also designed to 
evaluate the potential of the sow’s milk to modulate the systemic as well as local immune response 
against the antigen ovalbumin incorporated in the vaccine. Sixteen piglets of 28 days (d) of age 
were divided into 4 groups of 4 animals each. The first group was vaccinated with compressed 
tablets containing only ovalbumin (OVA); the second group was immunized with tablets containing  
ovalbumin and the B subunit of the flagellin from Salmonella enterica Typhimurium (OVA-FLA); 
the 3rd and 4th groups were immunized with tablets containing ovalbumin pre-incubated in sow milk 
with or without flagellin, respectively (OVA-LT or OVA-LT-FLA). The oral vaccination was 
performed in two periods of three days; the 1st  period being from day 28 to day 30 of age (D1-D3 
of the trial) and the 2nd  from 42 d to 45 d of age ( D14-D16).  Blood samples were collected at days 
1, 14, 21, 28 and 42 of the trial to determine, by ELISA, serum antibody titre against OVA. Feces 
samples were also collected before the first immunization and intestinal content from the ileum was 
collected at slaughtering to evaluate level of IgA anti-OVA by ELISA. All the animals were 
euthanized 42 days post-immunization to collect blood, mesenteric lymph nodes (MLN) and ileum 
content. The immune cells were isolated from the MLN and from blood and cultured  with OVA to 
evaluate the lymphocyte proliferative response by flow cytometry (CFSE cell proliferation kit) and 
production of the main cytokine produced in adaptative immune response such as Interleukine-2 
(IL-2) , IL-4, IL-10 and interferon-gamma (IFN-γ).  Experimental animal studies have indicated that 
oral administration of antigens targets the systemic T cell compartment, diminishes cell-mediated 
immune responses, and induces tolerance. This phenomenon might lead to the induction of 
cytokines such as Transforming Growth Factor beta (TGF–β) and IL-10, and consequently enhance 
antigen-specific antibodies such as IgA and IgG. While the humoral immune response is critical in 
the control of some mucosal pathogens, those effects might be inappropriate on other mucosal 
pathogens where cell mediated immune responses may play a larger role.   
 
Key words: Piglets, gut health, ovalbumin, sow’s milk , oral vaccination,  cytokines 
 
 
3.2 Introduction 
 
Over the past few decades, research regarding the development of new dietary formulation for 
weanling pigs to improve performance and health has gained in interest.  Since then, new pathogens 
emerge and it appears that new formulations with functional foods are needed to enhance immunity 
without the use of antibiotics with growth promoting action. Rather, nutritional approaches to 
enhance immune function should focus on supplying the nutrients at the appropriate times and in 
the appropriate amounts that complement the ‘pool’ associated with increased nutrient partitioning 
for immune function. As nutrients continue to be examined for their immunomodulatory properties, 
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it is important to carefully select criteria to be used to determine their effectiveness or response 
(Fulton, 2004). Specifically, it will be important for future studies in this area to select assays that 
are accurate in their estimation and are relevant and/or related to disease resistance (Cunningham-
Rundles, 1998). It is not clear how changes in relative immune organ weights relate to disease 
resistance. Furthermore, it is assumed that in vitro lymphocyte proliferative response to mitogenic 
stimulation involve similar signalization pathways and cytokine production  that triggers in vivo 
proliferation of lymphocytes after antigenic stimulations (Jun 2009). The gut is the largest lymphoid 
tissue in the body and therefore represents an attractive target for modulating immunity. Gut 
associated lymphoid tissue can be modulated by feeding supplements of live microorganisms, 
probiotics or prebiotics. Feeding probiotics and prebiotics results in improved gut health and 
increased enteric and systemic immune responses to specific pathogens (Erickson et al., 2000; 
Rastall et al., 2002).  Drastic changes in the gut microbial ecology are detrimental and can result in 
opportunistic infections. The immune system in the gastrointestinal tract plays a crucial role in the 
control of infection, as it constitutes the first line of defense against mucosal pathogens. The 
attractive features of oral immunization have led to the exploration of a variety of oral delivery 
systems. However, none of these oral delivery systems have been applied to existing commercial 
vaccines. To overcome this, a new generation of oral vaccine delivery systems that target antigens 
to gut-associated lymphoid tissue is required. One promising approach is to exploit the potential of 
microfold (M) cells by mimicking the entry of pathogens into these cells. Targeting specific 
receptors on the apical surface of M cells might enhance the entry of antigens, initiating the immune 
response and consequently leading to protection against mucosal pathogens. The aim of this 
preliminary study was to determine the potential encapsulated ovalbumin (OVA) into monolithic 
tablets made of carboxymethyl high amylase starch (CM-HAS) to induce a gut mucosal immune 
response against OVA. In previous study, CM-HAS has been already used succesfully to protect 
probiotics bacteria against gastrointestinal conditions (Calineescu et Matescuu, 2008).  The filament 
of the flagella, that gives the mobility to the bacteria, is a polymer constituted mainly by flagellin. 
In this study, the B subunit of the Salmonella enterica serovar Thyphimurium flagellin was chosen 
for is property to bind to toll-like receptor-5 and to pass through the M cells (Azizi et al., 2010) of 
the intestinal mucosa and so, deliver antigen to the Peyer patches which underlies the Microfold 
(M) cells. Through this oral vaccination approach, the immunological properties of sow’s milk was 
evaluated by measuring the potential of milk to modulate the immune response against ovalbumin 
encapsulated in CM-HAS. 
The experiment was subdivided in two animal trials. 
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3.3 Materials and methods 
 
3.3.1 First animal trial  
 
This first animal trial was designed to evaluate the potency of sow’s milk to modulate humoral 
immune response following an intramuscular administration of ovalbumin with or without sow’s 
milk.  
  
3.3.1.2. Reagents and vaccine preparation 
 
Ovalbumin and incomplete Freund adjuvant were purchased from Sigma-Aldrich. Sow’s milk 
obtained at day 3 of lactation was pasteurized by heating the sample at 60 ºC for 30 minutes with 
gentle shaking.  One hundred microliter of milk were plated on nutrient agar and MacConkey No.2 
agar plates to verify the pasteurization process. 
 
3.3.1.3. Animals, vaccine administration and blood samples 
 
Twenty four Yorkshire X Landrace piglets weaned at 21 days were split in 3 groups (n=8).  The 
piglets came from 3 different litters and were divided to ensure homogeneity between groups 
according to litter, weight (9.1± 0.95 kg) and sex in each group. The animals were housed in 
separate pens according to their groups.  All the piglets were vaccinated at day 1 (28 days of age) 
and day 14 of the project. Group A was vaccinated with 1 mg ovalbumin that was emulsified with 
incomplete freund adjuvant. Group B was vaccinated with 1 mg ovalbumin that was mixed with 20 
µL of pasteurized sow’s milk. Group C was vaccinated with 1 mg ovalbumin that was mixed with 
20 µL pasteurized sow’s milk and was then emulsified in incomplete freund adjuvant.  Blood 
samples were taken from the jugular vein at days 1, 14, 21, 28, 35 and 42 after the first vaccination. 
 
3.3.1.4. Enzyme-linked immunosorbent assay against ovalbumin 
 
After blood coagulation at room temperature and centrifugation, serum samples were stored at -
20ºC until analyzed. Anti-OVA antibodies were measured by specific ELISA.  Microtiter plates 
(Maxisorp, Nunc) were coated with a solution of 8 µg ovalbumin/mL 50 mM carbonate buffer pH 
9.6.  The plates were incubated overnight at 4ºC.  The plate was blocked with 0.05% Tween 20 in 
phosphate buffered saline (PBST) pH 7.2 for 1 hour at 37ºC.  Pre-titered serum used as standard 
and serum samples were diluted in PBST and then distributed in the plates.  The plates were placed 
at room temperature for 2 hours.  Horseradish-peroxydase (HRP) coupled anti-pig IgG (bethyl) 
58 
 
diluted in PBST was then added to the wells and incubated for 1 hour at 37ºC.  The plates were 
revealed with 100 µL TMB 2-component system (Kirkegaard, Mandel) for 3 minutes and then 
stopped with 100 µL of 2M sulfuric acid. Plates were read on a SpectraMax 250 Microplate Reader 
at a wavelength of 450 nm. Between each step, the plates were washed 5 times with PBST. The titer 
was extrapolated from the standard curve.  
 
3.3.1.5. Ovalbumin specific cell proliferation 
 
On day 35 following the first immunization, heparinized blood was collected from the pigs of the 3 
groups.  Peripheral blood mononuclear cells (PBMCs) were obtained by layering 30 ml of blood on 
Ficoll-Paque PLUS density gradient and were processed as described by Lessard et al. (2005). The 
cells were counted with Countess® automated cell counter (Invitrogen).  1,5x 107 cells were then 
transferred to a 15ml culture tube and centrifuged at 750 x g  for 5 minutes at room temperature.  
The cells were then resuspended in 750 µL of 0,5 µM carboxyfluorescein diacetate succinimidyl 
ester (CFSE, Invitrogen) and then incubated for 15 minutes at 37ºC in a 5% CO2 humidified 
atmosphere.  The cells were then centrifuged 5 minutes at 750 x g at room temperature and placed 
in a quenching media (RPMI + 7,5% Donor calf serum) to remove excess of dye. After a 15 
minutes incubation at room temperature, cells were centrifuge 5 minutes at 750 x g at room 
temperature and resuspended in complete media (RPMI + 10 % fetal bovine serum + 1X penicillin-
streptomycin solution) and then put in 24-wells cell culture plate at a concentration of 2.5x 106cells 
per well. The cells were then left unstimulated (control) or stimulated with 5 µg OVA/mL of media.  
The cells were then incubated for 6 days at 37ºC in a 5% CO2 humidified atmosphere.  After de 
proliferation period, the cells were centrifuged 5 minutes at 750 x g at room temperature and 
resuspended in fixation buffer (1% formaldehyde diluted in ISOTON II (Beckman coulter)) 
 
3.3.1.6. Flow cytometry analysis of cell proliferation 
 
The samples were analysed with a Becmand Coulter XL_MCL flow cytometer equipped with a 
488nm argon ion laser.  Cells were first gated according to forward scatter and side scatter to 
analyse the data from living lymphocytes.  Then the fluorescence level was evaluated with FL1 
channel.  The voltage was set to obtain fluorescence of non-stimulated cells (control cells with no 
fluorescence) in the third log of FL1.  A gate was place on the non stimulated cells sample of each 
animal with a percentage of gated cells of no more than 2%. The percentage of relative proliferating 
cells was then obtained from the OVA stimulated cells.  For each animal, all samples were taken in 
duplicate.   
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3.3.2. Second animal trial  
 
3.3.2.1. Cloning and expression of Salmonella enterica serovar Typhimurium’s B subunit 
Flagellin 
 
The purified FLA used for this study was kindly prepared by Dr. Archibault lab. 
 
3.3.2.2. Tablets preparation 
 
The monolithic tablets of carboxymethyl high amylose starch (CM-HAS) were provided by Dr. 
Mateescu.  They were prepared as described by Calinescu & Mateescu (2008).  The probiotic 
bacteria used in their experiment was replaced by 100 mg of ovalbumin (OVA) that was premixed, 
or not, for 1h with sow’s milk (SM).  Ten microgram of recombinant flagellin (FLA) prepared in Dr 
Denis Archambault’s laboratory by Aurélie Girard (PhD student) and graciously given was added, 
or not, to the tablets.  Hence, four types of tablets were produced: 1) CM-HAS + OVA; 2) CM-HAS 
+ OVA + FLA; 3) CM-HAS + OVA + SM; 4) CM-HAS + OVA + FLA + SM. 
 
3.3.2.3. Animals, vaccine administration, blood samples and feces samples. 
 
Sixteen Yorkshire X Landrace piglets weaned at 21 days were split in 4 groups (n=4).  The piglets 
came from 4 different litters and were divided to ensure homogeneity between groups according to 
litter, weight (10.74± 0.33 kg) and sex of the animals in each group. The animals were housed in 
separate pens according to their groups.  All the piglets were vaccinated by tablets administration on 
3 consecutive days on days 1 to 3 (28±1 to 30±1 days of age) and again, on 3 consecutive days from 
day 14 to 17 of the project.  Blood samples were taken at days 1, 14, 21, 28, 35 and 42 after the first 
day of vaccination.  Serum was stored at -20ºC until analysed.  Feces were collected on day 1 and 
42 of the project. Feces were diluted 10 times in PBS buffer, homogenized in stomacher 2 X 60 
second and then centrifuged at 3000 x g for 20 minutes at 4ºC.  The supernatant was stored at -20ºC 
until analysed.  The animals were euthanized at day 42 and mesenteric lymph nodes were used for 
cell proliferation assay (as described in sections 2.1.4 and 2.1.4.1) and gene expression study.   
 
3.3.2.4 Gene expression study 
 
Mesenteric lymph node were kept on ice in Hanks balanced salt solution without calcium and 
magnesium (HBSS) containing penicillin (200 I.U./mL) and streptomycin (200 µg/mL).  The lymph 
nodes were grinded in small pieces and then passed several times into a 5 ml syringes to obtain a 
single cell suspension. Cell suspension was transferred into 15 ml conical tube. The debris were 
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allowed to decant for 5 minutes and the supernatant containing cell suspension was carefully 
layered over 4 mL of Ficoll Paque Plus. After 40 minutes of centrifugation at 750 x g, the 
mononuclear cells were removed and diluted in 10 ml of HBSS containing antibiotics. Cells were 
centrifuged and washed twice.  Cells were then counted and 1x107 cells were placed in a 6 well 
culture plate with 3 ml per well of RPMI containing antibiotics and 10% FBS.  The cells were then 
stimulated with media (negative control) Concanevalin A at 0,5 µg/ml (positive control) or 
ovalbumin at 10 µg/ml.  The supernatant was carefully removed after 24 hours of incubation in a 
humidified atmosphere with 5% CO2 and cells were lysed adding 1 mL of Trizol reagent 
(Invitrogen). Cells were then mixed and transferred into tubes before freezing them at -80ºC. The 
RNA was extracted following the Trizol manufacturer’s instructions. Six micrograms of RNA were 
digested with DNase from Ambion’s DNA-free kit following the manufacturer’s recommendations.  
For each sample 1 µg of total RNA was used for cDNA synthesis using Superscript reverse 
transcriptase (200U/reaction; Invitrogen) and anchored oligo-dT-primers (500 ng/reaction).The 
reaction was carried out in a final volume of 20 µL in an appropriate buffer (50 mM TrisHCl, pH: 
8.3; 3 mM MgCl2, 75 mM KCl, 10 mM DTT) and dNTPs (final concentration of 0.5 mM) for 1 h at 
42°C. The cDNA samples were diluted 1:15 in ultrapure RNase DNase free water and frozen at -
20°C till being used.  Real-time PCR was performed with the 7500 Fast Real-time PCR system 
(Applied Biosystems, USA) to evaluate the expression of the cytokines IL-2, IL-4, IL-10, IFN-γ, 
and of the housekeeping genes cyclophillin and β-actin.  Primers for cytokines as well as for two 
housekeeping genes, accession numbers of target gene sequences, concentration of primer used and 
amplicon sizes are described in Table I. The PCR mixture was composed of: 5 µl POWER SYBR® 
Green Master Mix (Applied Biosystems, USA), 0.1 µl of AmpErase®Uracil N-glycosylase 
(Applied Biosystems, USA), each set of primers (Applied Biosystems, USA) specific to molecules 
and housekeeping genes at the concentrations indicated in Table I, 3 µl of 1:15 diluted cDNA, and 
ultrapure water to a final volume of 10 µl. Primers were designed using the IDT SciTools 
PrimerQuest software program (http://www.idtdna.com/Scitools/Applications/Primerquest/) and 
selected using the following criteria: (1) forward and reverse primers were placed on two 
consecutive exons, (2) no more than two Gs or Cs within the last five nucleotides in the 3′ termini, 
(3) the calculated melting temperature of each primer, with 50mM Na+, had no more than 2.5ºC 
between the primer pair  (4) primer length between 19 and 24 pb, (5) primer design insure minimal 
self annealing and primer dimers. The PCR cycling conditions used were in accordance with the 
manufacturer’s protocol. an initial Taq-polymerase activating step at 50 ºC for 2 min followed by a 
denaturation step at 95 ºC for 10 minutes, then 45 cycles with a 3 sec at 95 ºC denaturation step, 
0:30 min at 60 ºC annealing and extension step, during which data were collected. A melting curve 
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was also done to assess the amplification of only desired amplicon. Level of expression was 
determined using a standard curve of a dilution series of DNA plasmid for each gene tested (Pfaffl 
MW et al., 2001). These plasmid standards were created by cloning gene-specific cDNA PCR 
products using a TA Cloning kit according to the manufacturer’s instructions (TOPO®TA cloning 
dual promoter kit, Invitrogen, Burlington, Ontario, Canada). The normalized expression level of the 
target gene was obtained as follows: target copy number/β-actin copy number. Amplification 
specificity was checked using a melting curve following the manufacturer’s instructions. Each run 
included a no template control to detect DNA contamination of the reagents and each reaction was 
performed in quadriplicate. 
 
3.3.2.5 ELISA and specific cell proliferation against OVA 
 
The ELISA was performed on serum samples and on diluted feces supernatant as described in 
section 4.1.3.  Anti-pig IgG and IgA coupled to HRP were used to measure both antibody isotypes 
in feces supernatant. The specific cell proliferation induced by ovalbumin was also measure in 
blood, as described in section 4.1.4 and 4.1.4.1. 
 
3.4. Statistical analysis 
 
A statistical analysis was carried out by using  the  GLM procedure of SAS (SAS institute v.9e) to 
evaluate the presence/absence of response of the different kind of vaccination for parameters such 
as PBMCs specific proliferation, feces IgA-IgG contents and cytokines (IL2, IL4, IL10, IFN-Ɣ).   
Statistical analysis was performed using the procedure PROC MIXED of SAS (SAS Institute v.9e) 
to calculate the presence/absence of response of the variable serum IgG to identify signifcant 
differences between groups (P< 0.05 ; P<0.01).  
 
3.5. Results 
 
3.5.1 First animal trial 
 
3.5.1.1 Measure of circulating antibody against ovalbumin 
A strong increase in OVA specific serum antibody (Fig.1) were observed 21 days after the 
vaccination for the animals vaccinated OVA+IFA and with a tendency to decrease during the last 
weeks of the trial with an effect on time (P<0.01). For the group vaccinated OVA+SM+IFA the 
peak of specific serum antibody (Fig.1) was observed 28 days after the inoculation of the vaccine 
and decreased progressively until 48 d with an effect on time (P<0.01). For the OVA+SM group the 
test didn’t find a high level of OVA-specific serum antibody (Fig.1). These results indicate that the 
immune response was higher in the animals vaccinated with the OVA in the presence of the 
Incomplete Freund Adjuvant (OVA+IFA) compared to animals of OVA+SM group from 21 to 42 d 
and OVA+IFA+SM group at 21 d (P<0.01). This result indicate that sow’s milk use at our dosage 
was not as good as IFA to induce a strong immune response to OVA. Although antibody response 
was lower in OVA+SM the same decours of the animals vaccinated OVA+IFA with a peak at 21 
days after the first vaccination with an homogeneous decrease until the end of the first animal trial. 
Adjuvant potential of the Sow’s milk use at our dosage was not strong enough to determine a high 
presence of OVA specific serum antibody during the trial, although a low presence of the antibody 
was detected during the first animal trial and seems to have the same decours of the animals 
vaccinated OVA+IFA with a peak at 21 days after the first vaccination with an  homogenous 
decrease until the end of the first animal trial (P <0.01). 
 
  
Fig 1. Measure of circulating antibody against ovalbumin. Piglets (28 days of age)  coming from 3 different litters  
were vaccinated at day 1 and day 14 of the project.  Group OVA+IFA (A) was vaccinated with 1 mg ovalbumin that 
was emulsified with incomplete freund adjuvant.  Group OVA+SM (B) was vaccinated with 1mg ovalbumin that was 
mixed with 20 µL pasteurized sow’s milk.  Group OVA+SM+IFA (C) was vaccinated with 1 mg ovalbumin that was 
mixed with 20 µL pasteurized sow’s milk and was then emulsified in incomplete freund adjuvant.  Blood samples were 
taken at days 1, 14, 21, 28, 35 and 42 after the first vaccination. 
*OVA specific antibody mean reciprocity of titre in piglets (n=8/treatment).  Animals (28 days of age) were vaccinated 
2 times  at days 1 and 14 of the project. OVA+IFAÆ Ovalbumin+ incomplete Freund adjuvant; OVA+SM Æ 
Ovalbumin + sow’s milk; OVA+SM+IFA Æ Ovalbumin + sow’s milk + incomplete Freund adjuvant. 
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3.5.1.2 Measure of specific in vitro cell proliferation of Peripheral blood mononuclear cells after 
antigen (ovalbumin) recall   
 
Peripheral blood mononuclear cells proliferation marked with CFSE placed in the presence of OVA 
(Table 2 and Fig.2) was higher in the group vaccinated with OVA+IFA but not statistical 
differences were seen between the different groups. The animals vaccinated OVA+SM had 
tendencial higher proliferation percentage compared to the ones vaccinated OVA+SM+IFA. No 
significative difference in cell proliferation was seen and the level of circulating proliferating cells 
was shown. 
 
 
 
Fig.2 Specific peripheral blood mononuclear cells proliferation after in vitro antigen recall.On day 35 following 
the first immunization, heparinized blood was collected from the pigs of the 3 groups and isolated on density gradient..  
The cells were then left unstimulated (control) or stimulated with 5 µg OVA /mL of media.  After a 6 days incubation, 
the proliferation was measured by flow cytometry.  Control cells were used to gate basal proliferation, wich was 
substracted from proliferation seen in OVA-stimulated wells. 
 
3.5.2 Second animal trial 
 
3.5.2.1  Measure of circulating antibody against ovalbumin  
Higher serum IgG concentrations on day 21, 28, 35 and 42 (P<0.05) was observed in the group 
orally vaccinated with OVA+FLA+SM compared to other groups. The levels of serum IgG were 
significantly lower during all the trial period in the animal vaccinated orally with ovalbumin 
compared to the other groups.   
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Fig.3 Measure of IgG in the serum of animals vaccinated orally with ovalbumin by ELISA 
 
3.5.2.2  Measure of IgG and IgA in feces by ELISA 
 
After oral administration of the four different kind of vaccine the IgA level were higher at day 42 
compared to the IgA at day 1 of the trial (P<0.05). As shown in the Fig. 3 the level of the IgA at the 
beginning of the trial was homogeneous for all groups. Secretion and excretion of IgA into feces 
were remarkably higher in the group which received the oral vaccination with OVA+FLA+SM 
compared to the OVA+SM at 42 d after weaning (P<0.05). The amounts of IgA into feces in the 
OVA-oral vaccinated was lower at the end of the trial (P<0.05). At the beginning of the study also 
the level of IgG in the animals of the four groups were omogeneous. At the end of the trial the 
animals of the group vaccinated by OA+FLA+SM registered higher value of secreting and 
excreting IgG into feces. 
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 *
Fig.3 Measure of IgA in the feces of animals vaccinated orally with ovalbumin by ELISA. OVA: ovalbumin, 
OVA+FLA: ovalbumin+flagellin, OVA+SM : ovalbumin + sow’s milk and OVA+FLA+SM: ovalbumin + flagellin 
+ sow’s milk  
 
 
Fig.4 Effects of oral vaccination with OVA (ovalbumin), OVA+FLA (ovalbumin+flagellin),OVA+SM (ovalbumin + 
sow’s milk) and OVA+FLA+SM (ovalbumin + flagellin + sow’s milk) on IgG secretion and excretion into feces. 
 
3.5.2.3  Measure of specific in vitro cell proliferation of PBMCs after antigen (OVA) recall  
 
No statistical differences were shown for peripheral blood mononuclear specific cells proliferation 
marked with CFSE, in the presence of OVA, FLA or OVA+FLA between the four oral vaccinated 
groups ( Fig.5). The animals vaccinated with OVA shown the lowest proliferation percentage 
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compared to the other three groups. The PBMCs cells of the group OVA+SM shown higher specific 
proliferation percentage compared to the OVA and OVA+FLA+SM groups when stimulated with  
 OVA. 
 
 
 
Fig.5 PBMCs (peripheral blood mononuclear cells) proliferative response to OVA (ovalbumin), FLA (flagellin) or 
OVA+FLA (ovalbumin+flagellin) after oral administration of four kind of vaccine: OVA, OVA+FLA, OVA+SM 
(ovalbumin+sow’s milk) or OVA+FLA+SM. 
 
3.5.2.4  Results of real-time PCR: cytokine expression of MLN (mesenteric lynph node) cells 
stimulated in vitro with OVA.  
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Cytokines produced by MLN cells were analyzed following in vitro culture in the presence of OVA.  
Fig.6 and 7 show the levels of expression in cell culture of IL-4, IL-10 and IFN- Ɣ..  The MLN 
cytokine mRNA expression profiles from piglets after vaccination shows in Fig.6 that the 
expression of interferon gamma, the main TH1 cytokine driving cytotoxic response of CD8+ T cells 
was expressed at least 5 times more, when compared to ova vaccination alone, in the groups 
vaccinated in the presence of flagellin or sow milk but not in the combination of the two product, 
showing an negative effect of the combination. The same profile was observed with the IL-2, 
showing that the two treatments gived better proliferation than OVA alone or the mix of the thwo 
component. The production of IL-10 in the groups receiving sow milk showed the potency of sow 
milk to odulate immune response toward a tolerance profile. The level of IL-4 production was 
surprisingly low for all groups, indicating a strong bias to the TH1 profile. The high presence of IL-
2 was registered by the OVA group after the cells stimulation with the positive control of 
proliferation: Concanavalin A (ConA) was expected since this lectin induce strong proliferation of 
T cells.  
 
 
Fig.6-7 Cytokine mRNA expression in mesenteric lymph node after isolation and cell culture in the presence  
of the the vaccine antigen ovalbumin (OVA; Fig. 6) or a positive control of proliferation, concanavalin A (ConA; Fig. 7).    
  
 
 
67 
 
68 
 
3.6 Discussion and conclusion 
 
Over the past few decades, oral immunization has been extensively studied due to its many 
attractive features. The immunological potential, absorption, or limitation in the uptake of antigens, 
as well as the characteristic distribution of functional cell types in the gastrointestinal tract (GI) 
tract, have made it a vital target in the development of oral vaccines. The phenomenon of tolerance 
is a crucial challenge to overcome in the development of effective oral vaccines. Experimental 
animal studies have indicated that oral administration of antigen targets the systemic T cell 
compartment, diminishes cell-mediated immune responses, and induces tolerance. This 
phenomenon might lead to the induction of cytokines such as IFN-Ɣ and IL-2, and consequently 
enhance antigen-specific antibody responses such as IgA and IgG (Azizi et al., 2010). While the 
humoral immune response is critical in the control of some mucosal pathogens, its effect might be 
questionable for other mucosal pathogens where cell-mediated immune responses may play a larger 
role. On the other hand the absence of a potent oral vaccine might be due to other challenges, 
including antigen degradation by proteolytic enzymes, the low dose of antigen absorbed, a lack of 
potent mucosal adjuvants, the absence of actively directed antigens to microfold cells (M cells). To 
overcome these issues, further investigations regarding oral vehicle delivery systems that protect 
antigens and specifically target M cells are required. Targeting M cells by mimicking the entry of 
mucosal pathogens such as pathogenic E. coli, Salmonella, and Yersinia may reflect the in vivo 
binding specificity required by orally administered antigens. Regarding this aspect, a number of 
studies showed that these pathogens bind to specific lectins expressed on the apical surface of M 
cells (Holmgren et al., 2005). The binding of orally administered vaccines to M cell lectins was 
further studied in murine models and indicated that a-L-fucose-lectin (UEA-1) is able to bind 
specifically to M cells and, to a lesser degree, enterocytes (Holmgren et al., 2005). However, the 
characterization of murine M cells by this lectin-binding pattern did not reflect the glycosylation 
patterns of human M cells. Unfortunately, pig M cell features, function, and differentiation from 
neighboring enterocytes are not well understood. Further investigations using nutritional strategies 
and oral vaccination might generate more specifically direct oral delivery of antigens to pig M cells. 
However, as these molecules are also expressed on neighboring enterocytes, it will likely be 
difficult to devise an ideal oral delivery system for targeting M cells. The understanding of M cell 
function, identification of more specific apical surface molecules, and the improvement of intestinal 
M cell–like models are crucial for the design and further development of M cell–targeted vaccines. 
Of course we have to remember that in vitro assays are commonly used on standardized cell number 
as well as isolated cell populations, which does not reflect the cellular environment in vivo.  
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Until now, a small number of papers have been published to investigate the effect of oral 
vaccination with OVA, SM and FLA on humoral immunity in weaned piglets. IgG and IgA, the 
major serum immunoglobulins, are key components of the humoral immunity in all mammals (Li et 
al. 2007). Our results indicate, although the overall level of specific immunoglobulin was low, that 
the vaccination with OVA+FLA+SM can influence an immune response increasing feces IgA and 
IgG levels and was accompanied by enhanced serum IgG concentrations in weaned piglets. The 
results suggests that the presence of SM or FLA can influence the immune response against OVA 
and that there is a synergy between the two compounds (FLA+SM) but more knowledge will be 
neeed to understand exactly the way of action of these compounds. Politis et al. (2007) 
demonstrated the immune stimulatory action of milk to post weaned piglets and also in the current 
study the mechanism by which this vaccination enhanced immunoglobulin levels may be attributed 
to the immunostimulatory action of the peptide contained in the milk. Interestingly, introduction of 
these bioactive compounds to the immunological immature neonatal gastrointestinal tract may 
potentiate an inappropriate immune response. Immune stimulation accumulates in the partitioning 
of nutrients from normal growth to support components of the immune response improving also 
growth performance of the animals (data not shown) during a critical phase as the weaning. 
Cytokines are important molecules mediating antibody production and thus the immune response in 
the host. IL-2 and IL-6 are involved in immune regulation and host defense (Li et al. 2007). IL-10 
can inhibit the synthesis of pro-inflammatory cytokines such as IFN-γ and can suppress the antigen 
presentation capacity of antigen presenting cells (ajouter référence). IL-2 regulates the 
differentiation and activation of T cells, B cells, natural killer and lymphocyte-activated killer cells, 
monocytes and macrophages that are involved in cellular and humoral immune responses (Wang 
1991; Liu & Liu 1992). IL-4 plays a critical role in  activation of B-cell and T-cell proliferation and 
is a key regulator in humoral and adaptive immunity. IFN-Ɣ has potent antiviral properties that 
contribute to the control of acute viral infections and is an important mediator of cellular responses. 
Compelling evidence shows that many types of bioactive compounds can increase the production of 
cytokines (including IL-2 and IL-4), which play important roles in immune responses (Liu & Liu 
1992). In the current study, the treatment with OVA+FLA or OVA+SM but not the combination of 
the two immunomodulator (OVA+FLA+SM) enhanced MLN mRNA expression of IFN-Ɣ an  IL-2. 
Thus, the current results suggest that the oral vaccination with components such as milk or flagellin 
has the potential to activate lymphocytes and to modulate cytokine response in weaned piglets. The 
gut is a major immune organ in mammals. Specifically, the T and B lymphocytes proliferate and 
mature in the gut-associated lymphoid tissue (GALT), mounting a successful immune response to 
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antigens. Many studies have shown that the GALT is composed of immune cells and lymph nodes, 
conferring both non-specific and specific immune functions (Poussier & Julius 1994). IFN-Ɣ 
probably plays a key role in activation, proliferation and differentiation of T-cells, as well as 
improving both specific and non-specific immune responses in weaned piglets. The enhanced 
expression of IL-2, which is important for primary T-cell activation, could result in improved 
immunostimulation in pigs vaccinated with CMS tablets containing OVA with either FLA or SM. It 
is likely that stimulation of lymphocytes and modulation of cytokine production contributed to 
improve antibody response to OVA by the gut immune system. Further studies will explore the 
potential of these new diets strategies to prevent the negative impact of a pathogen challenge. 
In conclusion, oral vaccination could represent the future of the nutrition thanks to its positive 
action directly on the gut health influencing humoral immune response in piglets, suggesting an 
enhancement of host defenses against presenting pathogens. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
71 
 
 
3.7 References 
 
 
Alignani D, Maletto B, Liscovsky M, Ropolo A, Moron G, Pistoresi-Palencia MC. Orally 
administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young 
and aged mice. J Leukoc Biol. 2005;77:898-905. 
 
Batish, V.K.; Chander, H.; Zumdegni, K.C.; Bhatia, K.L.; Singh, R.S. Antibacterial activity of 
lactoferrin against some common food-borne pathogenic organisms. The Australian Journal of 
Dairy Technology 1988, 5, 16–18. 
 
Belkys A. Maletto, Andrea S. Ropolo, Diego O. Alignani, Miriam V. Liscovsky, Romina P. 
Ranocchia, Victor Gabriel Moron, and Marı´a C. Pistoresi-Palencia Presence of neutrophil-bearing 
antigen in lymphoid organs of immune mice. Blood, 1 november 2006 _ vol 108, n 9 
 
Boudry C., Buldgen A., Portetelle D., Gianello P., Théwis A., Leterme P., Dehoux J.P. Effect of 
bovine colostrum supplementation on cytokine mRNA expression in weaned piglets. Livestock 
Science 108 (2007) 295–298 
 
Boudry C., Dehoux J.P., Portetelle D., Buldgen A. Bovine colostrum as a natural growth promoter 
for newly weaned piglets: a review Biotechnol. Agron. Soc. Environ. 2008 12(2), 157-170  
 
Calinescu, C.  &  M. A. Mateescu. 2008. Carboxymethyl high amylose starch: Chitosan self-
stabilized matrix for probiotic colon delivery. Eur J Pharm Biopharm. 70(2):582-9. 
 
Franz J.& G. Corthier. Measurement of porcine faecal IgA, IgG and IgM levels 
by a competitive enzyme-linked immunosorbent assay Clin. exp. Immunol. (1981) 44, 645-649. 
 
Kai-Chuang Shi , Xin Guo , Xin-Na Ge , Qi Liu , Han-Chun Yang. Cytokine mRNA expression 
profiles in peripheral blood mononuclear cells from piglets experimentally co-infected with porcine 
reproductive and respiratory syndrome virus and porcine circovirus type 2. Short communication 
 
Kekarainen, T., Montoya, M., Mateu, E., Segale´ s, J., 2008. Porcine circovirus type 2-induced 
interleukin-10 modulates recall antigen responses. J. Gen. Virol. 89, 760–765. 
 
Kim, J., Ha, Y., Chae, C., 2006. Potentiation of porcine circovirus 2-induced postweaning 
multisystemic wasting syndrome by porcine parvovirus is associated with excessive production of 
tumor necrosis factoralpha. Vet. Pathol. 43, 718–725. 
 
Lessard, M., M. Dupuis, and C. Farmer. 2005. Effects of prolactin inhibition during late gestation 
on the immunity of gilts and foetuses. Can. J. Anim. Sci. 85:335–343 
 
S.G. Leonard, T. Sweeney, B. Bahar, K.M. Pierce, B.P. Lynch, J.V. O'Doherty. The effects of 
maternal dietary supplementation with seaweed extract and fish oil on the humoral immune 
response and performance of suckling piglets Livestock Science 134 (2010) 211–214 
 
L. L. Li, X.Wu , H.Z. Peng, M.Z. Fan, Z.P. Hou, X.F. Kong , Y.L. Yin, B. Zhang, T. J. Li, Y.Q. 
Hou , K.M. Yang, A.K. Li, C.Y. Liu, X.M. Qiu, and Y. L. Liu. The effect of dietary addition of a 
polysaccharide from Atractylodes macrophala Koidz on growth performance, immunoglobulin 
72 
 
concentration and IL-1b expression in weaned piglets. Journal of Agricultural Science (2009), 147, 
625–631. 
 
Longhi, C.; Conte, M.P.; Bellamy, W.; Seganti, L.; Valenti, P. Effect of lactoferricin B, a pepsin- 
generated peptide of bovine lactoferrin, on Escherichia coli HB101 (pR1203) entry into HeLa 
cells. Medical Microbiology and Immunology 1994, 183, 77–85. 
 
J. P. Lalle` s1-, P. Bosi2, P. Janczyk3, S. J. Koopmans4 and D. Torrallardona5 Impact of bioactive 
substances on the gastrointestinal tract and performance of weaned piglets: a review* 
Animal (2009), 3:12, pp 1625–1643 & The Animal Consortium 2009 
 
Maletto BA, Ropolo AS, Liscovsky MV, Alignani DO, Glocker M, Pistoresi-Palencia MC. CpG 
oligodeoxinucleotides functions as an effective adjuvant in aged BALB/c mice. Clin Immunol. 
2005; 117:251-26 
 
Maletto B, Ropolo A, Moron V, Pistoresi-Palencia MC. CpG-DNA stimulates cellular and humoral 
immunity and promotes Th1 differentiation in aged BALB/c mice. J Leukoc Biol. 2002;72:447- 
454. 
 
Pluske, J.R., Hampson, D.J., Williams, I.H., 1997. Factors influencing the structure and function of 
the small intestine in the weaned pig: a review. Livest. Prod. Sci. 51, 215–236. 
 
SAS. (2003). User's Guide: Statistics, Version 9.1 ed. 2002-2003. SAS Inst, Inc., Gary, NC. 
 
Tacchini-Cottier F, Zweifel C, Belkaid Y, et al. An immunomodulatory function for neutrophils 
during the induction of a CD4_ Th2 response in BALB/c mice infected with Leishmania major. J 
Immunol. 2000;165:2628-2636. 
 
Vishal Tripathi and Bhavana Vashishtha. Bioactive Compounds of Colostrum and Its Application 
Food Reviews International, 22:225–244, 2006 
8FL57oF25oR5dI- R691e02v39iew ternational, Vol. 22, No. 03, April 2006: s In
ilpoastthriu amnd Vashishtha TCro
 
 
Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: 
molecules, functions and pathophysiological aspects. Lab Invest. 2000;80:617-653. 
 
Xu Jun, Z. Anguo*, W. Zhisheng* and A. Dawei. Glycinin and β-conglycinin of soybean on the 
proliferation and immune function of suckling piglets peripheral blood mononuclear cells in in vitro 
culture. the Journal of Animal & Plant Sciences 19(3): 2009, pages:115-118 issn: 1018-7081 
 
Yip HC, Karulin Ay, Tary-Lehmann M, et al. Adjuvant- guided type-1 and type-2 immunity: 
infectious/ noninfectious dichotomy defines the class of response. j immunol. 1999;162:3942-3949. 
 
 
73 
 
 
Table I. List of genes and sequences of the primers used for real-time PCR. 
 
mRNA 
target 
Accession 
number 
Primers (5' → 3')a Product 
size (bp) 
Final 
concentration 
(nM)b 
IL-4 
 
AY294020 F:GGTCTGCTTACTGGCATGTACC 
R:CTCCATGCACGAGTTCTTTCTC 
117 F 150 
R 150 
IL-10 L20001 F:GATATCAAGGAGCACGTGAACTC 
R:GAGCTTGCTAAAGGCACTCTTC 
137 F 300 
R 300 
IFN-γ NM_213948 F:AGGTTCCTAAATGGTAGCTCTGGG 
R:AGTTCACTGATGGCTTTGCGCT 
101 F 300 
R 300 
β-actin U07786 F:CTCTTCCAGCCCTCCTTCCT 
R:GCGTAGAGGTCCTTCCTGATGT 
104 F 300 
R 300 
PPIA NM_214353 F:TGCAGACAAAGTTCCAAAGACAG 
R:GCCACCAGTGCCATTATGG 
133 F 300 
R 300 
aF and R indicate forward and reverse primers, respectively. 
bFinal concentration of forward (F) and reverse (R) primers. 
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 Milk rice in piglet nutrition: benefits or not? 
 
 
4.1 Abstract 
 
Rice milk has been shown to contain a high sugar level and antioxidants such as Ɣ-Oryzanol. For 
this reason the effects on growth performance and health status of piglets have been studied on 36 
litters from (Landrace x LargeWhite) x Penerland sows. At 10 days after birth 18 litters were 
supplemented  with rice milk (T) until weaning while the others 18 received creep feed (C). At 21 
days a total of 288 piglets were weaned. Half from each group (72 piglets) were randomly assigned 
to either control (C) or treated (T), so there were four experimental piglet groups: CC, CT, TC and 
TT. All the animals received a pre-starter (0-14 d post weaning) and a starter (14-42 d pw) diets. 
Piglets from CT and TT groups were also supplemented with rice milk from weaning to 14 days 
pw. Piglets of TC group had significantly higher weight at 42 d pw (P<0.01), an higher average 
daily gain (ADG) and dry matter feed intake (DMFI) (P< 0.01). Rice milk supplementation had no 
influence in glucose, urea, total protein and lysozyme. Reactive oxygen metabolites (ROMs) levels 
resulted lower in TT piglets than CC and C-T groups at 14 d-post w. (P<0.05). Total antioxidant 
capacity was higher in CC and CT than TC piglets at 14 d after weaning (P<0.05). The data from 
this trial suggest that rice milk was associated with greater post weaning growth and health status 
when supplementation was given only during the nursing period. 
 
Key words: piglets, rice milk, growth performance, antioxidant capacity, Ɣ-Oryzanol 
 
4.2 Introduction  
 
Rice milk is a kind of grain milk processed from rice. It is mostly made from brown rice and 
commonly unsweetened. The sweetness in most rice milk varieties is generated by a natural 
enzymatic process, cleaving the carbohydrates into sugars such as glucose and maltose. Compared 
to cow's milk, vegetable milks contain more carbohydrates, but do not contain significant amounts 
of calcium or protein, and no cholesterol or lactose. Commercial brands of vegetable milks such as 
rice milk, however, are often fortified with vitamins and minerals, including calcium, vitamin B12, 
vitamin B3, and iron. Characteristic of this product is beside the high level of glucose and maltose 
and high level of Ɣ-Oryzanol, a mixture of ferulic acid, esters of sterol and triterpene alcohols 
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(Table 2-3-4). In addition to its outstanding antioxidant activity, it has been demonstrated that Ɣ-
Oryzanol has multiple neutraceutical functions, including reduction of total cholesterol, 
improvement of the plasma lipid pattern and inhibition of platelet aggregation (Juliano et al.,2005; 
Nam et al., 2008). Recent studies report that Ɣ-Oryzanol acts as an active scavenger of diphenyl 
picrylhydrazyl (DPPH), hydroxyl, and superoxide radicals, and efficiently protects against lipid 
peroxidation (Xu et al., 2001). These studies suggest that OZ has high potential as a functional food 
ingredient and as a stabilizer of lipidic raw materials (Ismail et al., 2010). Ɣ-oryzanol showed 
potential antioxidant in vitro activity similar to vitamin E in the regulation of antioxidants and 
oxidative stress gene markers (Xu et al., 1999). 
 Before and after weaning the piglets undergo a stress-related growth check, often associated with 
anorexia and under-nutrition, with predisposition to diarrhea and infection. Due to its richness in 
carbohydrates such as glucose and maltose rice milk may play an important role in nursery piglets 
thanks to its high palatability and sugars and antioxidant availability. High feed palatability with  
sweeteners may also improve feed intake before and immediately after weaning (Naranjo et al., 
2010). Moreover carbohydrates present in rice milk may represent an important source of energy 
for the weaker piglets of litters which do not have enough strength to compete with the brothers for 
a correct consumption of maternal milk (Stephas et al., 1998). Carbohydrates sources have been 
evaluated as partial or total replacements for lactose in manufactured liquid diets for young pigs. 
Koreans researchers fed early weaned piglets (6,5 kg) with diets supplemented with lactose or 
maltose. No differences were shown on performance between the two treatments (Lee et al., 2000). 
The carbohydrate sources of rice milk (glucose and maltose) probably play an important role during 
the nursing phase determining more homogeneous weight at weaning of the piglets. In literature is 
reported that glucose can be a satisfactory energy source of carbohydrates such as lactose for the pig 
during its first week of life (Aherne et al., 1969). A study where lactose and glucose were compared 
as carbohydrate sources in piglets from 1 to 22 days of age shown that ADG, gain feed and the 
apparent digestion for crude protein, ether extract, nitrogen-free extract, ash, energy and dry matter 
were similar for the two groups. The weight of piglets at weaning has been shown to have a 
significant effect on their subsequent growth performance. For example, Kavanagh et al. (1997) and 
Mahan et al. (1998) demonstrated that compared to heavier pigs, lighter pigs at weaning had lower 
growth rates after weaning and required a greater number of days to reach a common slaughter 
weight. In addition, variation in piglet weights within a group at weaning can affect the productivity 
of commercial pig production systems, particularly those implementing all-in all-out animal 
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management (Hardy, 1998). Weaning weight has been shown to be closely related to birth weight 
(Wolter and Ellis, 2001) and to the amount of sow’s milk consumed by the piglet during lactation 
(Lewis et al., 1978). Providing piglets with supplementary liquid milk replacer during lactation can 
increase weaning weights (Azain et al., 1996; King et al., 1998). Therefore, the objective of the 
current study was to evaluate the effects of dietary supplementation with rice milk on growth 
performance and health status of piglets during the nursing and nursery period.  
 
4.3 Materials and methods 
 
4.3.1Animals and diet  
 
We studied 36 litters from (LxLW) sows (288 piglets LxLW)x Penerland matched for parity and 
assigned to 1 of 2 experimental groups (Control, C and Treated, T). There were two studies phases: 
(i) dietary treatments of litters from 10 days of age to weaning separated in two groups, and (ii) 
dietary treatment of the piglets from weaning (21 days of age) until 42 days after weaning. All 
animals were treated in accordance with European Community guidelines approved by the Italian 
Ministry of Health.  
 
4.3.1.1 Nursing period 
 
The litters were randomly allotted to control (C) or rice milk supplementation (T) groups of 18 
replicates each standardized to 9-10 piglets per sow (excess piglets at 2 d post parturition were 
selected randomly and placed with other sows in the same treatment group in litters of similar age). 
Group C received creep feed beside sow’s milk; group T received rice milk in addition to sow’s 
milk (no creep feed). The two groups were housed in separate sheds (8.0 x 5.0 m) with slatted 
concrete floors. The animals had free access to the sow’s milk and creep feed or rice milk from 10 d 
of age until weaning (21 d of age). Piglets body weight was determined at 10 d age and at weaning. 
 
4.3.1.2 Post-weaning 
 
At day 21, a total of 288 piglets were weaned by moving them to environmentally controlled pens, 
each replicate containing 12 piglets; males and females were separated and the animals were 
grouped by weight. Each pens was 2.69 m2 (2,5 m x 1 m), had a slatted floor, and was equipped 
with two water nipples and six-hole self-feeder. The piglets were allowed an ad libitum access to 
feed and water. The house was lit by a combination of daylight (through skylights) and artificial 
light (non-programmable). Ventilation was archieved by single, variable-speed fans linked to 
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temperature sensors. The temperature inside the building was approximately 28-30°C at the start of 
the trial, adjusted weekly until a final temperature of 20°C.  Half the litter in each sow group (C or 
T) were assigned to rice milk, the other half to control. So the piglets formed four experimental 
groups of 72 piglets each:  
C-C: creep feed nursing; dry feed post weaning; 
C-T: creep feed nursing; dry feed plus rice milk post weaning; 
T-C: rice milk nursing; drey feed post weaning; 
T-T: rice milk nursing; dry feed plus rice milk post weaning. 
All piglets were fed a prestarter diet from weaning to 14 d-post weaning (pw) and a starter diet from 
14 d to 42 d pw. In addition to basal diet, piglets from CT and TT groups had free access to milk 
rice from weaning to 14 d-post weaning. After 14 d from weaning all the animals were fed a starter 
diet (Table 1) and no more rice milk were supplemented. No antibiotics and other growth-
promoting agents were included in the diets.  
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  Table 1. Composition and calculated analyses of the experimental diets1 
Ingredients, % Prestarter 
24-38 days of age 
Starter 
38-66 days of age 
Maize meal 20.9 30 
Biscuits flaked  15 13.8 
Maize flaked 13 --- 
Barley 8 11.9 
Dried whey  7.5 5 
Soybean meal 44 % CP  6.5 6.6 
Probiolat1 5 5 
Herring meal  5 5 
Soy protein conc. (Soycomil) 5 3.5 
Whey solubile 5 2.5 
Wheat middlings  4 12 
Calcium carbonate 1 1.15 
Dicalcium phosphate 1 0.85 
L-Lysine HCl 78 0.7 0.4 
L-Threonine 0.6 0.15 
Soy oil 0.5 1 
Mineral Vitamin mixture3 0.5 0.5 
Antibiotics4 0.4 0.4 
DL-Methionine 0.25 0.1 
Salt 0.15 0.15 
Chemical analysis, % as fed  
ME, kcal/kg 3250 3150 
Crude protein, % 18.82 18.13 
Crude fibre, % 2.82 3.57 
Ether extract, % 5.62 6.03 
Ash, % 7.03 7.02 
Lysine, % 1.47 1.21 
Methionine, % 0.58 0.43 
Met+Cys, % 0.81 0.67 
Threonine, % 1.26 0.81 
Tryptophane, % 0.18 0.19 
Calcium, % 1.04 1.05 
Available phosphorus, % 0.45 0.44 
 
1 Probiolat: Whey concentrate protein + soybean concentrate protein. 
2 Inclusion per kg in the diet: vitamin A, 3.600.000 IU; vitamin D3, 360.000 IU; vitamin E (dl-α-tocopherol acetate), 24.000 mg; thiamine (vitamin B1), 800 mg; riboflavin (vitamin 
B2), 1200 µg; pyridoxine (vitamin B6), 1000  mg; cyanocobalamin (vitamin B12),8000 μg; vitamin K3, 400 mg; niacin (nicotinic acid), 50 mg; pantothenic acid, 3.600 mg; folic acid, 
400 mg; biotin, 60.000 μg; choline 90.000 mg; Mn (MnO), 8000 mg; Zn (ZnO), 29.000 mg; Fe (FeSO4·H2O), 46.000 mg; Cu (CuSO4·5H2O), 30.000 mg; Co (CoSO4·7H2O), 200 
mg; I (KI), 300 mg; Se (Na2SeO3), 70 mg
Table 2-3-4 characteristics of rice milk 
 
 
g/ 100 g (DM) 
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Value 
MOISTURE  86.12 
ENERGY   53 kcal/100g 
PROTEIN   8.28  
FAT   7.63  
FIBER   11.5  
ASHES  2.59  
CARBOHYDRATES  69.96   
GLUCOSE   54,75  
GALACTOSE  < 0.01 
FRUCTOSE   < 0.01 
LACTOSE   < 0.01 
SACCHAROSE  < 0.01 
MALTOSE   4.37  
VITAMINES    mg/kg (DM)   
VITAMINE B1   3.4 
VITAMINE B2   0.32 
VITAMINS PP   64  
ELEMENTS    mg/kg (DM)   
ZINC  5.96 
CALCIUM  159  
IRON (D.M)  7.77 
PHOSPHORUS  1896 
POTASSIUM   671  
SELENIUM   < 0.05 
SODIUM   2625 
Ɣ ORYZANOL (D.M)  31 mg / kg 
 
 
 
 
 
 
 
 
 
 
Table  4 Lipidic profile of rice milk % of total acids 
BUTIRRIC ACID  < 0.01 
CAPRONIC ACID  0.62  
ENANTIC ACID  < 0.01 
CAPRILIC ACID  7.35  
CAPRINIC ACID  5.49  
CAPROLEIC ACID  < 0.01 
LAURIC ACID  38.18 
LAUROLEIC ACID  < 0.01 
TRIDECANOIC ACID  < 0.01 
TRIDOCENOIC ACID  < 0.01 
MYRISTIC ACID  13.97  
MYRISTOLEIC ACID  < 0.01 
PENTADECANOIC AC.  < 0.01 
PENTADECENOIC AC.  < 0.01 
PALMITIC ACID  10.38  
PALMITOLEIC ACID  < 0.01 
EPTADECANOIC  C:17:0  < 0.01 
EPTADECANOIC C:17:1  < 0.01 
STEARIC ACID  2.93  
OLEIC ACID  12.6  
LINOLEIC ACID  8.25  
LINOLENIC ACID  0.25  
ARACHIC ACID  < 0.01 
EICOSENOIC ACID  < 0.01 
BEENIC ACID  < 0.01 
ERUCIC ACID  < 0.01 
LIGNOCERIC ACID  < 0.01 
SATURATED FATTY ACIDS  78.90  
MONOINSATURATED FATTY ACIDS  12.60  
POLINSATURATED FATT ACIDS  8.50  
 
Table 2 Analitical analysis of rice milk 
Table 3 Aminoacidic composition of rice milk (mg/kg DM) 
ASPARTIC ACID   80  
TREONINE   42  
SERINE   61  
ASPARAGINE  104 
GLUTAMMIC ACID  167 
GLUTAMMINE   28  
PROLINE   39  
GLICINE   50  
ALANINE   130 
VALINE   72  
CISTINE  < 5 
METHIONINE   38  
ISOLEUCINE   76  
LEUCINE   79  
TYROSINE   43  
PHENILANINE  48  
ORNITINE   < 5 
LYSINE   90  
HISTIDINE   26  
ARGININE   183 
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4.3.2 Recorded parameters 
 
4.3.2.1 Performance:  
 
Piglets were weighted individually at the beginning of the trial (10 d of age), weaning (21 d), at 14 
and 42 d post weaning (end of trial). Feed intake was recorded per replicate at the same ages as the 
weight controls. Performance parameters, average daily gain (ADG), dry matter feed intake (DMFI) 
and feed convertio ratio (FCR) were therefore determined.  
 
4.3.2.2. Health status 
 
A daily health check was carried out during the whole trial, in order to record all possible incidents 
and implement suitable measures. 
 
4.3.2.3. Sampling and analysis 
 
Feed and rice milk samples were collected and analysed for nutritional homogeneity (AOAC, 
2000). Blood samples were collected into a venoject tube from the jugular vein puncture, just before 
feeding, of 12 piglets of each before weaning at 10 days of age. At weaning half of the 12 piglets of 
the two nursing groups were transferred in one of the each of post weaning treatments and bleeded 
14 d post weaning. After clotting at +4°C for 1 h, sera were separated by centrifugation (800 g, 10 
min) on a Centrifuge Megafuge 10R (Haereus Italia, Rome, Italy) and immediately stored at -20°C 
until analysis. Serum samples were analysed for Urea and Glucose with Synchron CX5® of 
Beckman Coulter (Fullerton, CA, USA).  ROMs and Oxy adsorbent test according to Brambilla et 
al.(2001 and 2002). Lysozyme and total serum protein according to Amadori  et Archetti (2002).   
 
4.4 Statistical analysis 
 
The animals represented the unit for the statistical analysis on live body weight (LBW), ADG and 
serum metabolites data. Data relative to LBW, ADG and plasma metabolites were analysed by a 
mixed repeated procedure of SAS using the initial body weight as covariate (SAS System 9e; SAS, 
Cary,NC, USA). The replicates were retained as statistical unit for dry matter feed intake (DMFI) 
and feed conversion ratio (FCR) calculations. Data relatives to DMFI and FCR were also analysed 
by a Mixed procedure of SAS (SAS System 9e; SAS, Cary,NC, USA). Significance was declared 
for value of  P<0.05 and P<0.01.  
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4.5 Results  
 
4.5.1 Growth performance 
 
The effects of rice milk on piglets growth performance are shown in Table 5. During nursing phase, 
rice milk supplementation increased piglets LW (P<0.01) and ADG (P< 0.01). Piglets fed milk rice 
during nursing phase and basal diet after weaning (TC) were heavier than CC and CT groups at 14 d 
pw (P<0.05) and than CC, CT, and TT piglets at 35 d pw (P<0.05). Piglets from TC group had also 
a higher ADG during postweaning with respect to CC (P< 0.05) and CT piglets (P<0.01).  
Dry matter intake was higher in TC piglets than TT, but no difference was observed for CC e CT 
groups during postweaning. Non difference was detected for FCR in nursery phase.  
 
Table 5: Effects of Milk rice dietary administration on piglets growth performances  
Nursing Phase (10 d age – weaning) 
Item  Control  litter Treated litter  STD. 
ERR. 
P < 
Weight (Kg) 10 d age 4.51 4.53 8.07 0.967 
Weaning  6.24 A 6.91 B 8.08 0.01 
ADG g/d 10d -
weaning 
180 A 237 B 3.92 0.01 
Milk 
consumption 
g/d 
10 d age- 
weaning 
X 2.63 1.05 0.01 
Creep feed 
consumption 
g /d 
10 d age - 
weaning 
9.80 X 
Nursery Phase (weaning – 42 d pw) 
  C-C C-T T-C T-T STD.ERR. P < 
Weight (Kg) Weaning 6.23 a 6.26 a 6.90 b 6.91 b 0.23 0.047 
 14 d pw 9.77 A 9.52 A a 10.80 B 10.16 b 0.24  
 42 p.w 17.68 A 17.27 A a 19.13 B 17.98 A b 0.23  
ADG (g/d) Weaning -14 
d pw 
277 255 A 299 B 254 A 27.36 < 0.01 
 14 d pw- 42 
pw 
376 369 a 399 b 367 a 37.52 0.041 
 Weaning – 
42 d pw 
301a 292 A 331B b 308 30.01  
DMFI (g/d) Weaning -14 
d pw 
297 b 286 292 275 a 6.19 0.013 
 14 d pw- 42 
pw 
758 B 758 B 773 B 700 A 6.19 < 0.01 
 Weaning – 
42 d pw 
583 B 583 B 589 B 544 A 6.19 < 0.01 
FCR Weaning -14 
d pw 
1.15 1.30 a 1.06 b 1.18 0.07 < 0.05 
 14 d pw- 42 
pw 
2.40 2.53 a 2.32 b 2.29 b 0.07 < 0.05 
 Weaning – 
42 d pw 
1.85 1.94 1.76 1.78 0.07 0.828 
A, B Means within row with different  supscript differ at P<0.01;  a,b Means within row with different  supscript differ at P<0.05 
4.5.2. Blood Parameters 
 
The blood parameters examined in this study are presented in Table 6. No difference in glucose, 
urea, total protein and lysozyme serum concentration. Reactive oxygen metabolites levels (ROM’s) 
resulted lower in piglets fed rice milk before weaning throughout 14 d post weaning (TT) (P<0.05). 
No difference were observed shown between the group TT and TC.  Piglets fed rice milk only 
during nursing phase (TC) showed a lower total antioxidant capacity after weaning compared to the 
other groups (P<0.05).    
 
 
 
*
*P<0.05 
 
*
Fig.1-2 Shown the results obtained from serum ROMS and Oxy adsorbent test. 
Animals were bleeded at 10 d of age and at 14 d after weaning.
83 
 
84 
 
Table 6 Effects of rice milk supplementation on blood parameters 
 Diet   
Age C-C C-T T-C T-T SEM P < 
Glucose mmol/l 
10 d 6.95 7.05 6.88 6.52 0.306 0.235 
14 d p.w 6.71 6.78 7.60 6.84 0.306 0.095 
Lisozime microg/ml 
10 d 3.23 3.01 5.24 3.44 0.806 0.853 
14 d p.w 4.36 3.56 4.51 4.16 0.806 0.865 
Urea mmol/l 
10 d 2.55 2.48 2.18 2.20 0.309 0.522 
14 d p.w 2.33 2.11 2.11 2.41 0.309 0.503 
Oxy-adsorbent test µmol HCl 0/ml 
10 d 331 334.50 325.33 324.50 21.136 0.851 
14 d p.w 410.17b 416.17 b 330.67a 380.83 21.136 0.05 
Rom’s mmol H2O2 
10 d 40.1 34.15 44.03 34.5 9.096 0.656 
14 d p.w 39.16 b 44.48 b 36.88 35.53 a 8.67 0.286 
Total seroprotein g/l 
10 d 52.67 55 54.83 53.67 2.364 0.493 
14 d p.w 44.83 45.83 50.33 46.17 2.364 0.115 
Albumine % 
10 d 44.83 48.35 51.55 49.13 1.437 0.065 
14 d p.w 47.55 47.81 48.80 48.45 1.437 0.758 
Alfa % 
10 d 20.58 20.60 21.60 20.53 1.017 0.488 
14 d p.w 23.82 23.30 22.55 22.80 1.017 0.508 
Beta % 
10 d 18.22 16.38 16.18 17.47 0.919 0.414 
14 d p.w 17.75 17.38 18.23 17.03 0.919 0.367 
Gamma % 
10 d 16.37  14.67 10.67 12.87 1.209 0.067 
14 d p.w 10.88 11.50 10.42 11.71 1.209 0.456 
A/G 
10 d 0.83 0.94 1.06 0.97 0.053 0.061 
14 d p.w 0.91 0.92 0.96 0.95 0.053 0.951 
A, B Means within row with different  supscript differ at P<0.01 
a,b Means within row with different  supscript differ at P<0.05 
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4.5.3. Health status 
 
With regard to digestive problems, no soft faeces were recorded during the whole trial in any 
treatment and only one piglet was treated for diarrhea.  
 
4.6 Discussion and conclusion 
 
At weaning piglets faces three challenges. First there are major changes to its food supply. Not only 
the piglets have to find the new food from a creep feeder but the characteristic of this feed are 
completely different from the sow’s milk. The second major challenge at weaning is the change of 
the physical environment. At weaning litters are generally mixed together into weaner pools. The 
third challeng is the physiological stress that accompanies moving and mixing. When all these 
changes are taken into account it is little wonder tat the rate of growth of the piglet falls after 
weaning. 
Special diets and management schemes have been developed with the goal to overcoming the post-
weaning syndrome in piglets (Zehn-Ping et al., 2007). Systems which use milk-based liquid diets 
have demonstrated piglets growth performance comparable to that in suckling piglets (Kim et al., 
2004; Lecce et al., 1969).  
Aim of this trial was to determine the effects of dietary supplementation of rice milk on piglets 
growth and health status. In the present study we evaluated for the first time the use of an 
alternative milk in the nursing and nursery piglets. Piglets growth was higher when litters were fed 
rice milk until weaning. After weaning the positive effects of rice milk supplementation were 
reduced probably because the high palatability of the product favoured a high milk intake reducing 
dry feed intake. The higher growth of piglets supplemented with rice milk only during nursing may 
be attributed to the higher supply of sugars before the weaning leading treated litters to reach a 
more and higher homogeneous weight at the end of the suckling period compared to litters fed the 
creep feed. The richness of carbohydrates and its palatability make this product an interesting 
energy source rapidly available to evaluate during a critical period such as pre-weaning. The 
availability of these substances can homogenize the weight of the litters giving more available 
energy to the weakest animals that can’t get enough energy from the sow’s milk. The higher 
nutrients requirements and the absence of mother’s milk reduce the effects of rice milk in the 
immediate postweaning.  
However, it should be stated that rice milk is used in human nutrition since a long time, but it has a 
few chances to be used in animal nutrition due to the high production costs.  
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Beside the high sugar content, rice milk is also a great source of functional compounds such as γ -
oryzanol so that it might also have beneficial effects on health. In this study, we evaluated some 
parameters related to oxidative stress as, it is well known, that piglets are subjected to a high level 
of stress during weaning. Reactive oxygen species (ROMs) are very reactive molecules ranked as 
free radicals owing to the presence of one unpaired electron such as a superoxide ion (O21 ±), 
nitrogen oxide (NO) and hydroxyl radical (HO± ) (Aruoma, 1994). Even though naturally present in 
the organism, they are mainly connected to cell compartments and counterbalanced by natural anti-
oxidant molecules, such as glutathione, glutathione peroxidase, superoxide dismutase, Q coenzyme, 
vitamin E and vitamin C, acting as free radical scavengers (Miller et al., 1993). When unbalanced, 
they lead to the oxidation of DNA, proteins and polyunsaturated fatty acids (PUFA) and to the 
formation of hydroxyl radicals (HR), which include lipid peroxides. Such a consequence on 
membranes is the first step in a cascade mechanism that leads to the systemic progressive release of 
ROMs from cell compartments, thus causing an increase of their concentration in the blood. Due to 
a high susceptibility, the early weaning pigs are quite exposed to oxidative stress which increase the 
amount of substrate for ROMs activity and thus the risk of lipid peroxidation (Nolan et al., 1995; 
Brambilla et al., 2002).  
The early detection of oxidative imbalance by simple and reliable methods is important to prevent 
such consequences. The positive action on the parameters such ROMs and the oxi adsorbent test of 
the animals fed rice milk can be explained by the presence of the γ-oryzanol (OR). Infact is 
demonstrated that OR is one of the major compounds that contributes to antioxidant improvement 
and regulation of antioxidant and oxidative stress related genes of stressed rat liver (Hiramitsu et al., 
1991). Other studies demonstrated that OR up-regulates the antioxidant genes while down-regulates 
the oxidative stress genes marker (Maznah et al., 2010).  
In our study, a significant reduction in ROMs was observed only in piglets fed rice milk during 
nursing and nursery period (TT group) (P< 0.05). Our results are confirmed by a number of studies 
carried out in humans and mice on the health benefits of rice γ-oryzanol such as anti-inflammatory 
activity and inhibiting cholesterol oxidation (Rong et al., 1997; Akihisa et al., 2000; Xu et al., 2001; 
Rohrer and Siebenmorgen 2004; Imsanguan et al., 2007). γ-Oryzanol can inhibit or retard the 
oxidation of an oxiable substrate in a chain reaction protecting biolocal molecules and tissue from 
oxidative damage (Yoshida et al., 2003).  
The animals of the control litters (CC; CT) shown higher value in the oxy-adsorbent test (P< 0.05) 
compared to the animals of the TT group. This data are not easy to explain because in the literature 
there are no studies on the use of this product in pig nutrition but seems to give a positive response 
that found confirm in the research on the activities of γ-Oryzanol. The supplementation of the rice 
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milk did not influence negatively the health parameters of the treated animals before and after 
weaning, and we demonstrate that also the serum glucose level are similar to all the groups; this 
means that rice milk is a great energetic source with high availability that can play an interesting 
role expecially in the nursing phase on the weakest animals homogenizing the weight at weaning. In 
conclusion, it can be postulate that rice milk supplementation might have positive effects in growth 
and feed intake during the immediate postweaning if administered from 10 d of age.  
This study suggests that the dietary supplementation during nursery period can improve the growth 
performance in the piglets after weaning. Therefore this product may be considered a functional 
foods for its richness of  bioactive compounds such as γ-oryzanol. More research will be needed to 
understand the potential of this functional food in piglets diet. 
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Effects of plant polyphenols and mannan oligosaccharide on growth performance, 
antioxidant defense system and gut health in Escherichia coli Challenged piglets 
 
 
5.1 Abstract 
 
Objective of the current study was to evaluate the effects of plant polyphenols (PP) and/or, mannan 
oligosaccharide (MOS) on growth performance, plasma antioxidant capacity and health in E. Coli-
challenged weaned piglets. Ninety-six piglets (7.43 + 0.89 kg L.W., 21 d age) were randomly 
allotted into 4 dietary treatments: control (basal diet), 0.1% PP, 0.1 % MOS or PP+MOS in a 6 
weeks study. At 21 and 25 d on trial half piglets of each group were orally inoculated with 4 ml of 
E.coli (1×109 cfu/ml) and half with the same amount of saline water.  
No difference was observed in growth. Plasma urea was markedly increased in PP+MOS group 
compared to PP group (P< 0.05), and lysozyme content was significantly decreased in PP+MOS 
group compared to groups on d 7 (P< 0.05). PP+MOS dietary supplementation decreased intestinal 
lipase and trypsin compared to PP on d 21 (P< 0.05). Plasma malondialdehyde content (MAD) 
increased, while plasma total antioxidant capacity (TAOC) and catalase (CAT) activities decreased 
in piglets 6 days after infection. Challenged piglets fed PP and those fed MOS showed higher 
TAOC than challenged piglets fed PP in combination with MOS. CAT activity resulted higher in 
challenged piglets fed diet supplemented with PP or PP+MOS than control or MOS at d 13 after 
infection (P< 0.05). The results showed that dietary PP or MOS had the potential to improve 
enhance systemic antioxidant capacity. However no synergic effect was observed when PP and 
MOS were combined.  
 
Key words: plant polyphenol(PP); mannan oligosaccharide (MOS), growth performance; 
antioxidant capacity; piglets ; E.coli challenge 
 
5.2 Introduction 
 
The ban of antibiotics as feed additive requires alternatives to stabilize the performance and health 
particular of the young animals. The use of natural origin feed additive has gain credence due to the 
non-bacterial resistant, non-harmful and non residual property and the potential to promote the 
growth and health in animals. Plant polyphenols (PP) are a powerful kind of naturally bioactive 
compounds found in food such as fruits, wine and tea as well as wood waste like larch bark 
(Hammer et al. 1999; Heim et al. 2002). It is known for a long time that polyphenols like the 
flavanoid, epicatechin, are efficient scavengers of free radicals (Sichel et al. 1991). Polyphenols 
from grape seeds were reported to be responsible for the preventing oxidative damage to cellular 
DNA in vitro (Fan and Lou, 2004). Plant polyphenols (PP) had exhibited antimicrobial activity 
against bacteria causing food-borne disease (Abram and Donko, 1999; Taguri et al. 2004; Percival 
et al. 2006; Kim et al. 2009).  In animal study, PP had also shown the ability to improve gut 
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microflora balance (Ishihara et al. 2001). More important, the British Pharmacopoeia (1996 Edition) 
reported that microorganisms do not build resistance to benzyl alcohol, phenols, polyphenols, and 
similar products. Thus, antioxidant and antimicrobial activity as well as gut modulation effects of 
plant polyphenols have been suggested (Windisch et al. 2008). Although massive studies have 
demonstrated antioxidative and antimicrobial efficacy of PP in vitro, evidences from animal trials 
are still quite scarce. Prebiotics is another solution for alternative of antibiotics. The common used 
prebiotics include mannanooligosaccharides (MOS), fructooligasccharides and 
galactoligosaccharides. MOS is derived from the outer cell wall of yeast. Meta-analyses of literature 
had shown that MOS supplementation improve body weight gain and feed efficiency in piglets 
(Jennifer et al. 2003, Eugeniusz et al, 2006). In addition, MOS were also reported to lower the level 
of total cholesterol and LDL-cholesterol in serum (Eugeniusz et al, 2006) and to mediate 
immunomodulatory effects in gut-associated lymphoid tissue (Janardhana et al. 2009).  In modern 
swine production, the common practice of early weaning usually caused the post-weanling piglets 
suffering from microbially induced gastrointestinal pathologies or diarrhea .Enterotoxigenic 
Escherichia coli (ETEC), is reported to be one main etiological agent that cause piglet intestine 
disorder after weanling. ETEC is the most important and most common cause of piglet diarrhea 
identified by diagnostic laboratories and veterinary practitioners. It was estimated that ETEC 
infection accounted for 50% of mortality in post weanling diarrhea piglet (Gyles, 1994). It is 
worthwhile to explore the possible protective role of natural origin feed ingredient against the 
ETEC infection. Therefore the purpose of this study is to determine the efficacy of a prepared PP 
complex or MOS or both using post-weaning piglets in the presence of experimentally challenge of 
E.coli. Growth performance, haematological profile, antioxidant capacity, ileac inflammatory 
responses were investigated. 
 
5.3 Materials and methods 
 
5.3.1. Animals and diet 
Ninety-six barrows crossbred weaned piglets (7.43 + 0.89 kg L.W., 21 d of age) homogeneous for 
weight, age, and litter origin were used. Piglets were housed in 24 pens (4 piglets per pen) in an 
environmentally regulated room. Pigs had free access to feed and water in the pen equipped with a 
feeder and a nipple waterer. Room temperature was kept at 27°C during the first 3 days then 
decreased by 1°C  for each subsequent week until 25°C. 
 
 
After 1 week of adaptation to basal diet piglets were allotted to 4 dietary treatments: 1) Control 
(Basal Diet); 2) PP (1.0 g/kg diet); 3) MOS (1.0 g/kg diet); 4) PP+MOS (1.0 g/kg+1.0 g/kg diet). 
Each treatment consisted of 6 replicates. 
The basal feed (Table 1) was formulated according to NRC nutrient requirements (1998). Feed was 
offered ad libitum in a mash form.  
The main ingredients in PP mixture were from apple, grape seed, green tea and olive leaves 
polyphenols. PP mixture was prepared based on the results of in vitro trials (Zhang, not published 
data).  
The study lasted 42 days and was divided in two phases: pre-challenge (0-21 d)  and post challenge 
(25-42 d). At 21 and 25 d on trial, half piglets from each treatment (3 pens/12 piglet per treatment) 
were orally inoculated with 4 ml of 1×109 cfu/ml Escherichia coli while the other half received 4 ml 
of physiological saline solution.  The challenge strain used was an E. coli O139:K82 LT_ isolated 
from a clinical case with PWD. Strains of O serogroup 139 have a well-established association with 
both OD and PWD. 
 
 
 
.  
Fig1. Weaning Room of University of Milan  facilities 
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Table 1  Composition and nutrients composition of the basal diets 
Ingredients, % Prestarter 
22-36 days of age 
Starter 
36-64 days of age 
Maize meal 31.3 30.4 
Biscuits flaked 15 13.8 
Maize flaked 13 --- 
Barley 8 11.9 
Dried whey 7.5 5 
Soybean meal 44 % CP  6.5 6.6 
Probiolat2 5 5 
Herring meal  5 5 
Soy protein conc. (Soycomil) 5 3.5 
Whey solubles 5 2.5 
Wheat middlings  4 12 
Calcium carbonate 1 1.15 
Dicalcium phosphate 1 0.85 
L-Lysine HCl 78 0.7 0.4 
L-Threonine 0.6 0.15 
Soy oil 0.5 1 
Mineral Vitamin mixture2 0.5 0.5 
DL-Methionine 0.25 0.1 
Salt 0.15 0.15 
Chemical analysis, % as fed  
ME, kcal/kg 3250 3150 
Crude protein, % 18.82 18.13 
Crude fibre, % 2.82 3.57 
Ether extract, % 5.62 6.03 
Ash, % 7.03 7.02 
Lysine, % 1.47 1.21 
Methionine, % 0.58 0.43 
Met+Cys, % 0.81 0.67 
Threonine, % 1.26 0.81 
Tryptophane, % 0.18 0.19 
Calcium, % 1.04 1.05 
Available phosphorus, % 0.45 0.44 
 
1 Mos and/or Poliphenols included in T at 100 g/tonne (1 x 109 CFU/g feed); in T2 at 4 kg/tonne (1 x 109 CFU/g feed).   
2 Probiolat: Whey concentrate protein + soybean concentrate protein. 
3 Inclusion per kg in the diet: vitamin A, 3.600.000 IU; vitamin D3, 360.000 IU; vitamin E (dl-α-tocopherol acetate), 24.000 mg; thiamine 
(vitamin B1), 800 mg; riboflavin (vitamin B2), 1200 µg; pyridoxine (vitamin B6), 1000  mg; cyanocobalamin (vitamin B12),8000 μg; 
vitamin K3, 400 mg; niacin (nicotinic acid), 50 mg; pantothenic acid, 3.600 mg; folic acid, 400 mg; biotin, 60.000 μg; choline 90.000 mg; 
Mn (MnO), 8000 mg; Zn (ZnO), 29.000 mg; Fe (FeSO4·H2O), 46.000 mg; Cu (CuSO4·5H2O), 30.000 mg; Co (CoSO4·7H2O), 200 mg; I 
(KI), 300 mg; Se (Na2SeO3), 70 mg. 
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5.3.2. Growth performance and samples collection 
 
The piglets were weighted weekly and feed intake per pen was recorded accordingly. At days 7, 21, 
25, 28, 35 on trial, 1 piglet from each pen was selected and blood sample was taken from the jugular 
vein in heparinized centrifuge tube. Plasma was proceed by centrifugation at 4°C 1,800 × g for 10 
min. The resulting plasma sample was stored at –20°C pending analysis. 
At days 21 (before E. Coli challenge), 25 and 28 on trial, one piglet/treatment/d, homogeneous for 
weight was selected and slaughtered via exsanguinations in a standard commercial slaughter house. 
Digesta samples from distal duodenum were collected and immediately stored at - 80°C pending 
analysis. 
 
5.3.3 Chemical.analysis 
 
5.3.3.1 Blood parameters 
 
Blood samples were analysed by using the automated Sysmex XT-2000iV hematology analyzer and 
the following biochemical parameters were determined: Hemoglobin (HGB) and Hematocrit 
(HCT), Red Blood Cells Count (RBC), Mean Cell Volume (MCV), Mean Cell Hemoglobin (MCH), 
Mean Cell Hemoglobin Cconcentration (MCHC), Red distribution width (RDW), Platelet Count 
(PLT), Mean Platelet Volume (MPV), Platelet distribution width (PDW), White Blood Cells Count 
(WBC) as well as White Blood Cell Pprofiles,  including counts and percentages of neutrophil 
granulocytes (Neu), lymphocytes (Lym), monocytes (Mono),  eosinophil (Eos) and basophil (Baso) 
granulocytes. 
 
5.3.3.2. Plasma parameters 
 
Plasma urea nitrogen and lysozyme content 
Plasma was analyzed for urea nitrogen concentration (PUN) by using a commercial kit from 
Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Plasma lysozyme activity was 
measured according the method of Kreukniet et al. (1994) by using micrococcus lysodeikticus cells 
as substrate. 
Total protein and lipid profile 
The plasma protein and lipid profile analysis were carried out according to Amadori et Archetti 
(2002). 
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Assay of plasma antioxidant indexes and ceruloplasmin 
Total antioxidant capacity (T-AOC) was measured according to Benzie and Strain (1996). The 
marker of lipid peroxidation MDA was quantified by measuring the thiobarbituric acid (TBA) 
reactive substances with spectrophotometer at 535 nm (Wills, 1966). TBA-material is described as 
nM of malondialdehyde (MDA) per mg protein or per mL. Glutatione peroxidase activity (GSH-Px) 
was assayed by the method of Lawrence and Burk (1976) using hydrogen peroxide as the substrate. 
One unit of GSH-Px is expressed as the amount of GSH-Px needed to oxidized 1μmol of NADPH 
per min. Total superoxido dismutase activity (SOD) was assayed according to the methods of Spitz 
and Oberly (1989). Units of SOD activity were defined by the amount of the enzyme required to 
inhibit the rate of formazan dye formation by 50% under defined conditions. The catalse (CAT) 
activity was estimated by the decomposition of H2O2 to yield H2O and O2, and monitored changes 
in absorbance at 240nm for 2 min (Cohen, 1970). One unit of activity was expressed as the amount 
of enzyme catalyzing the decomposition of one μM of H2O2 per min at 25°C and pH 7.0. The 
specific activity of all enzymes assayed was expressed as activity per mL. Plasma ceruloplasmin 
concentration was determined by the procedure of Schosinsky et al. (1974) using o-dianisidine 
dihydrochloride as substrate.  
Plasma hydroxyl radical inhibiting capacity was determined according to Yu et al. (2008) using the 
Fenton reaction as the hydroxyl radical generation system and Rhodamine B as a 
spectrophotometric indicator. To define the hydroxyl radical oxidation one unit of plasma hydroxyl 
radical inhibiting capacity was defined by the capacity to reduce the concentration of H2O2 by 1 
mmol/L at 37°C for 1 minute in 1 mL of plasma under defined conditions.  
Superoxide anion and hydroxyl radical inhibiting capacity was estimated by using cytochrome c 
reduction method by capturing the superoxide anion produced from reaction system of xanthine 
oxidase plus hypoxanthine (or xanthine) at pH 7.4 at 550 nm (Babior et al. 1970). One unit of 
plasma superoxide anion inhibiting capacity was expressed correspondence to capacity of one mg 
of Vitamin C to inhibit superoxide anion production in one liter of plasma at 37°C for 40 min in the 
reaction system.  
 
5.3.3.3 Intestinal parameters 
 
Inducible nitric oxide synthase activity and Nitrite Synthesis assay.  
Ileal mucosa samples were homogenized using a tissue homogenizer with 9 volume ice cold saline 
(9 g sodium chloride/l L of distilled water). The homogenates were centrifuged at 1,800×g for 10 
min. The inducible nitric oxide synthase (iNOS) activity was measured according to the method of 
Devaux et al. (2001). Protein concentration in mucosal homogenates was measured by the method 
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of Lowry et al (1951) using bovine serum albumin as standard.The nitrate in the supernatant of 
mucosa homogenate was measured by the Griess assay (Devaux et al. 2001).  
Myeloperoxidase (MPO) activity 
MPO activity was measured using the O-dianisidine MPO (OD-MPO) assay according to Salter et 
al. (2001). MPO activity was expressed as the amount of enzyme necessary to produce a change in 
absorbance of 1.0 per minute and per gram of wet weight of tissue 
Digestive enzymes activity  
α-amylase was determined by using gelatinized maize starch as the substrate. The amounts of 
glucose released after incubation with portions of digesta were presumed to be directly proportional 
to the activity of α-amylase.  
Lipase activity was determined on the theory that the amount of standard sodium hydroxide 
required to neutralize fatty acids released from olive oil triacylglycerols is directly proportional to 
lipase activity. Digesta supernatant fractions (1 ml) were incubated with 3 ml olive oil 
triacylglycerols for 6 h at 37℃. The reaction was stopped by the addition of alcohol (950 ml/l) and 
titration performed with 0.05 M-sodium hydroxide solution. 
Pepsin content of the small intestine digesta was assayed by the method of Anson (1938). One unit 
of pepsin activity was equivalent to an increase in extinction at 280 nm of 0.001/min at 37℃. 
Trypsin activity was estimated in digesta of small intestine as described by Hummel (1959).  
 
5.4  Statistical analysis 
 
The data were analyzed using General Linear Model procedure of SPSS (15.0) software as a 4×2 
factorial arrangement with dietary treatments and challenge types (E.coli or saline) as main factors. 
The pooled growth performance was analyzed using ONE-WAY ANOVA procedure. The 
significance of differences among different treatments was evaluated by Least Significant 
Difference (LSD) post-hoc multiple comparisons test. Statistical significance was set at P <0.05. 
 
5.5  Results 
 
5.5.1 Growth Performance 
 
Table 3 shows the results on growth performance of piglets during the trial. There were no 
significant difference among treatments. During the first week FCR was better in Ctr and PP than 
PP + MOS but not compared to those fed MOS. During the second week of the trial FCR was better 
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in piglets fed only MOS or PP than those fed diet PP + MOS. Throughout the pre-challenge period 
(0-21 d) piglets fed Ctr or PP diets showed FCR values lower than those fed on PP+MOS (P<0.05). 
No effect of challenge and interactions between diet and challenge on growth performance were 
observed (Table 3). During the 4 days after the first challenge, there was a significant decrease in 
feed intake in PP and MOS groups compared to Control and PP+MOS groups, and feed efficiency 
in PP and MOS groups were higher than PP+MOS group (P<0.05). Two days after the E. Coli  
challenge, piglets fed MOS diet grew faster than those in Control and PP+MOS group (P<0.05). 
Body gain and FCR were lower in Control group compared to other treatment groups.  There was a 
sharp decrease of FCR in piglets during 25-28 days than 21-25 days. There were no differences of 
growth performance of piglets during 7 days after second challenge among all groups. Piglets fed 
PP and MOS diets had improved FCR during 7 days post primary challenge, FCR was higher in 
MOS group than Control group during 12 days post challenge (P<0.05). Since there were no 
challenge effect on growth performance. There were no significant difference among groups during 
35-42 d, dietary PP and MOS had improved feed efficiency compared with PP+MOS group during 
the period of whole 35 and 42 days (P<0.05) ( Table 3 ). PP dietary supplementation had higher 
FCR than others during the whole experiment period.  
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5.5.2. Blood parameters  
 
On d 25, no challenge effects and interaction of challenge and diet on plasma parameters were 
observed (Table 5). Dietary MOS enhanced peripheral blood RBC count, HGB content and PCV 
value compared with Control or PP+MOS diet (P< 0.05).  
On d 28, E. Coli challenge markedly increased blood PLT counts (P< 0.05). Dietary PP induced an 
increase of blood HGB content and PCV value compared with MOS or PP+MOS diet (P< 0.05).  
On d 35, challenge partially increased peripheral blood PLT counts (P= 0.081). Dietary PP induced 
a significant reduction of blood PLT content compared with control or MOS diet (P< 0.05). There 
were no interactions of diet and challenge on haematological profile. 
Table 5 haematological profile in piglets post infection  
 
Diet CT PP MOS PP+MOS SEM Diet Challenge P value 
Challenge 
 
Saline challenge 
 
Saline challenge 
 
saline challenge 
 
Saline challenge  
 
CT PP MOS PP+MOS 
 
saline challenge 
 
diet challenge Interaction 
d 25                 
WBC 106/mL 13.77 13.67 11.65 13.25 12.64 12.34 14.16 11.15 0.575 13.72 12.45 12.49 12.65 13.06 12.60 0.844 0.699 0.573 
RBC 
(109/mL) 5.92 6.01 5.81 6.63 6.71 6.79 6.18 5.84 0.094 5.97b 6.22ab 6.75a 6.01b 6.16 6.32 0.034 0.399 0.217 
HGB(g/dL) 9.50 9.87 9.37 10.73 10.80 11.07 9.93 9.30 0.178 9.68b 10.05ab 10.93 a 9.62b 9.90 10.24 0.067 0.351 0.301 
PCV (%) 32.00 32.93 31.33 35.90 35.67 36.63 33.90 31.23 0.550 32.47b 33.62ab 36.15a 32.57b 33.23 34.18 0.103 0.400 0.187 
PLT 408.33 440.67 330.33 330.33 251.67 277.67 344.67 280.33 23.883 424.50 330.33 264.67 312.50 333.75 332.25 0.16 0.975 0.885 
d 28                 
WBC 106/mL 12.36 12.20 20.11 12.78 11.75 13.14 13.09 14.94 0.879 12.28 16.45 12.45 14.20 14.44 13.27 0.316 0.554 0.251 
RBC 
(109/mL) 6.39 6.41 8.75 7.13 6.50 6.21 6.08 6.53 0.271 6.40 7.94 6.36 6.35 7.01 6.57 0.124 0.515 0.578 
HGB(g/dL) 10.33 10.07 13.50 10.90 9.53 9.33 9.35 9.97 0.389 10.20ab 12.20a 9.43b 9.72b 10.80 10.07 
 
0.081 
 
0.443 
 
0.516 
PCV (%) 34.07 33.67 44.23 35.50 31.93 31.67 30.80 33.77 1.008 33.87ab 39.87a 31.80b 32.58b 35.66 33.65 
 
0.070 
 
0.516 
 
0.391 
PLT 302.67 564.33 231 454 224 450 346.50 441.67 32.922 433.50 342.5 337 403.60 269.64 477.50 
 
0.683 
 
0.008 
 
0.840 
Mono % 54 64 52.67 61.67 62.67 72.67 52 62.67 1.991 59 
 
57.17 67.67 58.40 55.64 65.25 
 
0.226 
 
0.025 
 
0.999 
d 35                 
WBC 106/mL 12.56 13.67 19.47 16.19 11.95 14.95 14.97 18.25 0.86 13.11 17.83 13.45 16.37 14.75 15.76 0.180 0.555 0.522 
RBC 
(109/mL) 6.10 5.87 6.34 6.67 5.66 6.03 6.28 6.33 0.11 5.99 6.51 5.85 6.30 6.11 6.23 0.187 0.562 0.765 
HGB(g/dL) 10.13 10.00 9.67 10.17 9.37 9.97 9.50 10.07 0.15 10.07 9.92 9.67 9.74 9.65 10.05 0.814 0.224 0.810 
PCV (%) 34.20 33.90 33.33 33.63 31.90 33.50 32.23 34.07 0.49 34.05 33.48 32.70 33.01 32.86 33.78 0.805 0.393 0.841 
PLT 365.00 480.67 212.00 287.67 273.67 340.00 363.75 500.33 26.58 422.83a 249.83b 306.83ab 422.29a 308.23 402.17 0.069 0.081 0.959 
*Note: Data in the same line with different superscripts differ significantly (P<0.05).  
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5.5.3 Antioxidants 
Plasma antioxidant activities 
At d 21 (before challenge), piglets fed PP diet had decreased plasma MDA level (P< 0.05) 
and higher TAOC compared to Control and PP+MOS (P< 0.05) (Table 6). There were no 
other difference with regard to plasma antioxidant enzymes among groups.  
Challenge did not induce any effects on plasma antioxidant properties on d 4 post infection 
(Table 5). Dietary PP or MOS induced a significant increase of GPx activity compared to 
Control or PP+MOS treatments (P= 0.003). No interactions between diet and challenge 
were observed.  
Challenge tended to increase plasma MDA content (P= 0.078), and decreased plasma 
TAOC (P< 0.05) and CAT activity (P< 0.05) at 7 d post infection. There was no difference 
due to dietary treatments on plasma antioxidant activity. No interactions between diet and 
challenge were also found. 
At d 35 on trial  there was a reduction in plasma TAOC (P< 0.01). Dietary PP or MOS 
increased TAOC with respect to PP+MOS treatment (P< 0.05). PP or PP+MOS dietary 
supplementation markedly increased CAT activity compared with Control or MOS groups 
(P< 0.01). No interactions between diet and challenge was also found. 
E. Coli challenge tended to increase at d 25 (P= 0.077) or increased at d 28 (P= 0.01) 
plasma ceruloplasmin values (Table 7). At d 28 dietary supplementation with PP, MOS 
and PP+MOS did not inhibit the increase of ceruloplasmin expected from challenge, but 
comparatively decreased ceruloplasmin contents were observed in dietary PP ( P= 0.066) 
and PP+MOS (P= 0.066) treatments with regard to Control. 
 
 
 
 
 
 
 
 
 
103 
 
104 
 
Table 6 Antioxidant properties ( activity/mL) 
 Diet Challenge P 
  Ctr PP MOS PP+MOS NaCl. E.coli Diet Challenge 
7d         
MDA 5.08 3.64 3.71 3.81 / / 0.305 / 
TAOC 18.84 17.67 18.06 19.32 / / 0.537 / 
CAT 16.34 18.89 18.09 12.17 / / 0.565 / 
GPx 403.75 380.97 414.06 458.27 / / 0.377 / 
TSOD 102.75 94.42 75.75 103.29 / / 0.420 / 
         
21 d         
MDA 3.64 1.93 3.64 3.79 / / 0.076 / 
TAOC 17.73 b 22.08 a 19.91 ab 18.18 b / / 0.060 / 
CAT 16.37 27.41 17.22 32.25 / / 0.252 / 
GPx 396.87 410.04 384.4 452.89 / / 0.458 / 
TSOD 96.96 102.73 102.89 90.86 / / 0.383 / 
         
25 d         
MDA 3.68 2.33 4.09 2.73 2.69 3.73 0.177 0.102 
TAOC 19.55 21.39 20.28 21.64 20.90 20.55 0.684 0.799 
CAT 9.11 17.98 7.53 18.22 15.26 11.08 0.169 0.276 
GPx 348.21B 449.09A 485.56A 364.45B 405.19 418.47 0.003 0.601 
TSOD 97.34 101.65 97.79 94.73 100.86 94.89 0.712 0.175 
         
28 d         
MDA 3.64 2.93 4.24 3.27 2.93 4.11 0.509 0.078 
TAOC 24.77 23.75 27.02 22.58 27.59a 21.4 7b 0.678 0.047 
CAT 11.43 12.83 14.74 17.33 17.94a 10.23b 0.581 0.025 
GPx 494.83 467.78 394.14 486.75 446.97 474.78 0.215 0.446 
TSOD 97.21 100.23 99.38 95.46 97.92 98.22 0.586 0.911 
         
35 d         
MDA 8.95 6.33 8.09 7.91 7.76 7.88 0.571 0.933 
TAOC 20.78 22.78 22.80 18.76 22.71a 19.84b 0.091 0.031 
CAT 10.61B 18.01A 7.71B 18.96A 15.09 12.73 0.003 0.238 
GPx 630.64 621.58 623.05 642.27 640.86 617.91 0.922 0.347 
TSOD 89.88 92.34 89.78 94.55 91.06 92.31 0.738 0.737 
 
a,b = P< 0.05 
A,B = P< 0.01 
 
Table 7  Plasma ceruloplasmin content (mg/L) post challenge 
 
 
Diet CT PP MOS PP+MOS SEM Diet Challenge  P value 
Challenge NaCL Chal. NaCL Chal. NaCL Chal. NaCL Chal.  CT PP MOS PP+MOS NaCL Chal. diet Chal
. 
Int. 
d 28               
Ceruloplasmin 62.59 75.97 51.07 66.25 55.43 64.88 55.05 62.04 1.626 69.28 58.65 60.16 58.55 56.03 67.29 0.10 0.01 0.87 
d 35                 
Ceruloplasmin 85.09 71.05 75.75 72.86 75.97 76.02 64.39 72.09 3.146 78.07 74.30 75.99 68.24 75.30 73.01 0.72 0.72 0.60 
 
*Note: Data in the same line with different superscripts differ significantly (P<0.05). 
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Plasma superoxide anion and hydroxyl radical inhibiting capacity 
No main effects of diet, challenge and their interaction on plasma superoxide anion and 
hydroxyl radical inhibiting capacity were observed on  d 4 post infection (Table 8). On d 7 
post challenge, challenge decreased plasma superoxide anion (P< 0.05) and hydroxyl 
radical inhibiting capacity (P< 0.05). Dietary PP and MOS increased and plasma 
superoxide anion inhibiting capacity compared to Control group (P<0.05).  
Plasma superoxide anion inhibiting capacity was not influenced at d 13 post infection, diet, 
challenge and their interactions did not affect; piglets fed PP dietary supplementation had 
higher plasma hydroxyl radical inhibiting capacity than Control (P<0.05). No interaction 
between diet and challenge on plasma hydroxyl radical inhibiting capacity were observed. 
 
 
Table 8  Plasma superoxide anion and hydroxyl radical inhibiting capacity (U/L) 
 
  Superoxide anion inhibiting ability  Hydroxyl radical inhibiting ability 
Diet Challenge d 25 d 27 d 34  d 25 d 27 d 34 
CT Saline 187.38 183.43 181.90  595.85 683.55 543.05 
 Challenge 185.49 170.87 173.69  657.15 529.50 565.94 
PP Saline 195.04 188.53 171.78  897.92 684.46 697.24 
 Challenge 183.19 179.10 162.80  634.54 571.55 740.56 
MOS Saline 181.65 191.77 162.20  725.05 693.31 656.80 
 Challenge 186.88 184.81 170.04  792.38 683.20 638.61 
PP+MOS Saline 185.92 178.45 174.60  620.49 658.20 617.12 
 Challenge 187.20 172.04 171.12  761.77 562.01 686.85 
SEM  1.714 1.160 2.217  39.85 18.55 20.46 
554.49 b Diet CT 186.43 177.15b 177.80  626.50 606.52 
 PP 189.12 183.82 a 168.19  766.23 628.01 718.90 a 
 MOS 184.26 188.29 a 166.12  758.71 688.25 647.70 ab 
 PP+MOS 186.56 175.88 b 172.86  691.13 610.10 651.99 ab 
Challenge Saline 187.50 185.74 172.62  709.83 682.71 628.55 
 Challenge 185.69 177.13 170.01  711.46 583.74 657.99 
P Value 
Diet  0.800 0.005 0.250  0.580 0.394 0.079 
Challenge  0.605 0.002 0.481  0.984 0.016 0.482 
Interaction  0.365 0.795 0.523  0.315 0.708 0.891 
*Note: Data in the same column with different superscripts differ significantly (P<0.05). 
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5.5.4 Plasma metabolites  
 
No dietary treatment effects on plasma total cholesterol were observed. Dietary MOS 
decreased plasma total triglyceride content at d 7 of the experiment, and there were no 
difference at d 21 among treatments (Table 9). 
There were no differences in plasma total protein in piglets fed treated diets during pre-
challenge phase (Table 9). At 7 days, piglets from PP showed a lower PUN value than  
piglets fed PP+MOS (P< 0.05). With regard to plasma lysozyme activity, piglets fed 
PP+MOS diet had a decreased lysozyme content compared to other piglets (P< 0.05). 
During challenge there were no main effects of diet, challenge and their interactions on 
plasma urea nitrogen content in piglets (Table 10).  
Challenge did not affect plasma lysozyme content. Dietary PP increased plasma lysozyme 
activity compared to PP+MOS supplementation on d 28 (P< 0.05). No interactions 
between diet and challenge on plasma lysozyme content existed (P>0.05).  
 
Table 9 Plasma metabolites (mg/L) pre challenge 
 
Item CT PP MOS PP+MOS P value
Total cholesterol 
d 7 66.22±8.73 56.74±14.09 63.44±7.16 52.32±25.95  0.432 
d 21 69.02±7.88  85.01±11.27  81.81±15.03  75.18±8.60  0.120 
 
d 7 43.69±23.68 a 32.41±10.9 a b 15.36±9.11 b 43.51±19.12 a  0.031 
d 21 25.78±5.74 37.72±25.44 39.26±17.58 24.23±12.42  0.031 
Total protein (mg/mL) 
d 7 35.45±5.40 37.91±4.23 40.78±7.30 37.58±4.35 0.428
d 21 37.69±1.48 38.58±3.24 41.66±4.53 38.69±3.35 0.219
Urea nitrogen (mg/L) 
d 7 68.00±18.59 ab 53.18±17.96 b 80.70±25.20 ab 92.39±31.81 a 0.058
d 21 43.57±14.90 34.25±17.25 52.84±14.08 49.52±13.89 0.247
Lysozyme (µg/mL) 
d 7 6.53±0.58 a 6.69±0.46 a 6.40±0.48 a 4.87±1.89 b 0.027
d 21 6.66±0.51 6.33±0.71 6.81±0.33 5.66±1.75 0.222
*Note: Data in the same line with different superscripts differ significantly (P<0.05).  
 
Table 10  Plasma urea nitrogen (mg/L) and lysozyme content (µg/mL) post infection  
 
 
Diet CT PP MOS PP+MOS SEM Diet Challenge  P value 
Challenge Saline Challenge Saline challenge Saline challenge Saline Challenge  CT PP MOS PP+MOS saline challenge diet challenge Interaction 
d 25                  
Urea 
nitrogen 46.99 51.72 41.92 58.10 65.06 50.60 50.04 49.98 3.48 48.88 50.01 57.83 50.01 51.00 52.68 0.791 0.822 0.473 
Lysozyme 6.50 6.87 7.07 6.84 6.60 6.74 6.42 6.73 0.098 6.68 6.95 6.67 6.57 6.64 6.80 0.567 0.449 0.707 
d 28                 
Urea 
nitrogen 42.79 58.29 39.35 40.67 63.71 50.94 64.08 45.55 3.01 50.54 40.02 57.32 54.81 52.48 48.87 0.226 0.556 0.228 
Lysozyme 6.23 6.63 7.05 6.50 5.70 5.84 5.28 4.97 0.213 6.43ab 6.72 a 5.77 ab 5.09 b 6.05 5.986 0.083 0.854 0.864 
d 35                 
Urea 
nitrogen 91.20 61.88 64.78 69.26 84.94 71.55 75.83 74.68 4.881 76.53 67.02 78.24 75.25 79.19 69.34 0.853 0.328 0.632 
Lysozyme 6.71 5.60 6.72 6.59 6.63 6.40 6.21 5.97 0.144 6.15 6.67 6.51 6.09 6.57 6.14 0.461 0.156 0.600 
 
*Note: Data in the same line with different superscripts differ significantly (P<0.05).  
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5.5.5 Enzyme activities  
 
Ileal inflammatory enzyme activity and nitric oxide production 
On d 25, challenge led to a comparative enhancement of iNOS activity (P= 0.052) and NO 
production (P= 0.063), and significant increase of ileal activity of MPO (P= 0.001). No 
dietary effects and interactions between diet and challenge were observed (table 11).  On d 
28, challenge significantly increased ileal activities of iNOS, MPO, and NO production 
(P< 0.05). Dietary PP or PP+MOS significantly inhibit the increase of iNOS activity and 
NO production following challenge compared to control (P< 0.05). Dietary PP or MOS 
markedly suppressed the elevation of MPO activity post infection (P< 0.05). No 
interactions on the enzyme activity and NO production were observed. 
 
Table11 . Enzymatic activity and iNOS production (activity/mL) 
 Diet Challenge P 
  Ctr PP MOS PP+MOS NaCL E.coli Diet Challenge 
25 d 
MPO 0.38 0.33 0.33 0.37 0.25B 0.46A 0.799 0.001 
iNOS 1.02 0.95 1.00 0.99 0.84 1.14 0.983 0.052 
NO 4.60 3.21 5.85 2.25 2.45 5.51 0.360 0.063 
35 d 
MPO 0.36a 0.22b 0.24b 0.30ab 0.23b 0.33 a 0.045 0.014 
iNOS 0.98 0.81 0.93 0.94 0.73b 1.09 a 0.077 0.021 
NO 3.92 2.79 3.12 2.99 2.43B 3.99A 0.085 0.001 
 
a,b = P< 0.05 
A,B = P< 0.01 
 
 Digestive enzymes activity  
There were no significant difference in pH in stomach and small intestine digesta among 
treatments (Table 12). Dietary PP enhanced lipase activity compared to MOS and 
PP+MOS treatments (P<0.05). Trypsin activity in CT and PP groups was markedly higher 
than that in PP+MOS group (P<0.05). No difference was observed with regard to amylase 
and pepsin activity among treatments.  
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Table 12 Digestive tract pH and enzyme activity 
 
Item CT PP MOS PP+MOS P value 
pH  
stomach  4.84±1.27 5.02±0.55 5.40±0.95 5.60±0.45 0.667 
Small intestine 6.07±0.76 5.91±0.52 6.23±0.29 6.06±0.23 0.885 
Digestive enzyme activity (U/mg prot) 
Amylase   226.88±93.48 393.93±169.87 370.27±88.10 403.17±157.06 0.272 
Lipase  3.95±1.49 ab 5.97±1.91 a 3.39±0.75b 3.04±0.87 b 0.039 
Trypsin 241.96±53.61 a 243.47±40.92 a 181.20±23.11 ab 148.27±34.74 b 0.013 
Pepsin  3.97±1.74 4.34±1.77 4.71±1.55 4.54±0.83 0.910 
*Note: Data in the same column with different superscripts differ significantly (P<0.05).  
 
 
5.6  Discussion and conclusion 
 
Although some oligosaccharides and polyphenols are considered to be non-nutritive, 
interest in these compounds has arisen due to their possible beneficial effects on health. 
The ability of MOS to improve growth performance in piglets has been reported by several 
authors (Miguel et al. 2004; Rozeboom et al. 2005). It was observed that plant polyphenols 
supplemented in the diet at low dosage did not negatively affect the growth in chickens 
(Brenes et al. 2008) and pigs (Sehm et al. 2007). In the current study, feeding diets 
containing PP or MOS did not affect animal performance. Similar to our observations, 
Orban et al. (1997) did not observe changes of growth performance in piglets fed control 
diet or diet supplemented with either an antibiotic or an oligosaccharide, and a recently 
study in early weaned rabbits demonstrated that supplementation of the starter diet with 
MOS or inulin had no effect on growth of during the whole fattening period (Volek et al. 
2007). Miguel et al. (2004) reported that the growth promotion effect of a MOS (Bio-Mos) 
seemed to be pronounced in piglets that had a slow growth rate (< 180 grams per day) 
during the first 2 weeks postweaning. In the current study, Piglets gained more than 300 
grams per day during the second week post weaning, which demonstrated the diets were in 
high quality and piglets grew rapidly and healthily. The unexpected results of this study 
were that the dietary combination of PP and MOS impaired piglets’ growth performance, 
which suggested an unclear interaction between PP and MOS pending for further research. 
Our results indicated that E.coli challenge did not influenced negatively growth 
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performance in piglets. Oral inoculation of E.coli only partially reduced feed intake during 
21-35 d (P=0.117), 25-35 d (P=0.103), 28-35 d (P=0.104), suggesting a mediocre and 
chronic infection. The reason may be attributed to several factors, including diet quality, 
environmental conditions, health status within herd. In our research, the diets were in high 
quality, facilities and sanitary conditions were excellent. Thus the piglets were in good 
health status (with an average of around 5 log CFU E.coli and 5 log CFU clostridium in 
every gram of caecum content post infection, data not shown) and no piglets suffered from 
diarrhoea before the challenge and only one piglet undergone one day of slight diarrhoea 
after challenge in control group. And hence the infection resistance in the herd to E.coli 
challenge was higher. Similar to our results, no growth performance changes were 
observed in lambs after parenteral administration of E. coli O157:H7 (Demirel et al. 2007). 
Dietary PP or MOS decreased feed intake while improved feed efficiency during d 21-25, 
and improved feed efficiency during d 21-28. Furthermore, dietary MOS increased ADG 
during d 25-28, improved feed efficiency during d 21-35.  Unexpectedly, dietary PP+MOS 
didn’t exert effects on growth performance. There is little literature on dietary PP or MOS 
on growth performance in challenged piglets. It was reported by Demirel et al. (2007) that 
MOS fed lambs did not modify the growth after E.coli administration. While improved 
infection resistance effects of MOS were observed by Torrecillas et al. (2007) in Vibrio 
alginolyticus--infected European sea bass. Similarly, reduced gut associated lymphoid 
tissue (GALT) activation via the Peyer's patches in the ileum and improved health in 
piglets fed polyphenol rich apple pomace or red-wine pomace diet was reported by Sehm 
et al. (2007). These results suggested that dietary MOS or PP may increase the animal’s 
ability to cope with stress. In the current research, no detectable changes occurred in the 
levels of organisms in faeces and caecum content throughout the experimental period. 
Similar no impact results of dietary oligosaccharide on microbe population were also 
observed in other previous studies in piglets (Orban et al, 1996; van der Peet-Schwering et 
al. 2007). The lack of response of dietary supplements on microbial population would 
probably be ascribed to the nutritional balanced diet and the excellent facility or the health 
status of the piglets. No piglets suffered from diarrhoea in this study, suggesting that there 
were few problems with intestine health. It was possible that dietary treatments may affect 
other bacterial populations beyond those enumerated in this study. Dietary PP partially 
increased plasma total cholesterol content at 21 d in the present study (P<0.10). Less 
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accumulation of cholesterol in the aorta was observed in guinea pigs fed the grape diet 
(Zern et al. 2003). Apple polyphenols significantly decreased total cholesterol level in 
moderately obese adults (Nagasako-Akazome et al. 2007). Polyphenols decreased 
cholesterol in familial hypercholesterolemic swine (Metzger et al. 2009). Above studies 
were all performed in adult animals with comparatively higher basic cholesterol level 
compared with the current study using the growing piglets. More investigations are 
required to elucidate the effect of PP on cholesterol metabolism in growing animals. 
Effects of oligosaccharides on piglet blood lipid profile are not well defined. Results from 
Grela et al. (2006) showed that Fructooligosaccharides (FOS) and MOS addition lowered 
the level of total cholesterol distinctly and decrease triglyceride with tendency in piglets. 
Yalcinkaya et al. (2008) did not observed effects of MOS on serum triglyceride in broilers. 
MOS additive induced a transitory decrease of plasma triglyceride in the current study, 
different from the results of Santoso et al. (1995) and Kannan et al. (2005) in which MOS 
decreased serum triglyceride in broiler. The lower level of triglyceride was said to be due 
to increased level of lactic acid producing bacterial in the gut. Haematological analysis is 
one important adjuvant tool in the diagnosis of infection and its evolution. Oral inoculation 
of E.coli induced a significant increase of platelet(PLT) counts and monocyte percentage 
on d 7 post infection, and comparative increase of PLT counts on d 14 post infection 
(P=0.081), indicating the duration of transitional effects of infection. Limited information 
is available in the literature regarding the haematological changes in E.coli infected piglets. 
The increased platelet counts may be mediated by the activation of lipopolysaccharide 
(LPS), the major component of the outer membrane of Gram-negative bacteria such as 
E.coli or salmonella (Saluk-Juszcazk et al. 1999; Zielinski et al. 2001). Monocytes are the 
main cellular players responsible for the inflammatory response. Upon challenge, the 
activation of peripheral blood monocytes may enhance their attachment and or migration 
into infection sites and their various secretory and other functions such as phagocytic 
capacity of monocyte-derived macrophages, thus influencing the inflammatory reaction 
and pathogenesis (Kelley et al. 1998). Values of PCV, Hb and RBC generally fluctuate 
together, which make it advantageous in clinical practice that we could predict changes of 
Hb and RBC from the known value of PCV. Modern pigs are raised in confined house and 
have no access to obtain iron from soil and are susceptible to anemia. It was reported that 
pigs with access to an outdoor area had a 30% higher hemoglobin content in blood 
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(Chmielowiec-Korzeniowska et al. 2008). Increased blood HGB and RBC in piglets fed 
MOS diet on d 25 and increased HGB and PCV in PP fed piglets on d 28 demonstrated that 
the two supplements exerted favorable modulation in peripheral blood profile. 
Reactive oxygen species (ROS) and free radicals are generated and scavenged 
continuously within normal animal body and concentrations of ROS and free radicals 
maintain homeostatic. If ROS or free radicals are not removed in a timely manner by the 
antioxidant system, an imbalance between free radical generation and removal would lead 
to oxidative stress. Mammalian cells may encounter oxidative stress that causes destruction 
of macromolecules and abnormal function (Evans et al., 1997). The animals may show 
alteration of physiology and behavior and poor growth performance, or even suffer from 
various kinds of diseases under the condition of excessive ROS presence. Antioxidant 
enzymes such as glutathione superoxide dismuthase (SOD), peroxidase (GSH-Px) and 
catalase (CAT) play most important role in the antioxidant protective system. First, SOD 
converts superoxide anion to hydrogen peroxide in a cellular antioxidant reaction. 
Thereafter, GSH-Px and CAT independently detoxify produced hydrogen peroxide 
(Joeschke, 1995). In the present work, decreased systemic TAOC and CAT activity, 
increased MDA content were seen on 6 post infection, which indicated that the excessive 
release of ROS or free radical were beyond the scavenging capacity of antioxidant defense 
system. Increased TAOC and CAT activity in PP-fed piglets was observed on 14 d post 
infection, which suggested that dietary PP could enhance the capacity of scavenging free 
radicals and decrease the damage of tissues or cells due to infection. And the challenge 
effects on antioxidant defense system seemed to diminish thence.  In the current study, 
challenge led to a significant higher production of superoxide anion and hydroxyl radical 
generation in plasma due to challenge on d 28 which was perhaps due to increase of blood 
PLT counts. It is reported that bacterial LPS are able to activate blood platelet, and the 
activated platelets produce thiobarbituric acid-reactive substances, free radicals, and cause 
the secretion of the substances stored in platelet granules (Saluk-Juszcazk et al. 1999). 
Thus, the increased PLT counts may contribute the higher superoxide anion and hydroxyl 
radical production. Decreased plasma superoxide anion and hydroxyl radical inhibiting 
capacity on 7 d post infection were indicative of excess of ROS production in the 
inflammatory process. Excessive production of active forms of oxygen would damage the 
tissues of the macroorganism (Korkina et al. 1992). Enhanced plasma superoxide anion 
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and hydroxyl radical inhibiting capacity were seen in PP and MOS fed piglets on 7 d post 
infection and in PP fed piglets on 14 d post infection, which demonstrated that dietary 
supplement favorably affected the ability of animal to quench the ROS during challenge. 
Roles of potent scavengers of oxygen free radicals have been observed in polyphenols 
from apple (Lu and Foo, 2000), green tea (Salah et al. 1995; Unno et al. 2000), grape seed 
(Bagchi et al. 1997) and Olive leaves (Benavente-Garcia et al. 2000; Lee et al. 2009) in 
vitro. The present work confirmed the effects of plant polyphenosl mixture on superoxide 
anion inhibition and lipid peroxidation level reduction in animal challenge model. The 
current study indicated that dietary MOS may be also positively affect the antioxidant 
capacity of piglets since increased plasma GPx activity on d 25 and superoxide anion 
inhibiting capacity on d 28. Coincided with our results, previous studies had reported 
higher antioxidant activity in chickens and piglets fed MOS-supplemented diets (Zhou et 
al., 1999; Shao et al., 2000). Furthermore, oligosaccharides from agar were also shown to 
exert the in vitro and in vivo hepatoprotective effect through scavenging oxidative damage 
induced by ROS (Chen et al. 2006). As an acute-phase reactant, ceruloplasmin participates 
in inflammatory responses. An elevation of plasma ceruloplasmin concentration commonly 
accompanies pathological states include infection, trauma, surgery, tissue infarction and 
advanced cancer (Gabay and Kushner, 1999). Bacterial infection induced the increase of 
plasma ceruloplasimin concentration as part of the acute phase response, which is the 
natural response of body to extrinsic stimulation. However, excessive and long-term 
existence of ceruloplasmin is associated with injury of body. Comparable reduction in 
plasma ceruloplasmin in piglets fed PP and PP+MOS diets on 7 d post infection observed 
in the present study indicated that dietary PP was probably beneficial to shorten or 
overcome acute phase response. The ileum is a frequent site of involvement in necrotizing 
enterocolitis, a disease probably related to bacterial endotoxin (Hsueh et al. 1987). Due to 
its vulnerability to develop injury during bacterial challenge, we selected the ileum 
segment of intestine to examine the inflammatory response. During the early phase of 
infection, endotoxin and other bacterial by-products activated the primed neutrophiles, 
monocyte and macrophages, initiating a signal transduction cascade leading to the release 
of a number of pro-inflammatory cytokines and inducible enzymes such as: iNOS, 
inducible phospholipase A2 and the inducible cyclooxygenase (Lazarov et al. 2000), which 
would lead to a release of massive amounts of oxidants and cause further tissue damage. In 
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response to microbial invasion, MPO is released from the cytoplasmic granules of 
neutrophils and activated monocytes into the extracellular space and phagosome, where it 
generates hypocephalous acids that have a strong microbicidal effect. As an important 
component in degranulation material of leukocytes, MPO exert critical in animal innate 
host defenses and is used as a marker of inflammation caused by disease such as asthma, 
systemic vasculitis or environment irritants (Sugiyama et al. 2001). The increased MPO 
activity post infection on d 28 may partly due to the secretion of monocyte in the 
peripheral blood. The inhibition on the elevation of MPO activity due to E.coli infection in 
PP and MOS fed piglets suggested that dietary PP and MOS have the potential to alleviate 
the inflammatory response of the intestine. Although there was a marked elevation of ileac 
MPO activity on d 25, we didn’t observe the corresponding change of neutrophile or 
monocyte in peripheral blood. This may be related to the fact that the hematological and 
biochemical indices of pigs are affected by a broad range of environmental and 
physiological factors including nutrition, age, sex and zootechnical conditions. During the 
phase of infection, challenge induced significant elevation of MPO activity, suggesting the 
infiltration of neutrophils. On d 28, although the main effect of challenge on MPO activity 
was significant, the elevation of MPO activity was mainly from the Control group, and the 
MPO activity in challenged piglets fed PP and MOS diets retrieved to the normalcy.  Nitric 
oxide produced by iNOS is a central effector molecule in the innate immune system, and 
its primary function in host defense appears to be to damage and destroy pathogens 
(Nathan et al. 2000). Thus, nitric oxide is produced by the body to fight infections, whereas 
the excess production of NO in the subsequent or lasting phase is involved in cellular 
damage, tissue and .organ dysfunction (Liang et al. 1999).Activated neutrophils and 
macrophages express iNOS, and produce excessive amounts of NO, which play key roles 
in infection pathogenesis (Tsukahara et al. 2001). In the present study, challenge induced 
elevations of iNOS activity and subsequent NO production, indicating the involvement of 
inflammatory response. The reduced elevation of iNOS activity and NO production due to 
challenge on d 28 in PP fed piglets suggested that dietary PP might be beneficial to the 
local gut immunity and inflammatory response of the body. Our results showed that dietary 
PP had the potential to reduce the duration of enteric infection. On the 14th day post-
infection, judged by the antioxidant property and haematological profile, the effects of 
E.coli infection started to diminish. Only blood PLT counts and TAOC were negatively 
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affected in challenged piglets than the controls (P<0.05). Other parameters were not 
significantly affected. The results suggested that by the 14th day post infection, the 
systemic antioxidant defense capacity was beginning to recover. This was consistent with 
the similar growth performance subsequently. In this study, dietary PP inhibited the 
elevation of MPO and iNOS activity and NO production on 7 d post infection, suggesting 
the potential to reduce the duration of ileac inflammatory response. This was in agreement 
with the comparatively enhanced growth performance during the period d 35 to 42.  
Plant extracts and prebiotics represented typically natural origin components that favorably 
affect the growth of animals and are being widely used in EU. Combination with 
synergistically acting components of natural origin seems to be a promising way for the 
efficient replacement of antibiotic growth promoter from the viewpoint of practice (Bomba 
et al. 2006). Synergistic effects were observed in the constituents of green tea extract on 
protection against experimentally induced cytotoxicity in renal cells (Hisamura et al. 
2008).In co-culture studies, a synergistic effect of the probiotic strains and the green tea 
extract was observed against both Staph. aureus and Strep. pyogenes (Su et al. 2008). 
However, in the present study, administration of PP and MOS together failed to exhibit the 
cooperative or synergistic action in piglets. Information about the combination of plant 
extracts and oligosaccharide in animal trial is little. Reasons for the unexpected results 
were not clear, and the following possibility may affect. First, in our study, the formulation 
for combination PP and MOS was obtained from in vitro results based on optimization of 
antioxidant and antimicrobial activity. It was possible that the results of in vitro vary a lot 
with animal trial. Second, metabolites of PP and MOS in the animal body may react and 
form some deleterious substances which may impair or burden the innate immune system, 
since the decreased plasma lysozyme was observed on d 28. Third, the diet and the dosage 
may also affect the response of piglets to dietary manipulation. Our results may remind of 
the caution of the specious synergistic action between feed additives with their respectively 
beneficial effects in practice. Further studies are needed to elucidate the interaction of plant 
polyphenols and MOS in the piglet diet. In conclusion, this study demonstrated that dietary 
supplementation of PP or MOS did not substantially improved piglets’ growth 
performance. Dietary PP reduced systemic lipid peroxidation, enhanced the antioxidant 
defence system. Piglets fed diet with addition of PP in conjunction with MOS were 
characterized by the lower activity of digestive enzyme and lysozyme, higher plasma urea 
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nitrogen, and the inferior feed efficiency. The unfavourable responses of combination of 
PP and MOS might be indicative of some unclear interactive effects between the two 
additives. Growth performance was not a better indicator of degree of challenge than 
plasma antioxidant capacity and inflammatory enzymes. Administration of plant 
polyphenols and mannan oligosaccharide had the potential to improve feed efficiency 
during infection, while combination of PP and MOS had no effect. Dietary PP and MOS 
favourably affected the systemic antioxidant capacity by enhancing the GPx activity and 
TAOC. Dietary PP shortened the ileac mucosa inflammatory response via inhibition the 
elevation of MPO and iNOS activity and NO production. Further studies are warranted to 
clarify the mechanisms underlying the role of dietary PP and MOS on antioxidant capacity 
and gut health modulation as well as the interaction of PP and MOS in weanling piglets. 
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6.1 General discussion 
 
Weaning period is characterized by a marked reduction of volume of feed intake, poor 
growth and development, diarrhoea and increased risk of disease, particularly from 
enterotoxigenic E.coli (ETEC). The hypothesis is that the reduction of feed intake 
following weaning is critical in determining subsequent gut development, growth, 
maturation of gut-associated lymphoid tissue and related disease susceptibility (Pluske et 
al., 1997; Van Beers-Schreurs et al.,1998; Sprewenberg et al., 2001; Vente Spreuwenberg 
et al. 2003). A relationship between feed intake (FI) after weaning and villus height has 
been reported and it was speculated that this relationship may affect the overall efficiency 
of nutrient capture and utilisation (Pluske et al. 1997). It is also recognised that feed intake 
in pigs is highly variable following weaning. Our data confirmed that growth performance 
are clearly affected by weaning. In the trial that had the aim to determine the effects of 
dietary supplementation of rice milk on piglets growth and health status we evaluated for 
the use of a product rich in sugars and antioxidants in the nursing and nursery piglets and 
we saw that piglets growth was higher when litters were fed rice milk until weaning. The 
higher growth of piglets supplemented with rice milk only during nursing period may be 
attributed to the higher supply of sugars before the weaning leading treated litters to reach 
a more and higher homogeneous weight at the end of the suckling period compared to 
litters fed the creep feed.  
Also dairy products are known to have a beneficial effect on the gut-lymphoid associated 
tissue of the weaning piglets (Politis et al., 2007) and this was one of the principle of the 
first trial. This trial was designed with the aim to determine the effects of a new delivery 
system designed for oral vaccination or delivery of bioactive molecule in the gut.  The trial 
was also designed to evaluate the potential of the sow’s milk to modulate the systemic as 
well as local immune response against the antigen ovalbumin incorporated in the vaccine. 
Until now, a small  number of papers have been published to investigate the effect of oral 
vaccination with Ovalbumin (OVA), Sow’s milk (SM) and Flagelline (FLA) on humoral 
immunity in weaned piglets. Our results indicate, although the overall level of specific 
immunoglobulin was low, that the vaccination with OVA+FLA+SM influenced feces IgA-
G levels and was accompanied by enhanced serum IgG concentrations in weaned piglets. 
The action of these three compounds together determined higher response of the piglets 
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humoral immune system compared to other treatments. Others authors demonstrated the 
immune stimulatory action of milk to post weaned piglets and also in the current study the 
mechanism by which this vaccination enhanced immunoglobulin levels may be attributed 
to the immunostimulatory action of the peptide contained in the milk Politis et al. (2007). 
Interestingly, introduction of these bioactive compounds to the immunological immature 
neonatal gastrointestinal tract may potentiate an inappropriate immune response. Immune 
stimulation accumulates in the partitioning of nutrients from normal growth to support 
components of the immune response improving also growth performance of the animals 
(data not shown) during a critical phase as the weaning. Others author also reported the 
positive effects of these bioactive compounds such Spray dried plasma on the growth 
performance of the weaned piglets, modulating also the microflora increasing the number 
of lactobacilli in ileum and caecum (Torrallardona et al. 2003). 
In the last trial of this work  attention was focused to the stress that piglets face off at 
weaning in association with a challenge with E. coli during a dietary treatment of 
mannanooligosaccharides (MOS) and a mixture of Plant Polyphenols (PP). The use of no 
fermentable carbohydrates could enhance colonic microbial stability and diversity, with 
concomitant stimulation of the growth of Lactobacillus sobrius, a novel and beneficial 
member of the porcine commensal microflora (Konstantinov et al., 2004a). Nutritional 
supplementation (PP or MOS) improved feed efficiency in presence of E.coli challenge. 
Dietary PP or MOS had the potential to improve the antioxidant property, and dietary PP 
favorably modulated gut mucosa inflammatory response induced by E.coli infection. 
(Konstantinov et al. 2004 a; 2006 b). In the study presented no positive effect were shown 
on the microflora of the treated animals. Increased intake of prebiotics creates more 
favourable lumen conditions for gut health but direct evidence for enhanced resistance to 
unfavourable conditions is still lacking. Empirical evidence suggests that plant extracts 
may offer benefits in boosting the immune system; thus preventing disease in production 
animals and plant derived products have gained increased interest as possible as feed 
additives for non-ruminant species (Wenk 2003; Windish et al. 2008). Plants, and where 
they have been indentified their bioactive components, are very different and their 
potential to enhance pig health and immunity has only been scarcely evaluated in vivo. The 
study we conducted with or without MOS included the treatment with or without mixture 
of polyphenols from plant extract which does not allow the investigation of the immune 
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properties of a specific bioactive component; in fact this mixture was derived from a study 
in vitro using a large number of plant extracts to understand which could have more 
interesting results on the oxidative stress. The overall results demonstrated that dietary PP 
had the potential to enhance systemic antioxidant capacity, while dietary PP+MOS was 
adverse to growth probably due to some unclear interactions.  
To conclude, weaning period in pigs is complex and its nutritional control is not easy to 
achieve. However important progress has been made in understanding this complexity at 
the GIT level, with reference to the physiology, microbiota and local immune system. By 
contrast there is still the need for a basic knowledge on the functional foods to understand 
exactly their mechanism before to use these substances in commercial diets. 
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7.1 Summary 
 
At weaning piglets faces three challenges. First there are major changes to its food supply. 
Not only the piglets have to find the new food from a creep feeder but the characteristic of 
this feed are completely different from the sow’s milk. The second major challenge at 
weaning is the change of the physical environment. At weaning litters are generally mixed 
together into weaner pools. The third challenge is the physiological stress that accompanies 
moving and mixing. When all these changes are taken into account it is little wonder tat the 
rate of growth of the piglet falls after weaning (Pluske et al., 2000). 
Special diets and management schemes have been developed with the goal to overcoming 
the post-weaning syndrome in piglets (Zehn-Ping et al., 2007). Systems which use milk-
based liquid diets have demonstrated piglets growth performance comparable to that in 
suckling piglets (Kim et al., 2004; Lecce et al., 1969).  
Economic interests have a large impact on modern commercial pig production, and by decreasing 
the weaning age, the number of weaned pigs produced annually per sow have increased 
dramatically. Early weaning may have negative consequences, manifested as poor growth and 
PWD, because the pig’s GI tract is not fully developed at this young age. 
Related to the recent ban on in-feed antibiotics, many efforts have been made in the past 
years for optimizing further diet composition in terms of protein, AA and energy. 
Additional substances including bioactive molecules of milk, prebiotics, and compounds of 
plant origins with known antimicrobial properties have also been evaluated. It has become 
clear that diet supplementation with functional foods is probably the best way for 
preventing post-weaning gut disorders. Mainly of these compounds have also proven 
successful, acting on gut ecology and preventing outgrowth of pathogenic bacteria 
(Bontempo et al., 2007). However when these compounds play positive effects in vivo, 
their mechanisms of actions are still unclear, thus calling for additional work. 
Investigations in vitro, on the other hand, clearly show antimicrobial activity of the 
essential oils. They are supported by one or two mayor molecules or by more subtle 
synergistic interactions within the extract mixture. However, mayor discrepancies do exist 
between in vitro and in vivo results, the latter being variable and rather inconsistent. It 
appears that the diet itself may neutralize the antimicrobial activity of essential oils in vivo. 
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Finally the bioavailability and pharmakocinetics of these substances in pigs are  mostly 
unknown. This will undoubtedly constitute an area for future investigation.  
The aim of this PhD thesis was to evaluate the inclusion of different functional foods and 
strategy of oral vaccination in weaned piglets by different experimental approaches on 
growth performance, oxidative status, blood metabolites and gastrointestinal immune 
status. During past years research with animal models has identified different nutritional 
approaches that may modulate the production of key factors involved in the activation and 
regulation of innate and adaptive immunity. Development of new feeding strategies such 
as functional foods in the diet may influence the regulation of immune response decreasing 
the production of inflammatory factors, reducing the immunosuppressive effect caused by 
weaning improving the recovery of immune functions against pathogens. Nowadays there 
is much interest in the potential health benefits of functional foods such bioactive milk 
molecules and plant extracts as included in the diet of livestock. 
 In this chapter, due to the peculiarity of the three trials that were carried out during the last 
years, the results will be discussed separately. 
 
In the first study the aim was to evaluate the potential of the sow’s milk to stimulate the 
systemic as well as local immune response against the antigen ovalbumin incorporated in 
the vaccine in 4 groups of 4 animals each. Ovalbumin (OVA);  Ovalbumin and flagellin 
(OVA-FLA); OVA and sow’s milk (OVA-SM); (OVA-SM-FLA) to dosage the serum 
antibodies against OVA, IgA anti-OVA in feces, immunitary cells  cultivated with OVA  
to evaluate the response to the proliferation for cytometrie and the cytokines production 
Interleukine-2 (IL-2) and IL-4. Experimental animal studies have indicated that oral 
administration of antigens targets the systemic T cell compartment, diminishes cell-
mediated immune responses, and induces tolerance. This phenomenon might lead to the 
induction of cytokines such as TGF β and IL-10, and consequently enhance antigen- 
specific antibodies such as IgA and IgG. While the humoral immune response is critical in 
the control of some mucosal pathogens, its effect might be questionable on other mucosal 
pathogens where cell mediated immune responses may play a larger role. Until now, a 
small  number of papers have been published to investigate the effect of oral vaccination 
with OVA, SM and FLA on humoral immunity in weaned piglets. IgG and IgA, the major 
serum immunoglobulins, are key components of the humoral immunity in all mammals (Li 
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et al. 2007). Our results indicate that the vaccination with OVA+FLA+SM influenced 
feces IgA-G levels and was accompanied by enhanced serum IgG concentrations in 
weaned piglets. The action of these three compounds together determined higher response 
of the piglets humoral immune system compared to other treatments. In the literature is 
demonstrated the immune stimulatory action of milk to post weaned piglets and also in the 
current study the mechanism by which this vaccination enhanced immunoglobulin levels 
may be attributed to the immunostimulatory action of the peptide contained in the milk 
(Politis et al.,2007). Interestingly, introduction of these bioactive compounds to the 
immunological immature neonatal gastrointestinal tract may potentiate an inappropriate 
immune response. Immune stimulation accumulates in the partitioning of nutrients from 
normal growth to support components of the immune response improving also growth 
performance of the animals (data not shown) during a critical phase as the weaning. In the 
current study, the treatment with OVA+FLA or OVA+SM but not the combination of the 
two immunomodulator (OVA+FLA+SM) was able to enhanced MLN mRNA expression 
of IFN-Ɣ and IL-2, two important cytokines on the regulation of host immune response. 
Thus, the current results suggest that the oral vaccination with component such as milk or 
flagellin provokes a modulation of cytokine response in weaned piglets. The gut is a major 
immune organ in mammals. Specifically, the T and B lymphocytes proliferate and mature 
in the gut-associated lymphoid tissue (GALT), mounting a successful immune response to 
antigens. Many studies have shown that the GALT is composed of immune cells and 
lymph nodes, conferring both non-specific and specific immune functions (Poussier & 
Julius 1994). IFN-Ɣ probably plays a key role in activation, proliferation and 
differentiation of T-cells, as well as improving both specific and non-specific immune 
responses in weaned piglets. The enhanced expression of IL-2, which is important for 
primary T-cell activation, could result in a high immunostimulation following the 
treatment with the vaccine OVA+SM. It is likely that the increase of this cytokine 
production associated with the vaccination observed in this study contributed to higher 
antibody response improving the gut immune system. Further studies will explore the 
potential of these new diets strategies to prevent the negative impact of a pathogen 
challenge. In conclusion, oral vaccination could represent the future of the nutrition thanks 
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to its positive action directly on the gut health influencing humoral immune response in 
piglets, suggesting an enhancement of host defenses against presenting pathogens. 
 
The aim of the second trial was determine the effects of dietary supplementation of rice 
milk on piglets growth and health status. In the present study we evaluated for the first 
time the use of an alternative vegetable milk such rice in the nursing and nursery piglets. 
Characteristic of this product is beside the high level of glucose and maltose and high level 
of Ɣ-Oryzanol. In addition to its outstanding antioxidant activity, it has been demonstrated 
that Ɣ-Oryzanol has multiple neutraceutical functions, including reduction of total 
cholesterol, improvement of the plasma lipid pattern and inhibition of platelet aggregation 
(Juliano et al.,2005; Nam et al., 2008). Before and after weaning the piglets undergo a 
stress-related growth check, often associated with anorexia and under-nutrition, with 
predisposition to diarrhea and infection. Due to its richness in carbohydrates such as 
glucose and maltose rice milk may play an important role in nursery piglets thanks to its 
high palatability and sugars and antioxidant availability. Moreover carbohydrates present 
in rice milk may represent an important source of energy for the weaker piglets of litters 
which do not have enough strength to compete with the brothers for a correct consumption 
of maternal milk (Stephas et al., 1998). Piglets growth was higher when litters were fed 
rice milk until weaning. After weaning the positive effects of rice milk supplementation 
were reduced probably because the high palatability of the product favoured a high milk 
intake reducing dry feed intake. The higher growth of piglets supplemented with rice milk 
only during nursing may be attributed to the higher supply of sugars before the weaning 
leading treated litters to reach a more and higher homogeneous weight at the end of the 
suckling period compared to litters fed the creep feed. The richness of carbohydrates and 
its palatability make this product an interesting energy source rapidly available to evaluate 
during a critical period such as pre-weaning. In literature is reported that glucose can be a 
satisfactory energy source of carbohydrates such as lactose for the pig during its first week 
of life (Aherne et al., 1969). The availability of these substances can homogenize the 
weight of the litters giving more available energy to the weakest animals that can’t get 
enough energy from the sow’s milk.  
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However, it should be stated that rice milk is used in human nutrition since a long time, but 
it has a few chances to be used in animal nutrition due to the high production costs.  
In this study, also parameters related to oxidative stress were considered as it is well 
known that piglets are subjected to a high level of stress during weaning.   
Reactive oxygen species (ROMs) are very reactive molecules ranked as free radicals owing 
to the presence of one unpaired electron (Aruoma, 1994) such as a superoxide ion (O21 ±), 
nitrogen oxide (NO) and hydroxyl radical (HO± ). Even though naturally present in the 
organism, they are mainly connected to cell compartments and counterbalanced by natural 
anti-oxidant molecules, such as glutathione, glutathione peroxidase, superoxide dismutase, 
Q coenzyme, vitamin E and vitamin C, acting as free radical scavengers (Miller et al., 
1993). Due to a genetic susceptibility, the early weaning pigs are quite exposed to 
oxidative stress which increase the amount of substrate for ROMs activity and thus the risk 
of lipid peroxidation (Nolan et al., 1995; Brambilla et al., 2002). The early detection of 
oxidative imbalance by simple and reliable methods is important to prevent such 
consequences. The positive action on the parameters such ROMs and the oxi adsorbent test 
of the animals fed rice milk can be explained by the presence of the Ɣ-Oryzanol. Infact is 
demonstrated that Ɣ-Oryzanol is one of the major compounds that contributes to 
antioxidant improvement and regulation of antioxidant and oxidative stress related genes 
of stressed rat liver (Hiramitsu et al., 1991). Other studies demonstrated that Ɣ-Oryzanol 
up-regulates the antioxidant genes while down-regulates the oxidative stress genes marker 
(Maznah et al., 2010). The test to evaluate the antioxidant capacity of the piglets before 
and after a challenge such the weaning shown interesting data. The animals before weaning 
presented similar antioxidant capacity (evaluated by the oxy-adsorbent test and by ROMs) 
and after weaning the animals of the group that received the dietary supplementation with 
rice milk before and after weaning (TT) shown lower levels of ROMs compared to the 
animals of the animals that received the control diet in the nursing period (CC, CT)   
P< 0.05 while no differences where shown between the piglets of TC and TT groups. This 
confirm our hypotesis about the functionality of the rice milk supplementation in the pre-
weaning period.  
The animals of the control litters (CC; CT) shown higher value in the oxy-adsorbent test 
(P<0.05) compared to the animals of the TT group. This data are not easy to explain 
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because in the literature there are no studies on the use of this product in pig nutrition but 
seems to give a positive response that found confirm in the research on the activities of Ɣ-
Oryzanol. In conclusion, it can be postulate that rice milk supplementation might have 
positive effects in growth and feed intake during the immediate postweaning if 
administered from 10 d of age.  
This study suggests that the dietary supplementation during nursery period can improve the 
growth performance in the piglets after weaning. Therefore this product may be considered 
a functional foods for its richness of  bioactive compounds such as γ-oryzanol. More 
research will be needed to understand the potential of this functional food in piglets diet. 
 
Therefore the purpose of the third study was to determine the efficacy of plant poliphenols 
and/or mannanoligosaccharides on growth performance, haematological profile, 
antioxidant capacity and ileac inflammatory responses of post-weaning E.coli challenged 
piglets. Although some oligosaccharides and polyphenols are considered to be non-
nutritive, interest in these compounds has arisen due to their possible beneficial effects on 
health. Plant extracts and prebiotics represented typically natural origin components that 
favourably affect the growth of animals and are being widely used in EU. Combination 
with synergistically acting components of natural origin seems to be a promising way for 
the efficient replacement of antibiotic growth promoter from the viewpoint of practice 
(Bomba et al. 2006). Synergistic effects were observed in the constituents of green tea 
extract on protection against experimentally induced cytotoxicity in renal cells (Hisamura 
et al. 2008). In co-culture studies, a synergistic effect of prebiotic and the green tea extract 
was observed against both Staphilococcus aureus and Streptococcus pyogenes (Su et al. 
2008). However, in the present study, administration of PP and MOS together failed to 
exhibit the cooperative or synergistic action in piglets. Information about the combination 
of plant extracts and oligosaccharide in animal trial is little. Reasons for the unexpected 
results were not clear, and the following possibility may affect: first, in our study, the 
formulation for combination PP and MOS was obtained from in vitro results based on 
optimization of antioxidant and antimicrobial activity. It was possible that the results of in 
vitro vary a lot with animal trial. Second, metabolites of PP and MOS in the animal body 
may react and form some deleterious substances which may impair or burden the innate 
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immune system, since the decreased plasma lysozyme was observed on d 28. Third, the 
diet and the dosage may also affect the response of piglets to dietary manipulation. Our 
results may remind of the caution of the specific synergistic action between feed additives 
with their respectively beneficial effects in practice. Further studies are needed to elucidate 
the interaction of plant polyphenols and MOS in the piglet diet. In conclusion, this study 
demonstrated that dietary supplementation of PP or MOS did not substantially improved 
piglets’ growth performance. Dietary PP reduced systemic lipid peroxidation, enhanced the 
antioxidant defence system. Piglets fed diet with addition of PP in conjunction with MOS 
were characterized by the lower activity of digestive enzyme and lysozyme, higher plasma 
urea nitrogen, and the inferior feed efficiency. The unfavourable responses of combination 
of PP and MOS might be indicative of some unclear interactive effects between the two 
additives. Growth performance was not a better indicator of degree of challenge than 
plasma antioxidant capacity and inflammatory enzymes. Administration of plant 
polyphenols and mannanooligosaccharide had the potential to improve feed efficiency 
during infection, while combination of PP and MOS had no effect. Dietary PP and MOS 
favourably affected the systemic antioxidant capacity by enhancing the GPx activity and 
TAOC. Dietary PP shortened the ileac mucosa inflammatory response via inhibition the 
elevation of MPO and iNOS activity and NO production. Further studies are warranted to 
clarify the mechanisms underlying the role of dietary PP and MOS on antioxidant capacity 
and gut health modulation as well as the interaction of PP and MOS in weanling piglets. 
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